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ABSTRACT 
 
DEBJIT DUTTA: CHEMOSELECTIVE LIPOSOME FUSION FOR CELL-SURFACE 
AND TISSUE ENGINEERING APPLICATIONS 
(Under the direction of Dr. Muhammad Yousaf) 
 
Proper cell-cell communication through physical contact is crucial for a range of 
fundamental biological processes including, cell proliferation, migration, differentiation, 
and apoptosis and for the correct function of organs and other multi-cellular tissues. The 
spatial and temporal arrangements of these cellular interactions in vivo are dynamic and 
lead to higher-order function that is extremely difficult to recapitulate in vitro. The 
development of 3-dimensional (3D), in vitro model systems to investigate these complex, 
in vivo interconnectivities would generate novel methods to study the biochemical 
signaling of these processes, as well as provide platforms for tissue engineering 
technologies. Herein, we develop and employ a strategy to induce specific and stable 
cell-cell contacts in 3D through chemoselective cell-surface engineering based on 
liposome delivery and fusion to display bio-orthogonal functional groups from cell 
membranes. This strategy uses liposome fusion for the delivery of ketone or oxyamine 
groups to different populations of cells for subsequent cell assembly via oxime ligation. 
We demonstrate how this method can be used for several applications including, the 
delivery of reagents to cells for fluorescent labeling, the formation of small, 3D spheroid 
cell assemblies, and the generation of large and dense, 3D multi-layered tissue-like 
structures. We were also able to create dynamic and switchable cell tissue assemblies 
through chemoselective conjugation and release chemistry. Cell membranes are 
 iii!
decorated with a range of molecules that can be released in vitro for subsequent rounds of 
molecular conjugation and release. Each step to modify the cell surface: activation, 
conjugation, release, and regeneration can be monitored and modulated by non-invasive, 
label-free analytical techniques. Additionally, we also develop and demonstrate a novel 
liposome fusion based delivery strategy to incorporate a unique bio-orthogonal lipid that 
has the dual ability to serve as a receptor for chemoselective cell surface tailoring and as 
a reporter to track cell behavior. 
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CHAPTER 1 
 
Literature Review on Cell-Surface Engineering and it’s Applications 
 
1.1 Introduction 
 
Cell surfaces are fertile grounds for scientists to manipulate cell phenotypes and 
biological fates. These manipulations not only help to answer basic biological questions, 
but also serve roles in diagnostic and therapeutic applications. A number of synergistic 
approaches combining chemistry, material science and biology have been applied for 
direct engineering and manipulation of living cells. Desirable chemical functionalities 
and materials can be introduced onto the cell surface by covalent and noncovalent 
chemistry, as well as through specific biological recognition events, including 
antibody/antigen and ligand/receptor interactions. These strategies have been used in 
various applications that include designing biomaterial scaffolds1,2 to control cell fate, 
labeling cells with molecular and nanoparticle probes to image and visualize cellular 
processes and molecular pathways3-5, delivering diverse species into cells6,7, and 
patterning cells for drug discovery8-10. To date, cell-surface engineering has been 
primarily been achieved through the use of molecular biology and genetic engineering. 
However, perturbations of cellular physiology that are inherent to such strategies may 
interfere with significant cellular functions. Thus, there is a need of developing tools that 
will provide simple alternatives to genetic and biosynthetic pathways.  
Cell-surface modifications have been generally achieved using three methods: (1) 
covalent conjugation of surface protein amino groups, (2) incorporation of amphiphilic  
 2!
 
Table 1. Cell-Surface Modification techniques 
polymers into the lipid bilayer membrane of cells by hydrophobic interactions, and (3) 
electrostatic interactions between cationic polymers and a negatively charged surface.  
   Attempts have been made with various types of synthetic and natural polymers for the 
surface modifications of cells and biomaterials. Such methods are summarized in table 1. 
 
 Modification sites Treatment Cell Introduced functional 
groups or polymers 
Covalent bond Amino groups of 
membrane protein 
Membrane protein 
Chemical 
reaction 
 
 
Metabolic 
reaction 
Red blood cells, 
islets, peripheral 
blood 
mononuclear 
cells, murine 
splenocytes. 
Jurkat cells, 
HeLa cells, 
CHO cells 
PEG-NHS 
Biotin-NHS 
PEG-cyanuric 
chloride, Phosphine 
by Staudinger 
ligation 
Azide, biotin and 
ketone groups 
Electrostatic 
interaction 
Negatively charged cell 
surface 
Non-covalent 
reaction 
Islets, human 
fibroblasts, 
MCF-7 breast 
cancer cells, 
Mouse MSC 
Poly(diallyl dimethyl 
ammonium chlrode), 
Poly-L-lysine (PLL), 
Poly(ethyleneimine)  
Hydrophobic 
interaction 
Lipid bilayer membrane Non-covalent 
reaction 
Islets, HEK293, 
CCRF-CEM 
PEG-lipid 
PVA-alkyl 
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1.2 Covalent bond method 
     For the covalent conjugation of polymers, surface modifications of living cells have 
been achieved through chemical or enzymatic treatment or by metabolic introduction.10-19 
N-hydroxyl-succinimidyl (NHS) ester groups and cyanuric chloride are frequently used 
to chemically form covalent bonds to membrane protein amino groups. However, 
potential toxic effects may be exerted on membrane proteins.15-19 Enzymatic treatment 
and metabolic introduction have also been employed to add various functional groups, 
such as biotin, azido, and ketone groups to living cell surfaces.10-11 However, these 
technologies are limited to the introduction of specified small molecules to cells and may 
perturb cell physiology.12,13 Although covalent immobilization is expected to resist 
chemical degradation and be stable for long time periods, because of the covalent bond is 
formed with membrane proteins, the introduced polymer and functional groups disappear 
from the cell surface over time.14,16,22 
1.3 Hdrophobic interactions and cell-surface modification 
         Amphiphilic polymers, such as PEG-conjugated phospholipids (PEG-lipid) and 
poly(vinyl alcohol) bearing hydrophobic alkyl side chains (PVA-alkyl), have been used 
in cell-surface modification.12,13,20-26 In these methods, the hydrophobic alkyl chains of 
amphiphilic polymers are spontaneously anchored into the lipid bilayer membranes 
through hydrophobic interactions. These spontaneous insertions can be monitored by a 
surface plasmon resonance (SPR) when a PEG lipid solution is applied to supported lipid 
membranes that are formed on a SPR sensor. The spontaneous incorporation is greatly 
affected by the length of phospholipid alkyl chains, that is, their hydrophobicity. 
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1.4 Electrostatic interactions 
    Several groups have explored the possibility of constructing thin polymer membranes 
on the surface of cells through electrostatic interactions between negatively charged cell 
surfaces and cationic polymers and then further modified them using a layer-by-layer 
technique of anionic and cationic polymers.27-31 The ionic polymers that have been 
employed are poly(allylamine hydrochloride), poly(styrene sulfate), poly-L-lysine and 
poly(ethyleneimine). A layer-by-layer method is a simple and attractive technique to 
modify cell surfaces.32 The outermost layer of the polymer controls the surface properties. 
The thickness of the layer is also controllable by the number of polymer solution 
applications. Unfortunately, most polycations, such as PLL and PEI, were found to be 
extremely cytotoxic and severely damaged the treated cells. PEI, which interacts with 
cells, were not degraded and not excluded from the cell because PEI immediately 
destroyed the cell membrane after interaction with the cell surface. 
1.5 Bioactive substances immobilized through an intermediary molecule  
     Bioactive substances have been immobilized on cell surfaces. Two classifications of 
this method exist. The first strategy includes the immobilization of substances through an 
intermediary molecule, which is covalently bound to membrane proteins on the surface 
via amide bonding with hetero- or homo-bifunctional crosslinkers. In one example, biotin 
molecules were covalently bound to the amino groups of the proteins through 
crosslinkers. The surface was then sequentially treated with avidin and heparin solutions. 
Heparin was immobilized to the surface through an electrostatic interaction with avidin 
(isoelectric point of avidin, pI = 10). Phosphine molecules have also been covalently 
conjugated to amino groups of membrane proteins and then thrombomodulin was 
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immobilized using Staudinger ligation. The immobilization of serum albumin has been 
performed using PEG that was functionalized with NHS groups at both ends; was used 
for anchoring to the membrane protein amino groups and for the immobilization of serum 
albumin. These covalent modification methods have been reported to exert minor toxic 
effects on cell viability and cell functions.33 
The other method is formation of an intermediary polymer layer through hydrophobic 
interactions using amphiphilic polymers, such as PEG-lipid and PVA-alkyl, which bear 
various functional groups. The functional groups that are introduced on the cell surfaces 
through the amphiphilic polymers can be used for the immobilization of bioactive 
substances. In one example, PVA-alkyl presenting SH groups were used for the 
immobilization of bioactive substances displaying maleimide groups. By the same means, 
PEG-lipids presenting maleimide at the end of the PEG chain was also used for the 
immobilization of bioactive substances tethering SH groups without cytotoxicity.  
1.6 Dynamic surfaces for cell studies 
      Surface chemistry provides a useful approach to prepare customized model 
substrates.34,35 By using self-assembled monolayers (SAMs), it is possible to design 
model substrates36 with sufficient control over surface properties to potentially mimic 
cell-extracellular matrix (ECM) interactions.37-39 Introducing a dynamic aspect (i.e. the 
ability to modify the surface with an external stimulus) enables many further 
opportunities in designing surfaces for cell culture and the reversible control over surface 
properties.  
Dynamic control over SAMs for cell adhesion might provide an additional handle to 
direct and study the attachment of cells to surfaces. For example, SAMs would enable the 
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study of cell spreading from a predetermined pattern to screen the cytotoxicity of drug 
candidates.40 However, how to reversibly control the adhesion of cells to a dynamic 
substrates is not well understood. 
1.7 SAMs for cell adhesion 
         SAMs are spontaneously organized assemblies of molecules, formed by adsorption 
from the solution or the gas phase onto the surface of the solids.41-43 The molecules bear a 
terminus that has a specific affinity for a substrate, which is sufficient to displace 
preadsorbed materials. An extensive variety of functional groups that bind to specific 
metals, metal oxides, SiO2, and semiconductors are available.  
In vivo, most cells adhere to the ECM;44 conversely, in vitro, SAMs present a method to 
generate and study model substrates presenting specific ligands via which cells can 
adhere.45 The most important benefit of using SAMs for these studies, compared to 
methods that involve polymer films or adsorbed proteins, is the level of control over the 
exact composition of the substrate achievable via a predetermined approach. These are 
key aspects that are necessary for conducting mechanistic studies of cell immobilization 
and investigating intracellular signaling upon binding.  
1.8 Bioinert SAMs 
        Surfaces that are able to resist the nonspecific (physical) adsorption of biomolecules 
and cells are generally referred to as ‘bio-inert’ surfaces. Self-assembling compounds 
terminated with oligo- or poly(ethylene glycol) (OEG or PEG) units are used extensively 
to render surfaces inert to cell adhesion.46-50 However, the specific essential structural 
requirements to resist the adsorption of proteins and cells remain unclear.51 Nevertheless, 
there are several classes of SAMs that inhibit the adhesion of proteins and cells 
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effectively, including SAMs terminated with oligosarcosines, oligosulfoxides, 
perfluoroalkyls, or oligo(phosphorylcholine) groups.51-54 
Dynamic surfaces for immobilizing cells on-demand present new possibilities for 
studying the mechanistic pathways involved in responses to alterations in the cells’ 
immediate environment. Dynamic changes in the ECM affect cell behavior in several 
critical stages. Among these are the migration and differentiation of cells during the 
growth and spread of cancer. Our understanding of the dynamic processes, which occur 
in the ECM is limited due to their complexity, and hence, studying dynamic substrates 
that allow for explicit control over changes in the cell-adhesion properties may lead to 
improved understanding of the ECM as well as cell adhesion to surfaces. 
1.9 Cell-surface engineering: Applications and recent developments 
1.9.1 Cell Targeting: Delivery of systemically infused cells, particularly stem/progenitor 
cells, into damaged or diseased tissue holds enormous promise for treatment of a variety 
of disease worldwide.57 For instance, hematopoietic stem cell (HSC) transplantation (i.e. 
bone marrow transplantation), which has been used in clinic for several decades to treat 
blood diseases and cancer, requires systemically infused HSCs to home to the bone 
marrow from the blood. Mesenchymal stem cells (MSCs) are similarly believed to be 
home to various sites of inflammation and injury in the body after being systemically 
infused. MSCs are capable of differentiating into connective tissue cells types that can 
produce bone, cartilage, and fat, and produce immunomodulatory cytokines and are 
currently being tested in clinical trials for treatment of various diseases, including graft 
versus host disease, myocardial infarction, multiple sclerosis, and skeletal tissue repair. 
Unfortunately systemically administered therapeutic cells that are home to the target sites 
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at low efficiencies (typically < 1%), due to, at least in part, the lack of expression (or loss 
during culture expansion) of key homing receptors.58 Therefore, efforts have been made 
to introduce cell homing ligands onto cell membranes. Cell homing ligands (on the 
homing cell) and receptors (on the endothelium) allow homing cells to tether, roll, 
adhere, and then transmigrate on endothelium as part of the cell homing cascade. 
Methods include genetic59-61 and enzymatic engineering62 treatment with cytokines63 and 
chemical approaches.64,65 The Karp lab has recently developed a simple technology to 
chemically attach cell adhesion molecules to MSC surface to improve the homing 
efficiency of inflamed tissues. Their chemical approach involves the stepwise process 
listed below. 
1) Treat the cell amine groups with sulfonated biotinyl-NHS to introduce biotin 
groups on the cell surface; 
2) Add streptavidin, which binds to the biotin on the cell surface and presents 
unoccupied binding sites, and  
3) attach biotinylated homing ligands.  
In this model system, biotinylated sialyl Lewis X (SLeX), is a ligand that binds to P and 
E selectins, which are expressed on the inflamed endothelium and allows cells to roll on 
the endothelial layer. This ligand was conjugated on the MSC surface. The SLeX 
modified MSCs demonstrated a robust rolling response on a P-selectin coated substrate 
under shear stress conditions in vitro and on inflamed endothelium in vivo. In addition, 
homing ligands can be introduced onto the cell membrane using non-covalent chemical 
modification.66 In a recent work from Dennis and co-workers, MSCs were treated with 
palmitated protein G where the palmitate chain was incorporated into lipid bilayer  
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Figure 1.1 a) Schematic showing the targeting of cells from blood to inflamed 
endothelium expressing receptors that bind to ligands engineered on the cell surface. Two 
methods of engineering the homing ligand onto the cell surfaces, using covalent and 
noncovalent chemistry are shown in b) and c), respectively. b) A stepwise process of 
attaching SLeX to MSCs using biotin-streptavidin linkers and, c) incorporation of 
palmitated protein G into the cell membrane and subsequent conjugation with an ICAM-1 
antibody. 
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via hydrophobic interactions and protein G provides generic binding sites for antibodies. 
In a proof-of-concept work, intercellular cell adhesion molecule-1 (ICAM-1) was 
conjugated onto MSCs, which enabled the cells to bind to ICAM-1, a critical adhesion 
molecule expressed on activated endothelium. These chemical approaches to modify cell 
surfaces and immobilize required ligands are not limited to MSCs and the above-
mentioned ligands and should have broad implications on cell therapies that utilize 
systemic administration and require targeting of cells to specific tissues. Presumably, if 
we know which receptors are present on the endothelium in a targeted anatomical site, we 
could deliver cells specifically to that site by engineering the complementary ligands to 
the cell surface.  
1.9.2 Programmed cell-substrate and cell-cell assembly: The precise 3D arrangements 
and orientation of cells and their substrate (e.g., extracellular matrix) are key criterion in 
cell-based assays and microfluidic devices, as well as tissue engineering where one goal 
is to mimic the 3D complexity of native tissues.67 Towards this end, chemists and 
material scientists have begun to engineer cells with biorecognition moieties that are not 
possessed by native cells to control cell-cell and cell-substrate interactions.68,69 Francis 
and colleagues demonstrated the use of single-stranded DNA (ssDNA) to mediate cell 
adhesion on a substrate.70 In their work, ssDNA was attached onto cells via a Staudinger 
ligation reaction between azido (delivered to cell surface glycans via a metabolism 
process)71 and phosphine groups modified on ssDNA or by a simple NHS ester (on DNA) 
and NH2 (on cell surface).
72 The ssDNAs attached on cells directed the assembly of cells 
on complementary DNA-attached substrate via DNA hybridization. Such DNA-modified 
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cells can also be assembled on single cell level on microfabricated patterned sensor 
devices that may be used for single cell analyses, such as measuring cellular electrical 
and metabolic activation. In a more recent work from Mathies and co-workers,73 iridium 
oxide pH microelectrode arrays were patterned using lithography. The array was enclosed 
within a microfluidic channel on which ssDNA was attached using silane chemistry. 
Such devices could then capture complementary DNA-modified cells and measure the 
single cell metabolism using pH as an indicator. They demonstrated that such devices are 
able to discriminate between healthy primary T cells and cancerous jurkat T cells that 
have a higher metabolism.  
 The DNA-based approach can also be used for the programmable assembly of 3-D cell 
structure, which may find applications in synthesizing artificial tissues.74,75 Recently, 
Gartner and Bertozzi demonstrated the assembly of DNA-modified cells into 
microtissues in a well defined manner (i.e., structures were controlled by varying the 
DNA site density on the cell surface, cell concentration and DNA sequence). Briefly, by 
adjusting the stoichiometry (i.e., 1:50) of two Jurkat cell population that were modified 
with complementary DNA strands, single cell clusters were produced where the limiting 
cell type was surrounded by cells added in excess. Interestingly, using fluorescently 
labeled DNA, they showed that DNA strands are clustered at the cell-cell interface, 
confirming their specific role in cell-cell assembly. Significantly, such assembled cell 
clusters could be isolated and purified using flow cytometry and subsequently used as the 
core for further iterative cell assembly (i.e., adding another layer of DNA-modified cells). 
More importantly, the authors demonstrated that cells within the assembled microtissues 
communicate via a paracrine mechanism, which is a prerequisite for the development of 
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the therapeutically functional tissues. Specifically, in a proof-of-concept model, a CHO 
cell line engineered to express growth factor interleukin-3 (IL-3) was used as a first 
building block and the second was an untransformed hematopoietic progenitor cell line 
(FL5.12) whose survival and replication depends on the presence of IL-3. Cell 
composites were assembled using the above-mentioned and DNA and then embedded  
 
 
 
Figure 1.2 a) General schematic of multilayered cell assembly using DNA hybridization. 
b) Schematic of DNA hybridization between two cells (shown in red and green). c) 
Fluorescence image of a cluster of assembled cells (blue) with intercellular DNA linkages 
(green). Clustering of DNA crosslinkers cellular interfaces can be observed. d) Gating of 
assembled cells in fluorescence activated flow cytometry. e) Fluorescence image showing 
assembled cells isolated by flow cytometry. f) Fluorescence image of an assembled cell 
cluster from which (e)  a second assembly step occurred to acquire another layer of cells. 
 
within a 3-dimensional agarose matrix. After 16 h, the cell structures underwent 
accelerated growth due to the presence of IL-3. By contrast, when CHO cells lacking the 
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gene coding in IL-3 were used in the microtissue, FL5.12 cells showed no growth and 
instead underwent a morphological change corresponding to the absence of IL-3 induced 
apoptosis. Finally, other advantages of using DNA assembly in such systems include 
their reversibility and versatility with respect to engineering multiple orthogonal cell-cell 
interactions. In addition to ssDNA, self-assembled cargo-carrying DNA arrays can also 
be attached to cell surfaces. Reiche and colleagues attached hexagonal DNA arrays on 
cells using streptavidin and antibody as bridges.76 In their study, it was observed that one 
or two DNA array patches often attached to one cell, and that single DNA arrays often 
bridged cells. Occasionally, micron-sized DNA arrays seemed capable of binding to and 
enveloping multiple cells into larger cellular structures. These larger structures may have 
the potential to form the foundation for the construction of tissues or organs for 
transplantation in tissue engineering. 
Engineered cell-cell interactions in a bottom-up tissue engineering approach can also be 
achieved by attaching cell-adhesive polyelectrolyte patches on the cell surface. Swiston et 
al. recently used a photolithographic-patterning technique to engineer multilayer polymer 
patches containing a payload component (i.e., super-paramagnetic nanoparticles) onto T 
cell surfaces.77 The magnetic nanoparticles allowed cells to be spatially manipulated 
using an external magnetic field. Importantly, patch-functionalized cells could be 
programmed to assemble into sheets, rings, or cluster structures. Patches that are cell-
adhesive may allow the polymerization of cellular species, with individual cells being the 
monomers and the patches serving as bifunctional linkages, for construction of 
macroscopic, functional tissues. 
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1.9.3 Bioimaging and Sensing: One particularly important application of cell-surface 
engineering is to introduce sensing and imaging probes to visualize cellular and 
molecular events both in cells and living organisms. The Bertozzi group has pioneered 
the use of chemical reporters for such purposes with a focus on those that can be 
incorporated through metabolic pathways.78 
  
 
Figure 1.3 Overview of a cell functionalization scheme, using cell adhesive 
polyelectrolyte patches. In this particular example, cell adhesive region, payload region 
and release region are chitosan-hyaluronic acid, FITC-poly(allylamine hydrochloride), 
poly(methacrylic acid)-poly(N-isopropylacrylamide) respectively. a) A regular array of 
surface-bound patches spaced 50 µm apart. Payload regions are labeled green. After cell 
incubation and attachment, (b) a majority of the surface bound patches are occupied. Cell 
cytoplasm is labeled red. (c) After the temperature is reduced to 4 °C for 30 min, the 
patches are released from the surface while remaining attached to the cell membrane. 
Scale bars represent 25 µm.  
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An example of their technology is the engineering of chromatic polydiacetylene (PDA) 
polymer patches onto cell surfaces for imaging structural perturbations of the membrane 
bilayer.79 Specifically, vesicles comprising of diacetylene and lipid molecules including 
1,2-dimyristoyl-sn-glycero-phosphoethanolamine and 1,2-dimyristoyl-sn-glycero-3-
[phospho-rac-(1-glycerol)] were first formed in solution. These lipid vesicles were then 
fused with cell membrane and PDA was formed in situ upon UV-mediated 
polymerization. The conjugated PDA nanopatches on cells exhibited an intense blue 
color and underwent a blue-to-red color change upon structural perturbations of the cell 
membrane due to conformational transitions in the conjugated (ene-yne) polymer 
backbone. During this blue-to-red color transition, the initial non-fluorescent PDA also 
emitted fluorescence at 560 nm and 640 nm. The PDA nanopatches can therefore be used 
to visualize the cell bilayer perturbations induced by, for example, lidocaine, polymyxin-
B, cholesterol, and oleic acid and to screen toxic pesticides and other environmentally 
toxic small molecules.80 
1.9.4 Manipulating cell biological fate: One ultimate goal of engineering the cell surface 
is to use externally applied chemical moieties and materials to control cell biology. As an 
initial effort, Ingber and co-workers demonstrated the use of magnetic nanoparticles on 
cell membrane to regulate cellular signaling pathways.81 Specifically, mast cells express 
membrane Fc!RI receptors that can bind t the Fc region of IgE molecules. Multivalent 
antigens (dinitrophenyl DNP) that bind to IgE can then induce Fc!RI receptor 
oligomerization on cell membrane whereas monovalent antigens do not. The Fc!RI 
receptor clustering quickly triggers an intracellular signaling response characterized by a 
rapid rise of cytosolic Ca2+, which in turn leads to the local inflammatory response of 
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mast cells. Instead of using antigen ligand to induce such signaling pathway, Ingber and 
colleagues immobilized DNP-attached magnetic nanoparticles on IgE-tethered mast 
cells.82 The authors ensured that only one DNP molecule was attached on each particle so 
that receptor clustering did not occur. When an external magnetic field is applied, 
magnetic nanoparticles clustered on the cell membrane, which caused the oligomerization 
of Fc!RI receptors, a process that could be visualized by the local Ca2+ concentration 
change. Significantly, such magnetic nanoparticles mediated cellular signaling is 
reversible, switching on and off the magnetic field directly corresponds to a local Ca2+ 
concentration oscillation. 
 
 
 
Figure 1.4 Nanomagnetic control of receptor signal transduction. a) The biochemical 
mechanism that stimulates downstream signaling (left) involves the binding of multi-
valent ligands (represented by green hexagons) that induce oligomerization of individual 
IgE/Fc!RI receptor complexes. In the magnetic switch, monovalent ligand-coated 
magnetic nanobeads (dark grey circles), similar in size to individual Fc!RI receptors bind 
individual IgE/Fc!RI receptor complexes without inducing receptor clustering (centre). 
However, applying a magnetic field that magnetizes the beads and pulls them into tight 
clusters (right) rapidly switches on receptor oligomerization and calcium signaling. b) 
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The pseudocolored microfluorimetric image shows the local induction of calcium 
signaling (yellow) in cells near the tip of the electromagnet within 20 s of the field being 
applied. Scale bar represents 50 µm. c) Quantification of peak changes in intracellular 
calcium relative to time 0 measured within individual cells during a 1-min pulse of 
applied magnetic force as a function of the distance of the tip from the cell surface. d) 
Effect of a rapid cyclical magnetic stimulation regimen (40 s on, 20 s off) on intracellular 
calcium signaling. 
 
1.10 Membrane Fusion 
       Membrane fusion, one of the most fundamental processes of life, occurs when two 
separate lipid membranes merge into a single continuous bilayer. Experimental and 
theoretical studies83,84 concur that membrane fusion proceeds at least through two steps: 
membrane docking and actual fusion, resulting in the mixing of membrane lipids and 
membrane-bound contents. Fusion may occur upon close (1-2 nm2) docking of target 
membranes, driven by the binding of surface groups. Docking ‘strains’ the surfaces, 
allowing the lipids from the two membranes to mix and ultimately form a fusion pore that 
connects the two compartments. Insertion of a hydrophobic anchor into the lipid matrix 
can frustrate efficient lipid packing and activate the membrane toward noncovalent 
reactions, such as lysis and fusion. These reactions are essentially lipidic85 and are 
precisely controlled in nature by molecular recognition events. Much of our experimental 
data on selective membrane fusion has been gathered in studies of synaptic86 vesicle 
fusion machinery, as well as in viral membrane fusion machinery.87-89 Physical membrane 
deformation or insertion of a hydrophobic fusion peptide enables the formation of a high-
energy intermediate nonbilayer lipid surface90 that fuses with its target membrane when 
drawn into apposition by surface binding. Native membrane recognition elements are 
proteins and in class I viral fusion and synaptic vesicle fusion are coiled-coils. Helical 
bundle formation draws the membranes into apposition; this binding is thought to locally 
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dehydrate and mechanically deform the membrane, lowering the activation energy for 
lipid mixing and fusion. Notably, enveloped viruses such as HIV and influenza similarly 
employ coiled-coil recognition to guide fusion with the host membrane. While 
considerable advances have furthered our understanding of membrane fusion, fusion has 
proven difficult to study in living systems. Thus, the mechanism of vesicle fusion 
remains largely unknown. As a result, efforts have been made to interrogate whether 
recognition strategies between small molecules would also be fusion competent.91,92 Such 
a minimal fusogenic molecular system would be useful for determining the fundamental 
requirements for membrane fusion catalysis. A simple synthetic model system of specific 
fusion via molecular recognition would allow physical organic methods to be applied to 
rigorously probe the scope and limitations of controlled lipid membrane fusion.  In my 
work lipid vesicles, functionalized with ketone and oxyamine molecules, display 
complementary chemistry and undergo recognition, docking, and subsequent fusion upon 
covalent oxime bond formation. Liposome fusion was characterized by several 
techniques including, matrix-assissted laser-desorption/ionization mass spectrometry 
(MALDI-MS), light scattering, Fourier resonance energy transfer (FRET), isothermal 
calorimetry (ITC), and transmission electron microscopy (TEM). When cultured with 
cells, ketone- and oxyamine-containing liposomes undergo spontaneous membrane 
fusion to present the respective molecules from cell surfaces. The synthetic ketone and 
oxyamine molecules fused on the cell membrane serve as cell-surface receptors, 
providing tools for the attachment of other functional materials, biomolecules, and probes 
on cell surfaces. 
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1.11 Conclusions 
        Phospholipid vesicles (liposomes) are widely used for applications in cell tracking, 
nonviral gene transfer (transfection), and drug delivery. On the basis of their 
compositions, liposomes are more bioavailable than synthetic polymer capsules or 
quantum dots. Their cellular uptake has been intensely investigated and shows a strong 
preference for endocytotic cellular uptake over fusion or lipid-mediated poration. As 
discussed earlier, a continuous effort has been extended toward replacing genetic and 
molecular biology tools with simple chemical methods to modify cell surfaces with 
various probes, furthering applications in tissue engineering. Our liposome fusion 
strategy to engineer cell surfaces was inspired by the work of Wilson et al. and Csiszar et 
al. who reported a noncovalent cell-surface engineering strategy via cationic graft 
copolymer adsorption and a fluorescent cell labeling technique via cationic and aromatic 
lipid fusion, respectively. These methods are general and do not perturb the cellular 
machinery of the cells. Liposome fusion can serve as a very important tool among many 
other techniques that have been previously described to modify and tailor cell surfaces 
with biologically relevant molecules, significantly contributing to tissue engineering 
fields in generating 3D tissue constructs.  
1.12 Dissertation Organization 
  This dissertation is organized into seven chapters. Chapter I provides a general 
discussion of cell-surface engineering techniques and their biomedical applications. 
Chapter II describes the development of a chemoselective and electroactive fluid lipid 
bilayer system, which serves as a platform for studying ligand-receptor interactions. 
Chapter III reports the development of a chemoselective synthetic cell receptor system 
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based on a liposome delivery and fusion strategy. Chapter IV focuses on the application 
of the liposome delivery and fusion strategy to generate 3D spheroid cellular assemblies 
with controlled interconnectivity and patterned multi-layered tissue-like structures. 
Chapter V describes the development of a novel general and straightforward liposome 
fusion-based methodology to deliver dynamic and switchable bio-orthogonal chemistries 
to tailor cell membranes and direct the formation of 3D co-culture tissue structures. 
Chapter VI discusses the development and demonstration of a novel liposome fusion 
based delivery strategy to incorporate a unique bio-orthogonal lipid that has the dual 
ability to serve as a receptor for chemoselective cell-surface tailoring and as a reporter to 
track cell behavior. Chapter VII describes the general conclusions and future research 
projects.  
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CHAPTER 2 
 
Selective Tethering of Ligands and Proteins to a Microfluidically 
Patterned Electroactive Fluid Lipid Bilayer Array 
 
2.1 Introduction: 
 
The formation of supported fluid lipid bilayers on surfaces has generated 
tremendous research interest due to their ability to model the natural cell plasma and 
organelle membranes. As a result, these platforms have been used for a range of 
application from the design of biosensor technologies, the investigation of fundamental 
biomembrane properties1, intermembrane interactions2 to cell adhesion and migration.  To 
characterize lipid raft clustering and ligand-binding interactions at supported membranes 
several analytical tools have been employed, including atomic force microscopy (AFM),3 
surface plasmon resonance (SPR),4 and microfabricated microfluidic cassettes. To form 
patterns and arrays of bilayers on surfaces several strategies have been developed ranging 
from microcontact printing5, microfluidics6, nanoshaving7, mechanical scratching8, 
photolithography9 to photopolymerization10. Formation of these patterns and arrays serve 
as a platform to study a number of biomolecular and binding interactions11 to the lipid 
bilayer.  Ultimately, the information gathered from evaluating membrane interactions, 
may lead to the development of membrane based biomedical devices for conducting 
novel cell-based assays12 and potentially high throughput drug screens targeting 
membranes or membrane associated components13.  
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Various materials have been used as a support to form fluid bilayer membranes, 
including glass surfaces, metal oxide surfaces, flexible polymer cushions, self-assembled 
monolayers (SAMs), and SAM-supported polycationic layers.14-16 Among these 
platforms, SAMs of alkanethiols on gold, provide a well-defined conducting surface that 
is amenable to several analytical surface techniques to characterize and monitor the 
formation of bilayer membranes.17,18 Alkanethiols are synthetically flexible and/or 
commercially available, providing diverse opportunities for tailoring materials for a range 
of applications.19    
Many previous studies have used planar supported fluid lipid bilayers to evaluate 
ligand-receptor binding interactions where one component, usually the protein, was 
assembled with a vesicle formation prior to forming planar bilayers.20,,21 To our 
knowledge, there has been no quantitative and general chemoselective immobilization 
strategy to tailor and pattern fluid lipid bilayers with a variety of ligands for bio-
interfacial studies. 
Herein, we use a microfluidic lithography strategy to pattern two different SAMs 
on gold followed by the addition of electroactive vesicles for the generation of patterned 
fluid lipid bilayers capable of immobilizing a variety of ligands and biomolecules.  In 
order to support a fluid lipid bilayer on gold, a patterned siloxane-alkanethiol SAM was 
used to mimic the properties of glass siloxane surfaces.22 A SAM of mercaptopropyl 
trimethoxysilane (HO3SiSH) was formed, and a solution containing hydroquinone-
tethered alkane (H2Q) lipid vesicles was ruptured, generating a fluid bilayer surface. H2Q 
molecules were incorporated into the lipid vesicles prior to the formation of the bilayer.  
Upon formation of a bilayer the electroactive H2Q molecules can be electrochemically 
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oxidized to the corresponding quinone (Q), where the gold substrate is a working 
electrode. The resulting Q molecules permit the selective coupling of soluble oxyamine-
containing (RONH2) ligands.
23,24 As demonstrations of this strategy, oxyamine-rhodamine 
and glucose-oxyamine ligands were immobilized to electroactive lipid bilayers and 
characterized by electrochemistry and fluorescence microscopy.  Ultimately, this system 
provides an excellent platform for the chemoselective and biospecific immobilization of 
ligands to patterned fluid lipid bilayers for studying a variety of biomolecular interactions 
for a range of biotechnology and cell based applications. 
2.2 Materials and Methods 
2.2.1 Materials 
Egg palmitoyl-oleoyl phosphatidylcholine (egg-POPC) was purchased from Avanti Polar 
Lipids (Alabaster, AL), ConA-TRITC was obtained from Invitrogen (Carlsbad, CA), and 
all other chemicals were obtained from Sigma Aldrich. 
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Figure 2.1. List of molecules used in this study. (1) Hydroquinone-tethered alkane 
(H2Q); (2) egg palmitoyl-oleoyl phosphatidylcholine (egg-POPC); (3) 3-mercaptopropyl 
siloxane or siloxane-tethered alkanethiol (HO3SiSH); (4) tetra(ethylene glycol)-tethered 
alkanethiol (EG4SH); (5) Rhodamine-oxyamine (Rhod-ONH2); (6) Glucose-oxyamine 
(Glc-ONH2). 
!
2.2.2 Synthesis of 1,4-bis(tetrahydro-2H-pyran-2-yloxy)benzene (7) 
To a solution of hydroquinone (6.0 g, 54.5 mmol) in THF (40 mL) was added 2,3-
dihydropuran (44.0 mL, 245.3 mmol, 4.5 eq) and 3 drops of concentrated HCl. The 
mixture was stirred at room temperature for 8h, diluted with EtOAc (40 mL), washed 
with NaHCO3 (3 x 50 mL) and brine (1 x 25 mL), dried over MgSO4, and concentrated to 
a white solid. The solid was then dissolved in EtOAc and recyrstallized with hexanes to 
afford a white solid 7 (10. 02 g, 66%), 1H NMR (400 Hz, CDCl3, !): 1.67-1.58 (m, 6H, 
J=36; -CH2-), 1.88-1.85 (m, 4H, J=12; -CH2-), 2.03-2.00 (m, 2H, J=12; -CH2-), 3.62-3.60 
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(m, 2H, J=8; -CH2-), 3.98-3.96 (m, 2H, J=8; -CH2-), 5.34-5.32 (t, 2H, J=7; -CH-), 7.00 (s, 
4H; Ar-H).   
2.2.3 Synthesis of 2,2'-(2-dodecyl-1,4-phenylene)bis(oxy)bis(tetrahydro-2H-pyran) 
(8) 
To a solution of 7 (2.00 g, 7.0 mmol) in dry THF (40 mL) at 0°C was added tert-
butyllithium (4.6 mL of a 1.7 M solution, 9.1 mmol, 1.3 eq) dropwise over 15 min. The 
mixture was stirred at 0°C for 60 min and then slowly warmed to room temperature over 
3h. At this time, 1-bromododecane (5.08 mL, 21.0 mmol, 3 eq) was added and stirred for 
12h. The mixture was diluted with DCM (40 mL) and washed with NH4Cl (3 x 50 mL) 
and brine (1 x 25 mL), dried over MgSO4, and concentrated to afford a yellow oil. The 
mixture was purified by flash chromatography 95:5 Hex:EtOAc to elute a yellow oil 8 
(2.23 g, 71%), 1H NMR (400 Hz, CDCl3, !): 0.91-0.89 (t, 3H, J=8; -CH3), 1.27-1.23 (m, 
18H, J=16; -CH2-), 1.72-1.68 (m, 10H, J=16; -CH2-), 2.61-2.58 (t, 2H, J=12; -CH2-), 
3.65-3.63 (m, 4H, J=8; -CH2-), 5.80-5.78 (t, 2H, J=8; -CH-), 6.68 (s, 1H; Ar-H), 6.81 (s, 
1H; Ar-H), 6.84 (s, 1H; Ar-H). 
2.2.4 Synthesis of 2-dodecylbenzene-1,4-diol (hydroquinone-tethered alkane, H2Q) 
(1)  
To a solution of 8 (2.0 g, 4.5 mmol) in 40 mL of a 3:1:1 mixture of AcOH/THF/H2O was 
stirred for 16h. The mixture was then concentrated, diluted in EtOAc (20 mL) and 
washed with 1 mM NaOH (2 x 10 mL), dried over MgSO4, and concentrated to afford a 
white solid 1 (1.12 g, 90%), 1H NMR (400 Hz, CDCl3, !): 0.89-0.87 (t, 3H, J=8; -CH3), 
1.30-1.25 (m, 18H, J=20; -CH2-), 1.57-1.55 (m, 2H, J=7; -CH2-), 2.58-2.55 (t, 2H, J=12; -
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CH2-), 6.57-6.56 (m, 1H, J=4; Ar-H), 6.67-6.65 (m, 2H, J=7; Ar-H); LRMS (ESI) (m/z) 
[M-Na]+ calcd for C18H30O2, 301.56, found 301.15. 
!
!
!
!
Scheme 2.1. Synthetic route to hydroquinone-tethered alkane (H2Q, 1). Reagents and 
conditions: (i) 2,3-dihydropuran (4.5 eq), HCl (cat), THF, 8h, 66%; (ii) tert-butyllithium 
(1.3 eq), 1-bromododecane (3 eq), THF, 0°C, 3h, then 25°C, 12h, 71%; (iii) 3:1:1 
AcOH/THF/H2O, 16h, 90%. 
!
!
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2.2.5 Synthesis of 1,2,3,4,6-Penta-O-acetyl-!-D-glucopyranose (9) 
To a solution of acetic anhydride (50mL) was added sodium acetate (5.40 g, 66.6 mmol, 
3 eq.). The mixture was refluxed at 90°C for 20 minutes to which D-glucose (4.00 g, 22.2 
mmol) was added and stirred for 4 hours. The mixture was then concentrated, dissolved 
in methanol, and recrystallized with cold water. A white solid was then filtered and dried 
to afford (9) (7.44 g, 85%), 1H NMR (400 Hz, CDCl3, !): 2.01, 2.03, 2.07, 2.09, 2.13 (s, 
15H; CH3), 4.17-4.14 (m, 2H, J=12; CH2), 4.40-4.38 (2xm, 1H, J=7; CH), 4.71-4.69 (d, 
1H, J=8; CH), 5.32-5.31 (t, 1H, J=4; CH), 5.37-5.36 (t, 1H, J=4; CH), 5.41-4.40 (d, 1H, 
J=4; CH). 
2.2.6 Synthesis of O-(2,3,4,6-tetra-O-acetyl)-!-D-glucopyranosyl-bromoethyloxy (10) 
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To a solution of 9 (1.00 g, 2.56 mmol, 1 eq.) and ZnCl2 (catalytic) in anhydrous 
dichloromethane (15 mL) was added 2-bromoethanol (0.24 mL, 3.33 mmol, 1.3 eq.), 
followed by the addition of boron trifluoride diethyl etherate (0.41 mL, 3.33 mmol, 1.3 
eq.) dropwise at 0°C. The mixture was stirred under inert atmosphere (N2) for 6h at room 
temperature. Upon completion, the mixture was then washed with water (2x50mL), 
sodium bicarbonate (1M) (2x50mL), concentrated, and recrystallized in hexanes to afford 
a white solid 10 (0.93 g, 80%), 1H NMR (400 Hz, CDCl3, !): 2.01, 2.03, 2.07, 2.09 (s, 
12H; CH3), 3.50-3.49, 3.53-3.51 (2xm, 2H, J=8; CH2), 3.51-3.49 (m, 2H, J=8; CH2), 
4.11-4.08 (m, 2H, J=12; CH2), 4.30-4.28 (2xd, 2H, J=8; CH2), 4.58-4.57 (d, 1H, J=4; 
CH), 4.99-4.98 (t, 1H, J=4; CH), 5.13-5.12 (t, 1H, J=4; CH), 5.21-5.20 (t, 1H, J=4; CH), 
(ESI) (m/z) [M + H+]: 454.05. 
 
 
Scheme 2.2. Synthetic route to glucose-oxyamine (Glc-ONH2, 6). Reagents and 
conditions: (i) Ac2O, NaOAc (3 eq), ZnCl2 (cat), 90°C, 4h, 95%; (ii) 2-bromoethanol (1.3 
eq), ZnCl2 (cat), boron trifluoro diethyletherate (1.3 eq), DCM, 0°C-rt, 6h, 80%; (iii) N-
hydroxyphthalimide (1.5 eq), NaHCO3 (1.5 eq), DMF, 65°C, 8h, 76%; (iv) hydrazine (6 
eq), EtOH, rt, 48h, 67%. 
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2.2.7 Synthesis of O-(2,3,4,6-tetra-O-acetyl)-!-D-glucopyranosyl-ethyloxy-N-   
oxyphthalimide (11)  
To a solution of N-hydroxyphthalimide (1.07 g, 6.59 mmol, 1.5 eq.) in DMF (20 mL) at 
65°C was added sodium bicarbonate (0.55 g, 6.59 mmol, 1.5 eq.). The mixture was then 
stirred for 30 min until fully deprotonated (brown in color) to which 10 (2.00 g, 4.39 
mmol, 1 eq.) was added. The solution was stirred under inert atmosphere (N2) for 8 hours. 
After completion, the mixture was diluted with dichloromethane and washed with water 
(8x100mL) and 1 M NaHCO3 (3x25mL) or until the excess N-hydroxyphthalimide was 
completely taken up into the aqueous layer. The organic layer was concentrated and 
purified by flash chromatography (Hex/EtOAc, 3.5:6.5) to afford a pale yellow oil 11 
(1.49 g, 63%), 1H NMR (400 Hz, CDCl3, !): 2.09-2.00 (4xs, 12H; CH3), 3.78-3.76 (m, 
2H, J=8; CH2), 4.04-4.02, 4.4.39-4.37 (2xm, 2H, J=8; CH2), 4.09-4.06 (m, 2H, J=12; 
CH2), 3.50-3.48 ( 2xd, 2H, J=8; CH), 4.78-4.77 (d, 1H, J=4; CH), 4.97-4.95 (t, 1H, J=7; 
CH), 5.09-5.07 (t, 1H, J=7; CH), 5.31-5.29 (t, 1H, J=7; CH), 7.78-7.76 (2xm, 4H, J=8; 
4H), (ESI) (m/z) [M + H+]: 537.15.  
2.2.8 Synthesis of !-D-glucopyranosyl-propyloxy-N-oxyamine (Glucose-oxyamine, 
Glc-ONH2) (6)  
To a solution of 11 (0.912 g, 1.70 mmol) in ethanol (15 mL) was added hydrazine (0.327 
mL, 10.2 mmol, 6 eq). The mixture was stirred under inert atmosphere for up 48h. The 
mixture was then concentrated and purified by flash chromatography (MeOH/DCM, 3:7) 
to afford a white solid 6 (0.213 g, 52%), 1H NMR (400 Hz, CDCl3, !): 3.18-3.16 (t, 1H, 
J=7; CH), 3.27-3.24 (t, 1H, J=12; CH), 3.36-3.34 (m, 2H, J=8; CH2), 3.60-3.59, 3.57-3.56 
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(2xd, 1H, J=4, J=16; CH), 3.75-3.72 (2xm, 2H, J=12; CH2), 3.78-3.77 (m, 2H, J=8; CH2), 
3.93-3.91 (m, 1H, J=8; CH), 4.36-4.34 (d, 1H, J=8; CH); (ESI) (m/z) [M+H+]: 239.10. 
2.2.9 Formation of electroactive lipid vesicles  
Hydroquinone-tethered alkane (H2Q) (160 !L at 10 mol %) was reacted with egg-POPC 
(410 !L at 90 mol %) in chloroform for 4 h, followed by concentration under high 
vacuum. The dried lipid sample was then reconstituted in 2.43 mL of tris buffer, pH 7.4. 
The contents of the vial were warmed to 50˚C and sonicated at a 70% output for 15 min, 
with a tip sonifier, until the solution was clear. Large and small unilamelar vesicles 
(LUVs and SUVs, respectively) were then centrifuged for 30 min at 30,000g to pellet the 
LUVs, leaving the SUVs suspended in solution.  
2.2.10 Preparation of monolayers 
Gold substrates were prepared by electron beam deposition of titanium (6 nm) and gold 
(12-18 nm) on 24 mm " 100 mm glass microscope slides. The slides were cut into 2 " 2 
cm2 pieces and washed with absolute ethanol before use. The slides were then immersed 
in 1mM solution of 3-mercaptopropyl trimethoxysilane in EtOH for ~12 h.       
2.2.11 Generation of solid-supported electroactive lipid bilayers 
 A 3 mM solution of SUV (egg-POPC/H2Q, 9:1) in Tris buffer was added to a SAM-
modified gold substrate. Lipid bilayers formed by spontaneous fusion on the surface, and 
the non-adsorbed vesicles were removed by washing with PBS buffer (10 volumes). 
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2.2.12 Electrochemical characterization 
 All electrochemical measurements were performed using the Bioanalytical Systems 
Epsilon potentiostat. An Ag/AgCl electrode (Bioanalytical systems) served as the 
reference, the Au monolayer acted as the working electrode, and a Pt wire served as the 
counter electrode. The electrolyte was 1 M HClO4 and the scan rate was 100mV s
-1. 
Measurements were performed in a standard electrochemical cell. 
2.2.13 Fluorescence Recovery After Photobleaching (FRAP)  
For FRAP experiments, a fluorescent 7-nitrobenz-2-oxa-1,3-diazol-4-yl phosphocoline 
(NBD-PC) lipid, H2Q and egg-POPC (3:10:87) ratio bilayer on gold was excited by a 
Argon laser (488 nm) for a period of 2 min to induce photobleaching. The shutter was 
then closed after photobleaching and the observed fluorescence recovery was recorded at 
periodic intervals. To analyze the images to determine fluorescence recovery after 
photobleaching rates, processing software (LSM 510 Meta, Germany) was used. 
Approximately >95% of the fluorescence was recovered after 6 min the photobleaching 
step indicating an electroactive fluid lipid bilayer. 
2.2.14 Fluorescence microscopy characterization  
Fluorescent and brightfield microscopy was performed using a Nikon TE2000-E inverted 
microscope. Image acquisition and processing was performed using Metamorph software.  
2.2.15 Patterning of SAMs  
A polydimethylsilane (PDMS) microfluidic cassette was reversibly sealed to a bare gold 
surface. In order to pattern a SAM by microfluidic lithography (!FL), a 1 mM solution of 
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tetra(ethylene) glycol-terminated alkanethiol (EG4SH) in ethanol was flowed through the 
channels for 60 s. Without removing the cassette, ethanol was flowed through the 
channels and suction evacuated to clean the surface. The same cassette was then placed 
perpendicular to the newly patterned  EG4SH SAM, and !FL was performed with the 
exact same conditions for a second time, as previously described. The substrate was then 
rinsed with ethanol, dried, and immersed into a 1 mM solution of HO3SiSH in EtOH for 
16 h, in order to backfill the remaining gold with a SAM. 
2.2.16 Electroactive bilayer patterning and ligand immobilization 
!! To generate bilayer patterns, gold surfaces with pre-patterned EG4SH and HO3SiSH 
SAMs were immersed into a 3 mM solution of egg-POPC:H2Q (9:1) in Tris buffer for 1 
h. Substrates were then rinsed with PBS, dried with air, and oxidized electrochemically to 
present Q-terminated patterned bilayers. Rhod-ONH2 was reacted with the Q-terminated 
bilayers (7 mM in MeOH, rt, 4 h). Similarly, glucose-oxyamine (glc-ONH2) was also 
immobilized to microarrays of Q-terminated bilayers (20 mM in MeOH, rt, 4 h), and 
TRITC-conjuagted Concanavalin A (ConA) was added (1 mg/mL in DMSO, rt, 2 h). The 
resultant microarrays displaying Rhod and ConA were imaged by fluorescence 
microscopy. 
2.3 Results and Discussion 
2.3.1 Liposome preparation 
The general schematic illustrating the formation of embedded H2Q (Scheme 1, 1) lipid 
vesicles is shown in Figure 1. A solution of H2Q (1 mg/mL) and egg-POPC (10 mg/mL, 
2) in chloroform (CHCl3) was reacted for 4 h. During mixing, the alkane chain of the H2Q 
molecules behaved like lipid tails and spontaneously inserted within the lipid vesicle 
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membrane. The lipid mixture was then concentrated by speed vacuum for 4 h and 
reconstituted in Tris buffer, pH 7.4, 3 mM.  This solution was then ultrasonicated for 20 
min, generating a mixture of small and large unilamellar vesicles (SUVs and LUVs, 
respectively). The resultant solution was centrifuged (30,000g, 30 min) to pellet out the 
LUVs, leaving a suspension of H2Q-containing SUVs. 
 
Figure 2.2 General schematic for the formation of chemoselective, electroactive lipid 
vesicles. Hydroquinone-tethered alkane (H2Q) was reacted with egg palmitoyl-oleoyl 
phosphatidylcholine (egg-POPC). The mixture was then concentrated, reconstituted, 
ultrasonicated, and centrifuged to generate H2Q containing small unilamellar vesicles 
(H2Q-SUVs). 
 
2.3.2 Electroactive bilayer formation 
!
The SUV solution was then ruptured on a SAM of HO3SiSH generating a fluid bilayer 
with H2Q presented from the bilayer surface (Figure 2). Experimentally, a gold substrate 
was immersed in 1 mM solution of HO3SiSH (3) for 16 h to form a uniform SAM. This 
particular alkanethiol was selected due to its generation of a 2-dimensional network of 
silica when assembled on a surface in the presence of water. This in turn produces a 
model system where the Si-OH head group aids in maintaining bilayer fluidity. The 
SUV-containing suspension was then added to the SAM surface, resulting in spontaneous 
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fusion to form a planar bilayer. We have shown previously on gold and indium tin oxide 
surfaces that the H2Q molecules are redox active and can be oxidized to the 
corresponding Q by applying a mild electrochemical potential via the gold supporting 
electrode. The Q serves as a chemoselective site for ligand conjugation when reacted with 
an oxyamine-tethered (RONH2) ligand. The resulting oxime linkage is also redox active 
but with distinct and diagnostic peaks and can be monitored precisely by 
electrochemistry.25,26  
 
Figure 2.3. Schematic illustrating the formation of a self-assembled monolayer (SAM) 
supported, electroactive fluid bilayer for chemoselective ligand immobilization. (A) A 
thin layer of titanium then gold was evaporated onto a glass coverslip. (B) The substrate 
was immersed in a solution of 3-mercaptopropyl siloxane (HO3SiSH) in ethanol (EtOH) 
for ~16 h to form a SAM. (C) To generate a supported planar bilayer, a solution of lipid 
vesicles containing H2Q was added to the surface. The H2Q is electroactive and can 
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undergo a reversible electrochemical oxidation to generate the corresponding quinone 
(Q). (D) Addition of an oxyamine-tethered ligand (RONH2) reacts with the Q, generating 
a covalent interfacial oxime linkage (QOx).  The resultant oxime product is also redox 
active and provides a diagnostic electrochemical signal characterizing the amount or 
yield of reaction to the bilayer. 
 
2.3.3 Electrochemical characterization 
Ligand immobilization to H2Q-containing bilayers was characterized by electrochemistry 
and specifically cyclic voltammetry (CV) (Figure 3). The H2Q/Q redox couple, as seen 
from the blue trace showed unique oxidation and reduction peaks at 500 and 335 mV, 
respectively. After the surface was oxidized to Q, Rhod-ONH2 (5) was reacted (7 mM in 
H2O, 4 h), and the oxime-product (H2Qox/Qox) couple (red trace) displayed redox peaks at 
195 mV and 328 mV, respectively. There is a distinct peak potential shift from the H2Q/Q 
to the H2Qox/Qox redox couple, indicating that the ligand immobilization had occurred on 
the fluid lipid bilayer.27 Electrochemical measurements were performed in PBS pH 7.4, 
with a scan rate of 100 mV/s, versus a Ag/AgCl reference electrode. 
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Figure 2.4 Electrochemical characterization of the coupling reaction between a Q-
functionalized fluid lipid bilayer and soluble rhodamine-oxyamine (Rhod-ONH2) by 
cyclic voltammetry (CV). (A) A CV displaying the diagnostic peak potentials of the 
H2Q/Q (blue) redox couple with oxidation [O] at 500 mV and reduction [R] at 335 mV. 
(B) The resultant CV showing the oxime-product (QOx/H2QOx) couple of immobilized 
Rhod-ONH2 with peaks at [O] 328 mV and [R] 195 mV (red). 
 
2.3.4 Fluorescence Recovery After Photobleaching 
The electroactive bilayer fluidity was confirmed by conducting a fluorescence recovery 
after photobleaching (FRAP) experiment.28 Figure 4 shows the sequence of FRAP 
epifluorescent micrographs obtained after a small area (921 !m x 921 !m) was bleached 
(Argon laser, 488 nm) from 0 to 6 min. The exposed area was completely dark after 
photobleaching and gradually recovered its fluorescence (>95%) by 6 min. The extent of 
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recovery was quantified by comparing the fluorescence intensity of the exposed region 
normalized to the intensity of the unexposed region. 
! !
Figure 2.5 Fluorescence recovery after photobleaching (FRAP) experiment of H2Q 
containing bilayers to show bilayer fluidity on a HO3SiSH SAM.  (A) t = 1 min after 
photobleaching; (B) t = 2 min, with partial fluorescence recovery; and (C) t = 6 min, with 
almost complete recovery (>95%). (D) The recovery profile corresponding to the FRAP 
data as shown in A-C. Scale bar 200 µm.  
 
2.3.5 Ligand immobilization 
In order to spatially control the immobilization of oxyamine-tethered ligands from lipid 
bilayers on gold, tetra(ethylene glycol)-terminated alkanethiol29 (EG4SH, 4) was 
patterned by microfluidic lithography (!FL)30,31 and a SAM of HO3SiSH was backfilled 
in the regions containing bare gold (Figure 5). EG4SH is known to resist nonspecific 
protein adsorption and also prohibits bilayer formation. Therefore, a microfluidic casette 
was reversibly sealed to a gold surface, and a solution of EG4SH (1 mM in EtOH, 60 s) 
was flowed through the microchannels. The same cassette was then placed perpendicular 
to the newly patterned EG4SH SAM, and !FL was performed a second time. 
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Figure 2.6 Schematic for the generation of a chemoselective, electroactive, and patterned 
fluid lipid bilayer surface. (A) A PDMS microfluidic cassette was reversibly sealed to a 
bare gold substrate. (B) A solution of tetra(ethylene) glycol-terminated alkanethiol 
(EG4SH) in EtOH was flowed through the channels, forming a patterned EG4SH SAM by 
microfluidic lithography (!FL). (C) The same cassette was then removed and placed 
perpendicular to the newly patterned EG4SH SAM, and !FL was performed a second 
time to generate an intersecting EG4SH pattern. (D) The substrate was then immersed in a 
solution of HO3SiSH in EtOH for ~16h, in order to backfill the remaining bare gold 
regions. (E) A solution of lipid vesicles containing H2Q (H2Q-SUVs) was then added to 
the surface and underwent spontaneous fusion to form fluid bilayers only on the regions 
containing HO3SiSH. (F) The H2Q groups were electrochemically oxidized to Q groups, 
and an oxyamine-containing ligand (RONH2) was reacted to form a covalent oxime bond, 
resulting in a chemoselectively, electroactive, and  patterned ligand fluid bilayer. 
 
 The patterned gold substrate was then rinsed with ethanol, dried, and immersed into a 1 
mM solution of HO3SiSH in EtOH for 16 h, in order to backfill the remaining gold with a 
siloxane terminated SAM. To generate patterned, fluid bilayers, a pre-patterned surface 
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with EG4SH and HO3SiSH SAMs was immersed into a 3 mM solution of egg-POPC:H2Q 
(9:1) in Tris buffer for 1 h. The substrate was then rinsed with PBS, dried in air, and 
oxidized electrochemically to present a Q-terminated, patterned bilayer. To this surface a 
Rhod-ONH2 liagnd was reacted and immobilized (7 mM in MeOH, rt, 4 h). The resultant 
microarray displaying rhodamine was imaged by fluorescence microscopy (Figure 6). 
Control experiments were conducted to determine the fidelity of using the H2Q bilayer 
immobiliztion strategy. First, a patterned substrate was reacted with rhod-ONH2 without 
electrochemical oxidation to Q. A patterned, oxidized surface was also reacted with a 
non-functionalized rhodamine (does not contain an oxyamine group).  For both of these 
experiments, no fluorescence was observed.      
2.3.6 Protein immobilization 
This patterning strategy was also shown to be compatible with the chemoselective 
immobilization of a biospecific ligand to investigate protein-ligand interactions on the 
bilayer. After patterning an electroactive, fluid lipid bilayer, glucose-oxyamine (glc-
ONH2, Scheme 2, 6) was immobilized to Q-terminated bilayers (20 mM in MeOH, rt, 4 
h).32 After confirmation of the presence of a gluocose oxime-product by CV, TRITC-
conjuagted Concanavalin A (ConA) was added to the surface (1 mg/mL in DMSO, rt, 2 
h). ConA is a lectin, or carbohydrate-binding protein, that specifically recognizes and 
binds to glucose groups.33 As shown by the fluorescent image in figure 6, glc-ONH2 was 
successfully conjugated to patterned bilayers followed by biospecific recognition after 
treatment with ConA.  As a control, no fluorescence was observed when ConA was 
added to a patterned bilayer, not presenting bound glucose.  Importantly, the µFL formed 
EG4SH SAMs not only allow for patterning the bilayer but also renders the non-bilayer 
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regions inert to non specific protein adsorption.34,35 This feature is critical for extending 
this system to generate multicomponent ligand bilayers for proteomic and cell adhesion 
based studies.  
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!  
Figure 2.7 Fluorescent micrographs of ligand immobilization on patterned electroactive 
fluid bilayers. For all surfaces, EG4SH was first patterned by !FL then the remaining 
bare gold regions were backfilled with HO3SiSH.  To these surfaces, H2Q containing 
lipid vesicles were fused, electrochemically oxidized [O], and then reacted with an 
oxyamine-tethered ligands (RONH2). (Top) Glucose-oxyamine (Glc-ONH2) was 
immobilized to patterned fluid lipid bilayer surfaces, followed by the addition of 
fluorescent ConA-TRITC. (Bottom) Rhod-ONH2 was immobilized to patterned fluid lipid 
bilayers. 
 
 
2.4 Conclusions 
 In summary, we have developed a general method to pattern electroactive and 
chemoselective fluid lipid bilayers on gold surfaces for a range of biospecific ligand-
receptor interaction studies on model membranes.  To our knowledge, the described 
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methodology allows for the first time the tailoring of a patterned fluid lipid bilayer post 
bilayer formation with a range of ligands and/or proteins that can be characterized in situ 
electrochemically. Importantly, the !FL strategy is rapid and provides the ability to 
pattern a variety of shapes and feature sizes to generate unique bilayer microarrays.36 The 
Si-OH network, as generated by the presence of a HO3SiSH SAM, aids in maintaining 
bilayer fluidity, which is important in mimicking the natural cell membrane. The ability 
to generate fluid bilayer arrays on gold allows for several analytical surface spectroscopy 
techniques to characterize interfacial associations. In this study, a variety of oxyamine-
tethered ligands were successfully immobilized in arrays, indicating that a number of 
biomolecules can be presented from the surface for subsequent interrogation by other 
biologically-relevant compounds (proteins, nucleic acids, small molecules). Since the 
immobilization of ligands results in the formation of an electroactive oxime bond, ligand 
density and extent of reaction can be quantified and monitored by CV on a fluid lipid 
bilayer.  Since the interfacial reaction is electroactive and quantitative, multiple different 
ligands may also be immobilized to a single bilayer array.  By incorporating existing 
electrophoretic methods to generate fluid bilayer gradients, a method to generate ligand 
gradients for cell polarity and cell migration studies may be feasible.37 Furthermore, the 
immobilization strategy provides a method to conjugate other materials including, carbon 
nanotubes, quantum dots, colloids, polymer based nanoparticles and liposomes for a 
variety of optoelectronic and material applications.38-41 This platform is rapid and flexible 
and may be extended to many areas in biochemistry, cell biology and material science to 
study fundamental membrane activity (lipid microdomains) and enzymology, as well as 
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provide a high-throughput biotechnology platform for the development of highly 
integrated biosensors for small molecule screens or cell behavior based assays. 
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CHAPTER 3 
Cell-Surface Engineering by Liposome Fusion 
3.1 Introduction 
         Membrane fusion processes are ubiquitous in biology and span multi-cellular 
communication, extracellular signaling, the reconstruction of damaged organelles, and 
integration of cells into complex tissues and organs.
1
 As a result, there has been much 
interest in developing model systems to mimic biological membranes to investigate the 
mechanisms of fusion and for use in various biotechnological applications. For example, 
cells secrete and display proteins and lipids during vesicle trafficking events that either 
diffuse into the ECM or become components of the cell membrane after fusion.
2
 
Naturally, lipid vesicles provide an ideal platform for such studies and have been widely 
used to examine various membrane-related processes, including fusion.
3-5
 In order for 
fusion to occur, the membranes must be brought into close proximity, followed by bilayer 
destabilization.
6
 Fusion of such lipid vesicles or liposomes can be initiated by using 
divalent cations, polycations,
7 
positively charged amino acids
8
 and membrane-disrupting 
peptides.
9,10
  Historically, synthetic chemical agents have also been employed to fuse 
vesicle membranes
11-14
 through non-specific interactions. However, recent exciting 
efforts to improve selectivity and control over vesicle fusion have been achieved through 
the use of small, synthetic molecular recognition pairs.
15-16
 Since vesicle fusion is a 
natural process and has been shown to influence the construction of cells into 
multicellular organisms, much research has focused on using liposomes to deliver 
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cargoes, reagents, nanomaterials, and therapeutic agents to cells. To our knowledge, there 
have been very few reports of employing liposome fusion to cell membranes as a method 
to deliver small chemical functional groups in order to tailor the cell membrane for 
subsequent bio-orthogonal and chemoselective ligation reactions.
17,18
 This platform 
would find wide use in studying fundamental cell behavior, tissue engineering, and 
biomedical applications. 
Cell-surface receptors that decorate the cell membrane influence a number of 
biological processes, such as cell adhesion, differentiation, intercellular communication, 
and tissue formation.19 As such, methods that selectively engineer the cell surface by 
introducing chemoselective functional groups will have a significant role in directing and 
influencing many biological processes for applications in cell-based therapies, drug 
delivery, and tissue engineering.20-24 Previous cell-surface modification strategies involve 
the introduction of chemoselective functional groups through metabolic and genetic 
engineering approaches.25-27 However, such strategies may perturb cellular processes by 
altering cellular physiology.28  
In this chapter, we present a method to tether chemoselective ketone and oxyamine 
groups from cell surfaces by liposome delivery toward the goal of rewiring the cell 
surface. Alkyl ketone and oxyamine molecules spontaneously insert into lipid vesicles 
upon synthesis. When mixed, chemical recongnition occurs, producing stable oxime 
bonds under physiological conditions. The reaction is also bio-orthogonal and thus, does 
not interfere with any other chemical moieties in its cellular surroundings.29-32 The 
synthetic ketone and oxyamine molecules fused on the cell membrane serve as cell-
surface receptors, providing tools for the attachment of other functional materials, 
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biomolecules, and probes on the cell surface. Liposome fusion was characterized by 
matrix-assisted laser-desorption/ionization mass spectrometry (MALDI-MS), dynamic 
light scattering (DLS), Fourier resonance energy transfer (FRET), isothermal calorimetry 
(ITC), transmission electron microscopy (TEM), fluorescene-activated cell sorting 
(FACS), and fluorescene microscopy analyses.  
3.2 Materials and Methods 
3.2.1 Materials 
 All chemical reagents were of analytical grade and used without further purification. 
Lipids egg palmitoyl-oleoyl phosphatidylcholine (POPC), egg 1-palmitoyl-2-oleoyl-
phosphatidylglycerol (POPG), 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP), 
egg 1,2-diphytanoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-
4-yl) (ammonium salt) (NBD-PE), and egg 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod-PE) 
were purchased from Avanti Polar Lipids (Alabaster, AL). Antibodies and fluorescent 
dyes were obtained from Invitrogen (Carlsbad, CA). FITC labeled beads were purchased 
from Spherotech, Inc. (Forest Lake, IL) and all other chemicals were obtained from 
Sigma-Aldrich or Fisher. Swiss 3T3 albino mouse fibroblasts (fbs) were obtained from 
the Tissue Culture Facility at the University of North Carolina (UNC). 
Transmission electron microscopy images were acquired using a TF30He Polara G2 (FEI 
company) electron cryo microscope, operating at 300 keV. Images were recorded using a 
Tietz single port model 415 4k!4k CCD camera with a 15-µm pixel size. Fourier 
resonance energy transfer measurements were performed using a SPEX Fluorolog-3 
Research T-format Spectrofluorometer with an excitation wavelength of 471 nm. 
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Dynamic light scattering was performed using a Nikomp model 200-laser particle sizer 
with a 5 mW HeNe laser at an excitation wavelength of 632.8 nm and using a Wyatt 
DynoPro plate reader. Flow cytometry was performed using a Dako CyAn ADP 
(Beckman-Coulter, Brea, CA), and the data was analyzed with Summit 4.3 software. 
Phase contrast and fluorescent imaging was performed and processed using a Nikon 
TE2000-E inverted microscope and Metamorph software, respectively. Scanning electron 
microscopy images were obtained using a Hitachi S-4700 field emission scanning 
electron microscope (Hitachi High Technologies America, Inc., Schaumburg, Illinois).  
 
Scheme 3.1. List of liposomes, molecules, and cells used in this study. (1) Keto-LUV; (2) 
oxy-LUV; (3) keto-NBD-PE LUV; (4) oxy-rhod-PE LUV; (5) ketone-functionalized 
liposomes; (6) oxyamine-functionalized liposomes; (7) fluorescein-ketone; (8) rhod-
oxyamine; (9) ketone-functionalized fbs; and (10) oxyamine-functionalized fbs. 
 
3.2.2  2-(dodecyloxy)isoindoline-1,3-dione Synthesis (B) 
To a solution of N-hydroxyphthalimide (1.96 g, 12.04 mmol, 1.5 eq) and sodium 
bicarbonate (10.11 g, 12.04 mmol, 1.5) in DMF (20 mL) at 80°C was added 1-
bromododecane (1.93 mL, 8.02 mmol). The mixture was refluxed and stirred for 12 h. 
The reaction was diluted with DCM and washed with H2O (6 x 50 mL), 1 M NaHCO3 (3 
x 50 mL), and H2O (2 x 50 mL), dried over MgSO4, and concentrated to afford a white 
solid, B (2.66 g, 87 %). 1H NMR (400 MHz, CDCl3, !): 1.02 (s, 3H; CH3), 1.31-1.29 (m, 
14H, J = 8; CH2), 1.47-1.45 (m, 4H, J = 8; CH2), 1.60-1.57 (m, 2H, J = 12; CH2), 3.72-
3.70 (t, 2H, J = 8; CH2), 7.80-7.78, 7.85-7.83 (2 x m, 4H, J = 8; Ar-H). 
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3.2.3 O-dodecyloxyamine Synthesis (A) 
To a solution of B (2.65 g, 8.00 mmol) in dry DCM (30 mL) under inert atmosphere 
(Ar) was slowly added hydrazine (1.53 mL, 48.00 mmol, 6 eq). Upon addition, a white 
precipitate immediately formed. The mixture was stirred for 12 h. The reaction was 
diluted with DCM and washed with H2O (6 x 50 mL), dried over MgSO4, and 
concentrated to afford a pale yellow oil, A (1.18 g, 74 %). 1H NMR (400 MHz, CDCl3, 
!): 1.03 (s, 3H; CH3), 1.33-1.31 (m, 14H, J = 8; CH2), 1.43-1.41 (m, 4H, J = 8; CH2), 
1.50-1.46 (m, 2H, J = 16; CH2), 3.64-3.62 (t, 2H, J = 7; CH2). (ESI) (m/z) [M + H
+]: 
201.22.  
 
Scheme 3.2. Synthesis of O-dodecyloxyamine
a
 (A)"!
a
 Reagents and conditions. (i) N-
hydroxyphthalimide (1.5 eq), NaHCO3 (1.5 eq), DMF, reflux, 80 °C, 12 h; 87 % and (ii) 
hydrazine (6 eq), dry DCM, N2, 12 h; 74 %. 
3.2.4 (N-(4-(tert-butoxycarbonylamino)butyl)sulfamoyl)-2-(6-(diethylamino)-3-
(diethyliminio)-3H-xanthen-9-yl)benzenesulfonate Synthesis (C) 
To a solution of rhodamine lissamine (0.880 g, 1.53 mmol) in chloroform (CHCl3, 30 
mL) at room temperature (RT) was added N-BOC-1,4-diaminobutane (0.431 g, 2.29 
mmol, 1.5 eq) and TEA (0.305 mL, 2.29, 1.5 eq). The mixture was stirred for 8 h and 
then extracted with H2O (6 x 25 mL). The organic layers were concentrated to afford a 
dark purple solid 4. H1NMR was taken in CDCl3 to confirm C (1.045 g, 95 %). TLC 
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conditions for entire synthesis: CHCl3:MeOH (7.5:2.5). 
1H NMR (400 MHz, MeOD, !): 
1.09-1.07 (t, 6H, J = 8; CH3), 1.36-1.33 (m, 15H, J = 12; CH3), 1.66-1.64 (m, 4H, J = 8; 
CH2), 3.47-3.44 (m, 6H, J = 12; CH2), 4.20-4.18 (q, 4H, J = 7; CH2), 5.66 (s, 1H; Ar-H), 
5.77 (d, 1H; Ar-H), 6.01 (d, 1H; Ar-H), 6.34-6.30 (m, 2H, J = 16; Ar-H), 7.21 (d, 1H; Ar-
H), 7.29 (d, 1H; Ar-H), 7.98 (d, 1H; Ar-H), 8.04 (d, 1H; Ar-H). (ESI) (m/z) [M + H+]: 
716.31. 
3.2.5 5-(N-(4-aminobutyl)sulfamoyl)-2-(6-(diethylamino)-3-(diethyliminio)-3H-
xanthen-9-yl)benzenesulfonate Synthesis (D) 
To C (0.600 g, 0.837 mmol) was added a solution of TFA, H2O, and triisopropylsilane 
(TIPS) in a ratio of 95: 2.5: 2.5 (10 mL). The mixture was stirred at RT under N2 for 3 h 
and was then extracted with CHCl3 and H2O (4 x 25 mL). The organic layers were dried 
and concentrated to afford a purple solid, D (0.45 g, 85 %). 1H NMR (400 MHz, MeOD, 
!): 1.11-1.09 (t, 6H, J = 8; CH3), 1.33-1.31 (m, 6H, J = 7; CH3), 1.70-1.67 (m, 4H, J = 12; 
CH2), 2.63-2.62 (m, 2H, J = 4; CH2), 3.51-3.49 (m, 6H, J = 8; CH2), 4.20-4.18 (q, 4H, J = 
7; CH2), 5.64 (s, 1H; Ar-H), 5.71 (d, 1H; Ar-H), 6.02 (d, 1H; Ar-H), 6.32-6.30 (m, 2H, J 
= 8; Ar-H), 7.24 (d, 1H; Ar-H), 7.30 (d, 1H; Ar-H), 7.98 (d, 1H; Ar-H), 8.04 (d, 1H; Ar-
H). (ESI) (m/z) [M + H+]: 628.27. 
3.2.6 2-(6-(diethylamino)-3-(diethyliminio)-3H-xanthen-9-yl)-5-(N-(2,2-dimethyl-4,8-
dioxo-3,6-dioxa-5,9-diazatridecan-13-yl)sulfamoyl)benzenesulfonate Synthesis (E) 
 To a solution containing N,N’-dicyclohexylcarbodiimide (DCC, 0.394 g, 1.91 mmol, 2 
eq), N-hydroxysuccinimide (NHS, 0.220 g, 1.91 mmol 2 eq), and aminooxy acetic acid 
(0.356 g, 1.91 mmol, 2 eq) in DMF was stirred under N2 for 0.5 h. D (0.43 g, 0.684 
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mmol) was then added in DMF (20 mL), followed by TEA (excess). The mixture was 
strirred for 4 h and then concentrated. Flash chromatography was performed using 
CHCl3:MeOH (8:2) to elute, E. The product was concentrated to afford a purple solid 6 
(0.32 g, 60 %). 1H NMR (400 MHz, MeOD, !): 1.10-1.08 (t, 6H, J = 8; CH3), 1.39-1.36 
(m, 15H, J = 12; CH3), 1.65-1.63 (m, 4H, J = 7; CH2), 3.08-3.06 (m, 2H, J = 8; CH2), 
3.48-3.46 (m, 6H, J = 8; CH2), 4.17-4.15 (q, 4H, J = 7; CH2), 4.38 (s, 2H; CH2), 5.61 (s, 
1H; Ar-H), 5.73 (d, 1H; Ar-H), 6.02 (d, 1H; Ar-H), 6.31-6.30 (m, 2H, J = 4; Ar-H), 7.24 
(d, 1H; Ar-H), 7.32 (d, 1H; Ar-H), 7.96 (d, 1H; Ar-H), 8.09 (d, 1H; Ar-H). (ESI) (m/z) 
[M + H+]: 801.31. 
 
Scheme 3.3. Synthesis of rhod-oxyaminea (8). a Reagents and conditions. (i) N-BOC-1,4-
diaminobutane (1.5 eq), TEA (1.5 eq), CHCl3, N2, 25 ºC, 8 h; 95 %, (ii) triisopropylsilane 
(TIPS)/H2O/TFA (2.5 : 2.5 : 95), N2, 25 ºC, 3 h; 85 %, (iii) N-hydroxysuccinimide (NHS, 
2 eq), N,N’-dicyclohexylcarbodiimide (DCC, 2 eq), aminooxy acetic acid (2 eq), TEA 
(excess), DMF, N2, 25 ºC, 4 h; 60 %, and (iv) TIPS/H2O/TFA (2.5 : 2.5 : 95), N2, 25 ºC, 3 
h; 81 %. 
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3.2.7 5-(N-(4-(2-(aminooxy)acetamido)butyl)sulfamoyl)-2-(6-(diethylamino)-3-
(diethyliminio)-3H-xanthen-9-yl)benzenesulfonate (rhod-oxyamine, 7) Synthesis  
    To E (0.30 g, 0.374 mmol) was added a solution of TFA, H2O, and triisopropylsilane 
(TIPS) in a ratio of 95: 2.5: 2.5 (10 mL). The mixture was stirred at RT under N2 for 3 h 
and was then extracted with CHCl3 and H2O (4 x 25 mL). The organic layers were dried 
and concentrated to afford a purple solid and flash chromatography was performed using 
CHCl3:MeOH (8:2) to elute, 7 (0.21 g, 81 %) 
1H NMR (400 MHz, CDCl3, !): 1.12-1.00 
(t, 6H, J = 8; CH3), 1.42-1.40 (m, 6H, J = 7; CH3), 1.62-1.60 (m, 4H, J = 7; CH2), 3.07-
3.05 (m, 2H, J = 8; CH2), 3.45-3.42 (m, 6H, J = 12; CH2), 4.11-4.09 (q, 4H, J = 8; CH2), 
4.24 (s, 2H; CH2), 5.64 (s, 1H; Ar-H), 5.75 (d, 1H; Ar-H), 6.02 (d, 1H; Ar-H), 6.29-6.27 
(m, 2H, J = 4; Ar-H), 7.28 (d, 1H; Ar-H), 7.31 (d, 1H; Ar-H), 7.92 (d, 1H; Ar-H), 8.05 (d, 
1H; Ar-H). (ESI) (m/z) [M + H+]: 701.28. 
3.2.8 Formation of Lipid Vesicles. Liposome Fusion Studies 
Dodecanone (55 "L, 10 mM in CHCl3 at 5 mol %) was dissolved with egg palmitoyl-
oleoyl phosphatidylcholine (POPC) (430 "L, 10 mg/mL in CHCl3, at 95 mol %) and O-
dodecyloxyamine (60 "L, 10 mM in CHCl3 at 5 mol %) was mixed with POPC (410 "L, 
10 mg/mL in CHCl3 at 75 mol %), and egg 1-palmitoyl-2-oleoyl-phosphatidylglycerol 
(POPG) (92 "L, 10 mg/mL in CHCl3 at 20 mol %). Both lipid sample mixtures were then 
concentrated under high vacuum for 4 h. The dried lipid samples were reconstituted and 
brought to a final volume of 3 mL in PBS buffer, pH 7.4. The contents of the vial were 
warmed to 50˚C and sonicated for 20 min, in a tip sonicator, until the solution became 
clear and large unilamelar vesicles (LUVs) containing ketone (keto-LUV, 1) or oxyamine 
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(oxy-LUV, 2) groups were formed. Fourier resonance energy transfer (FRET) fusion 
studies. NBD-PE and rhod-PE were added to two separate vials at 2 mol %. The dried 
lipid samples were then reconstituted in 2.43 mL of PBS buffer, pH 7.4. The contents of 
the vial were warmed to 50˚C and sonicated for 20 min, in a tip sonicator, until the 
solution became clear, and LUVs containing ketone (keto-NBD-PE LUVs, 3) or 
oxyamine (oxy-rhod-PE LUVs, 4) groups were formed. Liposome fusion to cells. To 
generate ketone- and oxyamine-containing liposomes for cell fusion studies, dodecanone 
(55 !L, 10 mM solution in CHCl3 at 5 mol %) and O-dododecyloxyamine (60 !L, 10 
mM solution in CHCl3 at 5 mol %) were dissolved with egg-POPC (424 !L, 10 mg/mL in 
CHCl3 at 93 mol %) and 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP, 10 !L, 
10 mg/mL in CHCl3 at 2 mol %) in chloroform followed by concentration under high 
vacuum for 4 h. The dried lipid samples were then reconstituted and brought to a final 
volume of 3 mL in PBS buffer, pH 7.4. The contents of the vial were warmed to 50 ˚C 
and sonicated for 20 min, in a tip sonicator, until the solution became clear, and LUVs 
containing ketone (5) or oxyamine (6) groups were formed. 
3.2.9 Matrix-Assissted Laser-Desorption/Ionization Mass Spectrometry (MALDI-
MS) 
Preparation of gold-coated MALDI sample plates. Gold-coated MALDI sample plates 
(123 x 81 mm) (Applied Biosystems, Foster City, CA) were prepared by electron-beam 
deposition (Thermionics Laboratory Inc, Hayward, CA) of titanium (5 nm) and then gold 
(12 nm). In order to form self-assembled monolayers (SAM) of alkanethiolates on the 
plates, the slides were immersed in a 1-mM solution of aminooxyundecanethiol in EtOH 
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for approximately 1 min, rinsed with EtOH and dried, and then backfilled with a 1-mM 
solution of mercaptoundecanol in EtOH for 1 h. Once removed from solution, the 
surfaces were rinsed with EtOH and dried before use. Liposome preparation. Keto-
LUVs (1) were generated as previously described and were then delivered and allowed to 
react with the oxyamine-terminated MALDI sample plate (90 min). The plates were then 
washed with water (3 x 3 mL) and EtOH (2 x 3 mL) and dried before use. MALDI 
Analysis. MS analysis was carried out using an AB SCIEX TOF/TOF
TM
 5800 System 
(Applied Biosystems, Foster City, CA). 
3.2.10 Dynamic Light Scattering (DLS) 
Keto- (1) and oxy- (2) LUVs were generated as previously described and tested by 
DLS for monodispersity and uniformity. Light scattering experiments were performed 
using a Nikomp Model 200 Laser Particle Sizer with a 5 mW Helium-Neon Laser at an 
exciting wavelength of 632.8 nm. Standard deviation determinations were made using 
Gaussian analysis. A Wyatt DynoPro Dynamic Scattering Plate Reader was used to 
collect the light scattering data.  
3.2.11 Fourier Resonance Energy Transfer (FRET) 
Keto- (3) and oxy- (4) LUVs containing NBD-PE and rhod-PE, respectively, were 
generated as previously described and tested by FRET. All fluorescence measurements 
were performed in a SPEX Fluorolog-3 Research T-format Spectrofluorometer. NBD 
fluorescence was measured at 471 nm (excitation) and 531 nm (emission), maintaining 
narrow excitation slits to reduce light scattering interference. To obtain FRET 
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measurements, the NBD dye was excited at 471 nm, and the emission was scanned 
through 600 nm, and the emission signal for rhod-PE was observed at 578 nm. 
Fluorescence was followed immediately after mixing oxy-rhod-PE LUV (4, 3 mM in 
PBS, 100 µL) with keto-NBD-PE LUV (3, 3 mM in PBS, 100 µL) for approximately 2 h 
at 2 min intervals. The total lipid concentrations were adjusted to 0.2 mM, and the two 
LUV populations were had a 1:1 molar ratio. A constant flow of water was passed 
through the cuvette holder for temperature control. The temperature was maintained at 25 
°C. 
3.2.12 Isothermal Titration Calorimetry (ITC) 
Oxy- (2) and keto- (1) LUVs were made as previously described. Samples and PBS 
were degassed before use. Keto-LUV solutions were diluted to 0.02 mM in PBS at pH = 
7.4 and were placed in the cell. The oxy-LUV solution was then injected into the cell 
using a syringe. ITC was performed at 25 °C. No significant heat flow was detected when 
injecting PBS buffer into keto-LUV or injecting oxy-LUV into PBS buffer. ITC was 
performed on a MicroCal VP-ITC and data were fit to a single-site binding model using 
Origin. 
3.2.13 Transmission Electron Microscopy (TEM) 
Keto- (1) and oxy- (2) LUVs were made as previously described (0.2 mM in PBS, pH = 
7.4). The two vesicle solutions (1:1) were mixed at room temperature for 30 min. 4 µL of 
vesicles suspended in buffer were applied to standard lacey carbon EM grids were 
prepared according to published methods. The specimens were blotted from behind and 
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then submerged into aurenyl acetate solution for staining. The hydrated specimens were 
then placed into a TF30He Polara G2 (FEI company) electron cryo microscope operating 
at 300 keV. Images were recorded using a Tietz single port model 415 4k ! 4k CCD 
camera with a 15 micron pixel size on the chip. Pixel sizes at the specimen level were 
used to calculate accurate dimensions for the specimen. 
3.2.14 Rewiring Cell Adhesion 
Briefly, mixed self-assembled monolayers (SAMs) presenting oxyamine (OA) or 
aldehyde (Ald) and tetra (ethylene glycol) (EG4) groups were patterned using 
microfluidic lithography and microfluidic oxidation, respectively.39,40 The percentage of 
OA and Ald groups were minimal (1/9 OA:EG4, 1 mM in EtOH total) to ensure 
resistance to nonspecific protein and cell adhesion and determined by reaction of redox 
groups by electrochemistry.44 Swiss 3T3 albino mouse fbs were cultured with keto- (5) or 
oxy- (6) LUVs (previously described), separately, and were then seeded (~104 cells/mL) 
to surfaces patterned with OA or Ald, respectively. Over the course of 4 days, cells 
adhered, spread, and proliferated, filling out the patterned regions of the surface due to 
the interfacial oxime reaction. Cells cultured with liposomes, not containing the key 
functional groups, did not attach to the patterned surfaces. Substrates were then stained 
and imaged by fluorescence microscopy. An exposure time of 400 and 1200 ms were 
used to image nuclei and actin, respectively. 
3.2.15 Fibroblast (Fb) Culture 
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Swiss 3T3 albino mouse fbs and Rat2 fbs were cultured in Dulbecco’s Modified Eagle 
Medium (Gibco) containing 10 % calf bovine serum (CBS) and 1 % 
penicillin/streptomycin at 37 °C in 5 % CO2. Delivery of functionalized liposomes to 
cells. Cells were seeded onto a tissue culture plate and allowed to grow for 48 h at 37 °C 
in 5 % CO2 in CBS media. Solutions of keto-LUV (5) were reacted with rhod-oxyamine 
(7, 7 mM in H2O, 100 µL added to 4 mL) for 30 min and then added to cells for 4 h. The 
cells were then washed with PBS (4 x 4 mL) and imaged under a fluorescence 
microscope with an exposure time of 1/1200 s. Cell-surface reaction to ketone-
presenting cells. Solutions of keto-LUV (5, 1 mg/mL) were added to the culture to give 
the desired final ketone concentration of 100 µg/mL in a total volume of 2 mL. The cells 
were incubated with the keto-LUVs for 4 h and washed with PBS (4 x 25 mL), followed 
by addition of rhod-oxyamine (7, 7 mM in H2O, 100 µL added to 4 mL) dye and 
incubation for 30 min. The cells were then washed with PBS (4 x 4 mL) and removed 
with a solution of 0.05 % trypsin 0.53 mM EDTA and re-suspended in serum-free 
medium (~104 cells/mL). The cells were then seeded to a fibronectin-coated surface for 2 
h. After 2 h, serum-containing media was added for cell growth and imaged after 3 days. 
3.2.16 Flow Cytometry 
Fluorescence activated cell sorting (FACS) analysis was performed in order to 
quantify the approximate number of ketone and oxyamine groups at the cell surface after 
membrane fusion. Liposomes (5) were prepared as described above and were delivered to 
Swiss 3T3 albino mouse fbs in culture (3 mM in tris buffer, 400 µL added to 4 mL, 16 h). 
A time course assay was also conducted using FACS to determine whether the chemistry 
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was being carried on after cell growth and division. Fbs (8) were reacted with hydrazine-
conjugated biotin (3 mM in CBS, 1 mL added to 4 mL CBS in cell culture, 1 h) after 
culture with keto-containing liposome for 1, 3, 5, and 7 d. Fluorescein-conjugated 
streptavidin (1 mM in CBS, 0.5 mL added to 4 mL CBS in cell culture, 1 h). A control 
cell population (not displaying ketone groups) was only incubated with biotin-hydrazide 
and streptavidin-fluorescein for 1 h each, under the same conditions. Cells were then 
centrifuged (5 min, 1000 rpm), resuspended in RMPI (without phenol red), centrifuged (5 
min, 1000 rpm), and resuspended in RPMI (~107 cells/2 mL). Fluorescence 
measurements were calibrated using RCP-5-30 beads (~107 beads/mL, Spherotech, Inc., 
Lake Forest, IL) of known fluorescein equivalent molecule density. Fluorescent 
intensities based on number of cells counted were compared to the standard bead and 
control cells lacking fluorescent molecule conjugation and approximate numbers of 
fluorescent compound bound to the surface was calculated. Flow cytometry was carried 
out using a Dako CyAn ADP (Beckman-Coulter, Brea, CA), and data was analyzed with 
Summit 4.3 software.   
3.3 Results and Discussion 
3.3.1 Fusion Methodology and Dynamic Light Scattering 
In previous studies, we have shown how chemoselective oxime chemistry can be used 
to present biospecific ligands from supported, model fluid lipid bilayer membranes for 
subsequent recognition by protein receptors.
38
 Using this oxime ligation strategy, we 
generated a number of large unilamellar vesicles (LUVs) that present ketone or oxyamine 
functional groups and employed them in liposome-liposome fusion, Fourier resonance 
energy transfer (FRET), and liposome-cell fusion studies. For liposome-liposome fusion 
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analyses that include matrix-assisted laser-desorption/ionization mass spectrometry 
(MADLI-MS), dynamic light scattering (DLS), and transmission electron microscopy 
(TEM), dodecanone and dodecyloxyamine molecules were incorporated, separately, into 
neutral, egg palmitoyl-oleoyl phosphatidylcholine (POPC) at a ratio of 5:95 to form keto-
LUVs (1) and oxy-LUVs (2), respectively (Figure 1a and 1b). Dodecanone molecules 
were mixed with POPC and fluorescence donor, egg 1,2-diphytanoyl-sn-glycero-3-
phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (NBD-PE) at a ratio of 
5:93:2 to form keto-NBD-PE-LUVs (3), while dodecyloxyamine molecules were 
incorporated into POPC, negatively charged, egg 1-palmitoyl-2-oleoyl-
phosphatidylglycerol (POPG), and fluorescence acceptor, egg 1,2-dipalmitoyl-sn-
glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (rhod-PE) at a ratio 
of 5:73:20:2 to form oxy-rhod-PE-LUVs (4). These chemoselectively tailored liposomes 
(3 and 4) were used to conduct Fourier resonance energy transfer (FRET) studies (Figure 
1c). Finally, liposomes that contained dodecanone, POPC, and cationic lipid, 1,2-
dioleoyl-3-trimethylammonium-propane (DOTAP) (5:93:2, 5) and liposomes that 
composed of dodecyloxyamine, POPC, and DOTAP (5:93:2, 6) were generated to 
investigate liposome-cell fusion processes (Figure 1d). Cationic lipid, DOTAP, was 
incorporated to induce membrane fusion.39,40 Our general fusion methodology is 
described in Figure 1a. Two liposome populations (1 & 2, 3 & 4, or 5 & 6) were mixed, 
resulting in liposome docking, adhesion, and finally fusion due to the formation of stable, 
interfacial oxime bonds. Depending on the application, liposomes to each other, forming 
larger liposomal structures or to cell surfaces, demonstrating non-invasive, cell-surface 
engineering. Mixing 1 and 2 resulted in a gradual increase in size over a period of 2 h,  
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Figure 3.1 General schematic and corresponding lipid components for the formation of 
fused and adhered liposomes based on chemoselective oxime conjugation. (a) When 
mixed, ketone- and oxyamine-tethered liposomes react chemoselectively to form an 
interfacial, covalent oxime linkage, resulting in liposome docking and adhesion. Docked 
liposomes either fuse or form multi-adherent structures. (b) Dodecanone molecules were 
incorporated into neutral, POPC at a ratio of 5:95 to form keto-LUVs (1), while O-
dodecyloxyamine molecules were incorporated into POPC and negatively charged, 
POPG at a ratio of 5:75:20 to form oxy-LUVs (2). These liposomes were used for 
liposome-liposome fusion studies. (c) Dodecanone molecules were incorporated into 
POPC and fluorescence donor, NBD-PE at a ratio of 5:93:2 to form keto-NBD-PE LUVs 
(3). O-Dodecyloxyamine molecules were incorporated into POPC, POPG, and 
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fluorescence acceptor, rhod-PE at a ratio of 5:73:20:2 to form oxy-rhod-PE LUVs (4). 
These liposomes were used for FRET studies. (d) Dodecanone molecules were 
incorporated into POPC and positively charged, DOTAP at a ratio of 5:97:2 to form 
ketone-presenting liposomes (5). O-Dodecyloxyamine molecules were incorporated into 
POPC and DOTAP at a ratio of 5:93:2 to form oxyamine-presenting liposomes (6). These 
liposomes were used for cell-liposome fusion studies. 
 
followed by no change in size (Figure 2d). In a control reaction, LUVs not presenting 
ketones were reacted with LUVs containing oxyamines (1). Likewise, LUVs containing 
ketone groups (2) were mixed with LUVs that did not display oxyamines. For both of 
these control experiments, no size change was observed over time. This result strongly 
supports that liposome adhesion and fusion are driven by chemoselective oxime bond 
formation between the ketone- and oxyamine-alkanes.  
3.3.2 MALDI-MS 
Oxime conjugation, after keto-LUV (1) fusion, was confirmed by MALDI-MS analysis. 
Self-assembled monolayers (SAMs) of aminooxyundecanethiol were formed on a gold-
coated, sample plate. A solution containing keto-LUVs (1) was then allowed to fuse and 
react with the surface for 90 min, followed by MALDI-MS examination. A mass of 387 
units was detected, confirming successful oxime conjugation, resulting from liposome 
fusion on the surface (Figure 2a). 
3.3.3 TEM  
Structural insight into the formation of different adhered and fused liposomes was 
observed through TEM (Figure 2b).
41
 Vesicles of different sizes and shapes result after 2 
h of liposome mixing (keto-LUV, 1 and oxy-LUV, 2). The liposome size gradually 
increases with time and is consistent with the data collected from other sizing 
experiments (e.g., DLS). Upon reaction, the following three structures were observed: 
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multi-adherent liposomes that were not fused, partially fused liposomes, and completely 
fused, large uni- and multi-lamellar liposomes (Figure 2b). 
3.3.4 DLS 
DLS was performed upon mixing liposomes (1 and 2) to monitor vesicle size change as a 
function of time. Increases in vesicle size were observed due to aggregation, adhesion, or 
fusion (blue trace, Figure 2d). Liposome saturation was reached ~80 min after mixing. 
Without the presence of ketone and oxyamine functional groups, the LUV size remains 
constant (red trace, Figure 2d). 
 
Figure 3.2 Characterization of the formation of fused and adhered liposomes based on 
chemoselective oxime conjugation. (a) Mass spectrometry (MS) data representing the 
oxime ligation of keto-LUVs to self-assembled monolayers (SAMs) of oxyamine-
terminated alkanethiol on a gold surface is displayed. Matrix-assisted laser 
desorption/ionization (MALDI) was performed after keto-LUVs were delivered to the 
surface, and a mass of 387 units was detected, confirming oxime conjugation. (b) 
Structural analyses using transmission electron microscopy (TEM), representing the 
adhesion and fusion of keto- (1) and oxy- (2) LUVs over time. The following images are 
shown from left to right: multi-adherent liposomes that are not fused; partially fused 
liposomes; and a single, large liposome after complete fusion. The scale bars represent 60 
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nm. (c) Fourier resonance energy transfer (FRET) analysis of liposome adhesion and 
fusion was monitored over 2 h. Fluorescence emission of keto-NBD-PE/PC LUVs (3), 
excited at 460 nm, was observed by scanning 475-600 nm (green trace). Fluorescence 
emission of keto-NBD-PE/PC LUVs (3) mixed with oxy-rhod-PE/PC/POPG LUVs (4) is 
represented (purple trace). A new FRET emission peak is observed at 578 nm showing 
mixed liposome adhesion. (d) Dynamic light scattering (DLS) was performed upon 
mixing liposomes (1 and 2) to monitor vesicle size change as a function of time. 
Increases in vesicle size were observed due to aggregation, adhesion, or fusion (blue 
trace). Liposome saturation was reached ~80 min after mixing. Without the presence of 
ketone and oxyamine functional groups, the LUV size remains constant (red trace). 
 
3.3.5 FRET 
 Figure 2c shows a liposome fusion assay involving FRET characterization. A lipid-
bound FRET pair, NBD-PE (donor) and rhod-PE (acceptor), were incorporated at 2 mol 
% concentration during liposome generation to produce keto-NBD-PE LUVs (3) and 
oxy-rhod-PE LUVs (4), respectively. Hypothetically, fusion of these vesicles should 
result in a gradual decrease in the donor emission peak and an increase in acceptor 
emission peak
40
 due to the close proximity of these dyes. As shown, vesicle mixing 
resulted in this FRET fusion signature. Fusion was observed immediately upon mixing 3 
and 4, slowing within 2 h to a stable population, which is similar to earlier sizing results. 
An emission peak was not observed for the acceptor rhodamine dye when performing 
control experiments that tested the energy transfer with an LUV that did not contain 
oxyamines. Similar results were observed when LUVs that did not contain ketones or 
oxyamines were mixed. This data further supports that liposome aggregation and fusion 
is based on chemoselective oxime bond formation.  
3.3.6 Cell-Surface Labeling 
Chemical approaches to engineer cell surfaces have emerged as powerful tools for a 
variety of biomedical and biotechnological applications, including tissue engineering, 
drug delivery, and cell-based therapies.24 Several metabolic and genetic approaches to 
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display small molecular recognition pairs at cell surfaces for further covalent 
modification have been achieved through Click chemistry42 and Staudinger ligation.20 
However, such strategies may alter cellular physiology and interfere with normal 
biochemical pathways.28 In this report, we use oxime chemistry to tailor and fluorescently 
label cell surfaces via a novel liposome fusion strategy. As mentioned, cationic lipid, 
DOTAP, was incorporated within keto- and oxy-LUVs to initiate electrostatic 
destabilization and subsequent fusion to the cell membrane.
39
 As such, the minimum 
DOTAP concentration required to facilitate liposome-cell fusion was determined to be 2 
% through fluorescence labeling optimization. Keto-LUVs were generated using DOTAP 
and POPC concentrations that ranged from 0.5 % to 5 % and 90 % to 94.5 %, 
respectively, while maintaining a 5-% ketone concentration. These liposomes were 
incubated with fibroblasts (fbs) for 4 h, conjugated with an oxyamine-tethered rhodamine 
(rhod-oxyamine, 8) (0.7 mM, 2 h), and the cell fluorescence intensities were then 
compared. From 2 % to 5 % DOTAP, the intensities were almost identical, indicating that 
2 % DOTAP is sufficient to initiate fusion.  
Given this optimized lipid ratio (POPC/ketone or oxyamine/DOTAP at 93:5:2), two cell-
surface engineering methods were employed to fluorescently label fbs. Similar to our 
optimization experiments, a solution of keto-LUVs (5, 200 µL, 0.6 mM) was added to fbs 
in culture for 2 h, resulting in membrane fusion and subsequent display of ketones from 
the cell surface (9) (Figure 3d). Rhod-oxyamine (8, 100 µL, 0.7 mM in H2O) was then 
added the cells for 2 h. After oxime formation, the fbs were washed with PBS, 
trypsinized, diluted with CBS-containing media (~102/mL), seeded to a glass substrate, 
and imaged under a fluorescent microscope. As observed in figure 3f, the conjugation of 
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rhod-oxyamine with ketone-presenting fbs resulted in the red fluorescence labeling of 
cells. When the control fbs (i.e., no ketone groups present) were reacted with rhod-
oxyamine (8) and then imaged, no fluorescence was observed (Figure 3e). Demonstrating 
the flexibility of this liposome-based surface labeling strategy, we modified fb surfaces to 
present a ketone-functionalized fluorescein dye (7) after oxy-LUV-ketone-fluorescein 
conjugation and subsequent membrane fusion (Figure 3a). A solution of oxy-LUVs (6, 3 
mM) was incubated with a ketone-functionalized fluorescein (7, 0.15 mM, 1 eq, 2 h), 
generating fluorescently labeled liposomes. The liposomes were then added to fbs in 
culture for 2 h. After fusion, the cells were washed with PBS, trypsinized, diluted with 
CBS-containing media (~102/mL), seeded to a glass substrate, and imaged under a 
fluorescent microscope. Figure 3c presents green fluorescently labeled fbs after fusion 
with fluorescein-functionalized LUVs. When liposomes, not containing oxyamine groups 
were incubated with fluorescein-ketone and added to fbs in culture for 2 h, no 
fluorescence was observed (Figure 3b). Thus, our control images indicated that reaction 
and labeling does not occur without the proper oxime recognition pair (Figure 3b and 3e). 
Furthermore, under these conditions, we observed no changes in cell behavior upon 
liposome fusion to cells. This is a very important feature for future in vivo applications. 
Thus, by combining liposome fusion and oxime chemistry, we were able to tailor the cell 
surface with either ketone groups or oxyamine groups, which may act as chemoselective 
cell-surface receptors for a range of small molecules, ligands, biomolecules, and 
nanoparticles. 
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Figure 3.3 (Top) Schematic describing the delivery and subsequent fusion of fluorescent 
liposomes to cell surfaces with corresponding brightfield and fluorescent images. (a) 
Oxy-LUVs (6, 3 mM) were reacted with fluorescein-ketone (7, 0.15 mM, 2 h) to generate 
green fluorescent liposomes. The fluorescent liposomes were then added to fbs in culture, 
resulting in the fluorescent labeling of cells after liposome fusion to the cell membrane. 
Micrographs show (b) control cells where liposomes not containing oxyamine groups 
were incubated with fluorescein-ketone and added to fbs in culture for 2 h. and (c) green 
fluorescently labeled cells after oxyamine-functionalized liposomes were incubated with 
fluorescein-ketone and delivered to fbs (2 h). (Bottom) General schematic and images for 
cell-surface tailoring using liposome fusion and chemoselective oxime chemistry. (d) 
Keto-LUVs (5, 3 mM) were added and fused with the cells to display these groups from 
the cell surface (9). Addition of rhod-oxyamine (8, 0.7 mM in H2O, 2 min) resulted in 
chemoselective oxime formation and red fluorescent labeling of the cells. Images display 
(e) control fbs where liposomes not displaying ketones were fused to the membrane (2 h) 
and rhod-oxyamine was added and no fluorescence was observed and (f) fluorescently 
labeled cells after ketone-functionalized liposomes were fused to fbs (2 h) and cells were 
-incubated with rhod-oxyamine. Scale bars for b and c and d and e represent 50 and 30 
µm, respectively. 
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3.3.7 Cell Patterning: Rewiring Adhesion 
 The ability to pattern and adhere cells to different materials, such as thin metal films, 
polymer scaffolds, and nanoparticles, with a simple and straightforward chemoselective 
and bio-orthogonal approach would be beneficial for cell biology, tissue engineering, and 
biotechnology. Thus, we employed our liposome fusion-based toward cell-surface 
engineering to modify and rewire cell surface to adhere to patterned 2D substrates, 
directed through stable oxime bond conjugation. Figure 4a and 4b illustrate the strategy 
to rewire cell surfaces for the goal of cell adhesion to self-assembled monolayers (SAMs) 
of alkanethiolates on gold substrates. Employing microfluidic oxidation34 and 
lithography,35 aldehyde and oxyamine SAMs, respectively, were patterned at a ratio of 10 
%. The remaining 90 % of the surface was backfilled with tetra(ethylene glycol) 
alkanethiol, which is known to pacify biomaterials against nonspecific protein adsorption 
and cell adhesion.36 Meanwhile, fbs were cultured separately with keto- (5) and oxy-
LUVs (6, 3 mM, 4 h), resulting in membrane fusion and subsequent display of ketones 
(9) and oxyamines (10) from cell surfaces. The resulting ketone- and oxyamine-
presenting fbs were then seeded (~102 cells/mL, 2 h) to the patterned oxyamine and 
aldehyde substrates, respectively, and allowed to react and form stable oxime linkages in 
the patterned regions. The cells were cultured for 4 d on these substrates, growing and 
proliferating in the patterned regions. The results of patterned keto-fbs on oxyamine 
SAMs are shown in figure 4c; patterned oxy-fbs on aldehyde SAMs are displayed in 
figure 4d and 4e. Furthermore, unmodified cells did not attach to the surface. Thus, this 
strategy allows for a bottom-up, bio-orthogonal synthetic approach to rewire how cells 
adhere to materials and does not require metabolic or genetic cell manipulations.  
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Figure 3.4 Schematics and fluorescent micrographs of rewired cells adhered to patterned 
self-assembled monolayers (SAMs) of alkanethiolates on gold substrates. (a and b) Keto- 
(5) and oxy-LUVs (6, 3 mM, 4 h) were cultured with separate fb populations, producing 
ketone- and oxyamine-presenting fbs (9 and 10, respectively). These cells were then 
seeded (~10
2
 per mL, 2 h) to patterned, oxyamine- and aldehyde-terminated SAMs (10 
%), respectively, and allowed to adhere through stable oxime conjugation. The 
unpatterned surface regions present tetra(ethylene glycol), which resists cell and protein 
adsorption. The cells then grew and proliferated only filling out the oxyamine- and 
aldehyde-tethered surface regions, respectively. (c) A fluorescent micrograph of 
patterned ketone-fbs (9), adhered to an oxyamine-terminated SAM is shown. (d and e) 
Fluorescent micrographs of patterned oxyamine-fbs (10), adhered to an aldehyde-
terminated SAM are demonstrated. Cells were stained with DAPI (blue, nucleus) and 
phalloidin (red, actin). 
 
3.3.8 Flow Cytometry 
 Flow cytometry was performed to further verify the ability of tailoring small molecules 
to cell surfaces through covalent oxime bond formation. This method also enables the 
quantification of ketone and oxyamine molecules that are present at the cell surface after 
liposome delivery and subsequent membrane fusion. Liposomes that incorporated  
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Figure 3.5 Cell surface molecule quantification using flow cytometry. (a) Oxy-LUVs (6, 
3 mM) were added to fbs in culture (4 h), resulting in membrane fusion and subsequent 
display of oxyamine groups from cell surfaces (10). Ketone-functionalized fluorescein (7, 
0.15 mM 2 h) was then reacted with the fbs, generating fluorescently labeled cells. (b) 
Liposomes with varying oxyamine mol % (0 %, 1 %, 5 %, and 10 %) were generated and 
cultured with separate populations of fbs. After reacting with ketone-fluorescein, the cell 
populations were washed with PBS, trypsinized, centrifuged, resuspended in RPMI 
media, and tested using FACS analyses. As shown, the fluorescence intensity increased 
with increasing oxyamine concentration. (c) The number of present molecules at the cell 
surface with respect to oxyamine concentration was quantified using flow cytometry. A 
bead with a known FITC molecule density was employed as a standard comparison to 
calculate the number of oxyamines after oxy-LUVs (6) with 0 %, 1 %, 5 %, and 10 % 
oxyamine was cultured with cells. As the oxyamine concentration increased, the 
molecules per cell increased linearly (0 %, 128; 1 %, 1600; 5 %, 9800; and 10 %, 17400). 
Twenty thousand cells were counted for each sampling. 
 
varying oxyamine concentrations of (i.e., 0, 1, 5, and 10 mol %) were generated (6, 3 
mM) cultured with separate fb populations for 4 h, resulting in membrane fusion and 
oxyamine display (10, Figure 5a). A ketone-modified fluorescein dye (7, 0.15 mM, 2 h) 
was then conjugated to the cell surfaces in each population, producing green 
fluorescently labeled fbs. The FACS analyses results are demonstrated in figure 5b. 
Twenty thousand cells were counted for all samples. As shown, the fluorescence intensity 
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increases with increasing number of oxyamine molecules present for fluorescein 
conjugation. Additionally, the control cell population that was fused with unmodified 
liposomes and reacted with ketone-fluorescein (7) demonstrated the lowest intensity. 
Furthermore, a bead with known FITC molecule density was calibrated and used as a 
standard comparison to quantify the number of oxyamine molecules present at the cell 
surface after fusion.
37
 Figure 5c displays the correlation between oxyamine mol % and 
oxyamine molecules per cell counted by FACS analyses. The calculated molecules per 
cell for the control fbs and oxyamine-presenting fbs that were fused with 1 %, 5 %, and 
10 % oxyamine were approximately 128, 1300, 9800, and 17400, respectively. A linear 
trend was observed; as the molecule concentration increased, the fluorescence intensity 
and number of molecules at the cell surface increased. Thus, the density of molecules that 
decorate cell surfaces can be controlled and quantified using this liposome fusion-based 
methodology for cell-surface engineering.  
3.4 Conclusion 
In summary, we developed a chemoselective synthetic cell receptor system based on a 
liposome delivery and fusion strategy. Ketone and oxyamine groups were introduced to a 
liposomal system and chemoselective vesicle fusion was achieved using molecular 
recognition and interfacial oxime bond formation. Subsequent delivery of the decorated 
liposomes to cells lead to fusion and modification of a cell surface by bio-orthogonal 
reactive groups that serve as synthetic chemoselective cell receptors. Ketone and 
oxyamine modified cells were patterned on solid surfaces, displaying oxyamine and 
ketone groups respectively. Thus, rewiring cell adhesion was achieved using 
chemoselective oxime bond formation and without using any cell adhesive ligands, such 
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as Arg-Gly-Asp (RGD) and fibronectin. Since no biomolecules are used with this 
strategy, no long-term stability and degradation issues in complex cell culture media or in 
vivo will affect cell targeting or cell assembly. This methodology may have diverse 
applications in biomedical technologies including tissue engineering and regenerative 
medicine. Cells displaying ketone and oxyamine groups can react chemoselectively to 
form three-dimensional (3D) and tissue-like structures as directed through in situ oxime 
bond formation. This method can be extended to generate 3D cell co-culture systems and 
study cell-cell interactions. The ketone- and oxyamine-functionalized liposomes may 
have extensive applications in drug delivery and diagnostic applications, in which the 
interior of the liposome contains cargo while the exterior surface can be simultaneously 
functionalized with the tracking agent. 
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CHAPTER 4 
Synthetic Chemoselective Rewiring of Cell-Surfaces: Generation of 
Three-Dimensional Tissue Structures 
 
4.1 Introduction 
Cells that make up tissues and organs exist and communicate within a complex, three-
dimensional (3D) environment. The spatial orientation and distribution of extracellular 
matrix (ECM) components directly influences the manner in which cells receive, 
integrate, and respond to a range of input signals.
1
 As such, cellular interactions with 
ECM molecules and/or other cells have been extensively investigated for fundamental 
studies in development, cell motility, differentiation, apoptosis, paracrine signaling, and 
applications in tissue engineering.
2,3
 There has been tremendous effort toward the design 
and fabrication of 3D scaffolds that mimic ECM properties and induce tissue formation 
in vitro, utilizing various biomaterials, biodegradable polymers,
4  
collagen,
5
 and 
hydrogels.
6,7
 Among the major challenges facing the use of these technologies for tissue 
engineering are the abilities to force contact between multiple cell types in 3D to control 
the spatial and temporal arrangement of cellular interactions and tailor and mold the 
biomaterial to recapitulate the 3D, in vivo environment under laboratory constraints. 
Without the use of engineered scaffolds in culture, most cells are unable to form the 
necessary higher-order 3D structure required for the anatomical mimicry of tissue and are 
limited to random migration, generating two-dimensional (2D) monolayers. As a result, 
several approaches, including the use of dielectrophoretic forces,
8,9
 laser-guided 
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writing,
10-12
 surface manipulation,
13
 and a number of lithographic printing techniques
14-17
 
have been integrated with 3D scaffold designs to produce multi-type cellular arrays
9,11,17
 
or 3D cell clusters or spheroids.
7,8,13
 In a recent pioneering study by Bertozzi and Gartner, 
3D aggregates consisting of multiple cell types were formed within a hydrogel matrix 
through DNA hybridization after cell surfaces were engineered with complementary short 
oligonucleotides via a metabolic labeling approach.
7
 However, for some applications, the 
presentation of cell-surface DNA may not be stable for extended time periods in cell 
culture or in vivo.
18
  
Other approaches to cell-surface engineering have also been undertaken to 
incorporate a functional group into a target biomolecule, such as an endogenous protein, 
utilizing a cell’s biosynthetic machinery.
19,20
 These strategies aim to produce a site that 
can then be covalently modified with its delivered counterpart or probe. However, most 
of these protein-based tags are large and bulky and become problematic when interacting 
with the other glycans and biomolecules on the cell suface.
21,22
 Additionally, the 
perturbation of cellular physiology with biomolecules at the cell surface may result in the 
interference of significant biochemical pathways or cellular functions.
23,24
 Thus, a 
methodology that combines cell-surface modification, without the use of molecular 
biology techniques or biomolecules, and a simple, stable bio-orthogonal conjugation 
bottom-up approach that is capable of directing tissue formation would greatly benefit a 
range of medical applications such as wound healing and burn treatment.  
Herein, we develop and employ a novel strategy to induce specific and stable cell-cell 
contacts through chemoselective cell-surface engineering based on liposome delivery and 
fusion of bio-orthogonal functional groups to cell membranes.
25
 Using a cationic lipid, 
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membrane fusion,
26,27
 rather than the endocytotic cellular uptake of vesicle contents, is 
induced. This enables the presentation of bio-orthogonal ketone and oxyamine molecules 
from cell surfaces for subsequent chemoselective oxime ligation. No proteins or large 
biomolecules are used in this strategy, and therefore, cellular physiology is not perturbed. 
We demonstrate how this method may be used in several applications including, the 
delivery of reagents to cell surfaces, formation of 3D spheroid assemblies of cells with 
controlled inter-connectivity, and patterned multi-layered cell tissues. Furthermore, 3D 
multi-layered stem cell and fbroblast (fb) co-cultures were generated, and differentiation 
was induced to form tissue-like structures of adipocytes and fbs. To our knowledge, this 
is the first report utilizing tailored liposomes to modify a living cells surface through 
membrane fusion for subsequent bio-orthogonal tailoring to generate 3D tissue-like 
structures. 
4.2 Materials and Methods 
4.2.1 Materials 
All chemical reagents were of analytical grade and used without further purification. 
Lipids egg palmitoyl-oleoyl phosphatidylcholine (POPC) and 1,2-dioleoyl-3-
trimethylammonium-propane (DOTAP), egg were purchased from Avanti Polar Lipids 
(Alabaster, AL). Antibodies and fluorescent dyes were obtained from Invitrogen 
(Carlsbad, CA). Trypan blue viability dye was obtained from Hyclone (Fisher Sci, 
Pittsburgh, PA), and all other chemicals were obtained from Sigma-Aldrich or Fisher. 
Swiss 3T3 albino mouse fibroblasts (fb) were obtained from the Tissue Culture Facility at 
the University of North Carolina (UNC). Rat2 fb transfected with m-cherry were 
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obtained from the Bear Lab (UNC Chapel Hill, NC). Human Mesenchymal stem cells 
(hMSCs) were purchased from Lonza (Basel, Switzerland). 
Phase contrast and fluorescent imaging was performed and processed using a Nikon 
TE2000-E inverted microscope and Metamorph software, respectively. Scanning electron 
microscopy images were obtained using a Hitachi S-4700 field emission scanning 
electron microscope (Hitachi High Technologies America, Inc., Schaumburg, Illinois). 
Confocal micrographs were taken and processed using a Nikon Eclipse TE2000-E 
inverted microscope (Nikon USA, Inc., Melville, NY) and Volocity software, 
respectively.  
4.2.2 2-(dodecyloxy)isoindoline-1,3-dione Synthesis 
To a solution of N-hydroxyphthalimide (1.96 g, 12.04 mmol, 1.5 eq) and sodium 
bicarbonate (10.11 g, 12.04 mmol, 1.5) in DMF (20 mL) at 80°C was added 1-
bromododecane (1.93 mL, 8.02 mmol). The mixture was refluxed and stirred for 12 h. 
The reaction was diluted with DCM and washed with H2O (6 x 50 mL), 1 M NaHCO3 (3 
x 50 mL), and H2O (2 x 50 mL), dried over MgSO4, and concentrated to afford a white 
solid (2.66 g, 87 %). 1H NMR (400 MHz, CDCl3, !): 1.02 (s, 3H; CH3), 1.31-1.29 (m, 
14H, J = 8; CH2), 1.47-1.45 (m, 4H, J = 8; CH2), 1.60-1.57 (m, 2H, J = 12; CH2), 3.72-
3.70 (t, 2H, J = 8; CH2), 7.80-7.78, 7.85-7.83 (2 x m, 4H, J = 8; Ar-H). 
4.2.3 O-dodecyloxyamine Synthesis 
To a solution of 2-(dodecyloxy)isoindoline-1,3-dione (2.65 g, 8.00 mmol) in dry DCM 
(30 mL) under inert atmosphere (Ar) was slowly added hydrazine (1.53 mL, 48.00 mmol, 
6 eq). Upon addition, a white precipitate immediately formed. The mixture was stirred for 
12 h. The reaction was diluted with DCM and washed with H2O (6 x 50 mL), dried over 
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MgSO4, and concentrated to afford a pale yellow oil (1.18 g, 74 %). 
1H NMR (400 MHz, 
CDCl3, !): 1.03 (s, 3H; CH3), 1.33-1.31 (m, 14H, J = 8; CH2), 1.43-1.41 (m, 4H, J = 8; 
CH2), 1.50-1.46 (m, 2H, J = 16; CH2), 3.64-3.62 (t, 2H, J = 7; CH2). (ESI) (m/z) [M + 
H+]: 201.22. 
4.2.4 Liposome Fusion to Cells 
To generate keto-LUV and oxy-LUV, dodecanone (55 "L, 10 mM solution in CHCl3 
at 5 mol %) and alkane-tethered oxyamine (60 "L, 10 mM solution in CHCl3 at 5 mol %) 
were dissolved with egg-POPC (424 "L, 10 mg/mL in CHCl3 at 93 mol %) and 1,2-
dioleoyl-3-trimethylammonium-propane (DOTAP, 10 "L, 10 mg/mL in CHCl3 at 2 mol 
%) in chloroform followed by concentration under high vacuum for 4 h. The dried lipid 
samples were then reconstituted and brought to a final volume of 3 mL in PBS buffer, pH 
7.4. The contents of the vial were warmed to 50˚C and sonicated for 20 min, in a tip 
sonicator, until the solution became clear, and LUVs containing ketone or oxyamine 
groups were formed. 
4.2.5 3D Spheroid Generation 
Keto-LUV and oxy-LUV were added to two separate fb populations in culture for (3 mM 
in tris buffer, 400 µL added to 4 mL, 16 h), resulting in fusion and display of ketones and 
oxyamines from the cell surface. Oxyamine-presenting Rat2 fb contained an m-cherry 
label (nucleus) for enhanced visualization, while the ketone-presenting Swiss 3T3 albino 
mouse fb contained no fluorescent label. These two cell populations were then 
trypsinized and mixed together (~204 cells/mL, 4 mL total) in serum containing (10 % 
CBS, pH of 7.4) media in a 10 mL-flask and incubated at 37 °C and 5 % CO2 for 3 h. 
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After mixing, the cells were seeded on a glass surface (~204 cells/mL, 1 mL) and 
visualized under a Nikon TE2000-E inverted microscope or by scanning electron 
microscopy. Image acquisition and processing was performed using Metamorph 
software. An exposure time of 75 ms was used to image all spheroids. 
4.2.6 Scanning Electron Microscopy (SEM) of 3D Spheroids 
After spheroids were assembled in solution (reaction for 3 h as described above) and 
delivered to a glass slide (~204 cells/mL, 1 mL, 0.8 x 0.8 cm2) and the fixed with 10 % 
formalin in PBS for 15 min. The substrate was then washed with water (15 min), and 
cells were then dehydrated stepwise in 30, 50, 70, 90, and 100 % ethanolic solutions for 
15 min each. After critical point drying and sputtering 2 nm of gold, the sample was 
ready for imaging using a Hitachi S-4700 field emission scanning electron microscope 
(Hitachi High Technologies America, Inc., Schaumburg, Illinois). 
4.2.7 Fibroblast (Fb) Culture 
Swiss 3T3 albino mouse fb and Rat2 fb were cultured in Dulbecco’s Modified Eagle 
Medium (Gibco) containing 10 % calf bovine serum (CBS) and 1 % 
penicillin/streptomycin at 37 °C in 5 % CO2. Delivery of functionalized liposomes to 
cells. Cells were seeded onto a tissue culture plate and allowed to grow for 48 h at 37 °C 
in 5 % CO2 in CBS media. Solutions of keto-LUV were reacted with rhod-oxyamine (7 
mM in H2O, 100 µL added to 4 mL) for 30 min and then added to cells for 4 h. The cells 
were then washed with PBS (4 x 4 mL) and imaged under a fluorescence microscope 
with an exposure time of 1/1200 s. 
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4.2.8 hMSC (human mesenchymal stem cell) culture 
hMSCs and basic, growth, and differentiation media were obtained from Lonza (Basel, 
Switzerland). hMSCs were cultured in Dulbecco’s Modified Eagle Medium (Gibco) 
containing 10 % fetal bovine serum (FBS) and 1 % penicillin/streptomycin at 37°C in 5 
% CO2. Adipogenic differentiation was induced by culturing with induction medium as 
described in the Lonza protocol. 
4.2.9 Immunhistochemistry 
After the growth of 3D tissue-like structures and co-culture with Swiss 3T3 albino 
mouse fb, surfaces were fixed with formaldehyde (4 % in PBS, 30 min). Substrates were 
then immersed in a solution containing water and 60 % isopropyl alcohol (3-5 min), 
followed by staining with Oil Red O (5 min) and Harris Hemotoxylin (1 min) (6,7). 
Substrates were visualized by phase contrast microscopy using a Nikon TE2000-E 
inverted microscope. Image acquisition and processing was performed using Metamorph 
software. An exposure time of 75 ms was used to image all HMSCs.  
4.2.10 Directed 3D Tissue-like Multi-Layers 
Ketone-functionalized fibroblast cells were seeded (~104 cells/mL) to microcontact 
printed patterned (1 mM hexadecanethiol in EtOH, printed on gold 5 s, backfilled with 1 
mM EG4 in EtOH, 16 h) surfaces presenting fibronectin (10 mg/mL, 2 h) for 2 h. The 
cells were allowed to grow for 3 days (serum-free media, 37 ºC in 5 % CO2).
29 
Oxyamine-functionalized fibroblast cells (~104 cells/mL) were then seeded to surfaces for 
2 h followed by addition of serum-containing (10 % CBS) media to promote cell growth. 
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The cells were cultured for 3 more days before imaging. Controls showed no multi-layer 
formation when oxyamine or ketone groups were not presented on the cell surfaces or 
when two ketone-presenting cells interacted with each other or when two oxyamine-
presenting cells interacted with each together. Only when the correct oxime pair is 
combined do multi-layers of cells form. After generation, substrates were fixed, stained, 
and imaged by confocal microscopy as described below. 
4.2.11 Cell Staining for Imaging 
Cells were fixed with formaldehyde (4 % in PBS) and permeated (PBS containing 0.1 % 
Triton X–100). A fluorescent dye mixture, containing phalloidin-TRITC (actin) and 
DAPI (nucleus) was then made in PBS containing 5 % normal goat serum and 0.1 % 
Triton X –100. Cells were incubated with the dye solution for 2 h. The substrates were 
then secured in fluorescence mounting medium (Dako, Carpinteria, CA, USA), which 
enhances the visualization of cells when viewed under a fluorescent microscope on a 
glass cover slip. An exposure time of 400 and 1200 ms were used to image nuclei and 
actin, respectively. 
4.2.12 Confocal Microscopy 
Cell clusters and tissue formation were visualized with a Nikon Eclipse TE2000-E 
inverted microscope (Nikon USA, Inc., Melville, NY). Data was analyzed by Leica 
software and a spectral confocal microscope (LeicaMicrosystems, Bannockburn, IL). An 
average of 84 image scans were used to generate the 3D reconstructions with Volocity 
software. 
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4.2.13 3D Co-Culture Spheroid and Multi-Layer Generation 
Spheroids: Keto- and oxy-LUVs were generated as previously reported and were added 
to hMSC and Swiss 3T3 albino mouse fb (3 mM in tris buffer, 400 µL added to 4 mL, 16 
h), respectively, and were cultured, resulting in fusion and display of ketones and 
oxyamines from the cell surface. These two cell populations were then trypsinized and 
mixed together in serum containing (10 %  FCS, pH of 7.4) media in a 10 mL flask and 
incubated at 37 °C and 5 % CO2 for 1, 2, 3, and 5 h. After mixing for the allotted time, 
cells were seeded onto a glass surface and visualized under a Nikon TE2000-E inverted 
microscope under the brightfield setting (75 ms exposure time). Controls were also 
performed where hMSCs displaying ketone groups were co-cultured with fbs (not 
displaying oxyamine groups) for each of the corresponding time points, 1, 2, 3, and 5 h, 
seeded onto glass, and imaged under the brightfield setting (75 ms). Image acquisition 
and processing was performed using Metamorph software. Multi-layers: Ket- and oxy-
LUVs were added to hMSC and Swiss 3T3 albino mouse fb (3 mM in tris buffer, 400 µL 
added to 4 mL, 16 h), respectively, and were cultured, resulting in fusion and display of 
ketones and oxyamines from the cell surface. hMSCs displaying ketone groups were 
trypsinized and cultured on glass slides (105 cells/mL) and allowed to grow for 2 days. 
Fibroblasts presenting oxyamines were then trypsinized and added (105 cells/mL) to the 
hMSCs. These cells were co-cultured in media (10 % FCS) for 3, 5, and 7 d, resulting in 
the formation of 3D multi-layered, tissue-like structures of hMSC and fb. 
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4.2.14 Cell Viability Assay 
Cell viability of 3D spheroid and multi-layered tissue-like structures was assessed by 
performing a trypan blue viability assay (Hyclone, Fisher Sci, Pittsburgh, PA). Fb 
spheroid and multi-layer structures were prepared as previously described. A solution of 
0.4 % trypan blue in PBS was made and diluted in CBS (1:1) containing the spheroids (1, 
3, and 5 h after mixing, 204 cells/mL) in solution and multi-layer cell sheets (3, 5, and 7 d 
after a second fb population was added, 105 cells/mL) on a glass slide. Trypan blue was 
allowed to react with the cells for 2 min, at which time spheroids and surfaces were 
imaged and false colored with blue for enhanced visualization using a Nikon TE2000-E 
inverted microscope. As a control, cells were cultured for 7 days to generate a multilayer 
and were then fixed as mentioned above. Trypan blue was allowed to react for 2 min, and 
cells were imaged. For phase contrast and fluorescent imaging, exposure times of 75 and 
400 ms were used, respectively.  
4.3 Results and Discussion 
4.3.1 Overview of the Method 
Vesicle fusion was directed through the use of molecular recognition and 
chemoselective ligation toward the goal of rewiring cell adhesion to generate 3D multi-
layers of cells. Using liposomes as the simplest model of a cell, we previsouly 
demonstrated and extensively characterized the parameters for chemoselectively driven 
liposome fusion. Vesicles were tailored with ketone (dodecanone) or oxyamine (O-
dodecyloxyamine) molecules. The resulting two populations of vesicles were used to  
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Figure 4.1 General schematic describing 3D tissue formation via liposome fusion and 
chemoselective cell-surface tailoring. (A) Dodecanone molecules were incorporated into 
neutral, egg palmitoyl-oleoyl phosphatidylcholine (POPC) and positively charged, 1,2-
dioleoyl-3-trimethylammonium-propane (DOTAP) at a ratio of 5:93:2 to form ketone-
presenting liposomes (1). (B) Dodecyloxyamine molecules were incorporated into POPC 
and DOTAP at a ratio of 5:93:2 to form oxyamine-presenting liposomes (2). (C) Two 
fibroblast (fb) populations were cultured separately with ketone- (1) or oxyamine- (2) 
containing liposomes. Due to the presence of a positively charged liposome fusion 
occurs, producing ketone- (3) and oxyamine- (4) tethered fbs. Upon mixing these cell 
populations, clustering and tissue-like formation, based on chemoselective oxime 
conjugation, occurred.  
      
study liposome adhesion or fusion to one another via oxime conjugation. This system was 
then integrated with mammalian cells in culture to fuse liposomes to cell membranes for 
applications in small molecule delivery and cell-surface engineering. In this study, we 
used this membrane modification strategy to direct the assembly of 3D spheroid clusters 
and tissue-like structures by culturing two cell populations functionalized with oxyamine- 
and ketone-containing groups. Since this method is general, bio-orthogonal, chemically 
stable (oxime bond), and non-cytotoxic, patterned multi-layered tissue-like structures of 
different geometric shapes could also be fabricated without the use of 3D scaffolds to 
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confine the cell populations. We also show that this method has promising use in stem 
cell transplantation by co-culturing human mesenchymal stem cells (hMSCs) with 
fibroblasts (fbs) and inducing adipocyte differentian while in a 3D multi-layered tissue-
like structure.  
For membrane fusion studies, dodecanone and dodecyloxyamine were incorporated 
separately into netual, egg palmitoyl-oleoyl phosphatidylcholine (POPC) and cationic, 
1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) lipids at a ratio of 5:93:2 (Figure 
1A and 1B). The alkane-tethered ketone and oxyamine molecules spontaneously insert 
themselves into the vesicles during syntheses.28 Cationic lipid, DOTAP, was added to 
favor and enhance membrane fusion, and subsequent display of lipid components at the 
cell surface, rather than endocytosis of the vesicle contents.26,27 Our general fusion 
strategy to generate 3D tissue-like structures is represented in figure 1C. When cells are 
incubated with ketone- (1) or oyamine- (2) containing liposomes, membrane fusion 
occurs, resulting in the presentation of ketone and oyamine groups from cell surfaces (3 
and 4). When these cell populations are cultured together, interconnected, 3D tissue-like 
structures form, mediated through chemoselective oxime conjugation. These stable tissue 
stuctures can be generated in solution or on a solid support. 
4.3.2 3D Spheroid Assembly 
The ability to generate multicellular connected tissues of multiple cell types in vitro is 
crucial for studying the complex interplay of cells in a range of organs in vivo and for 
developing strategies for synthetic tissue transplantation. With varying successes, a 
number of current strategies to generate 3D cell connections rely on forcing mixed cell 
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populations into complex microfabricated wells or vessels. Therefore, we extended this 
liposome fusion, oxime-based strategy to generate 3D spheroid assemblies of 
interconnected cells using two different cell-type populations (Figure 2). The oxyamine-
presenting rat2 fbs (4) contained a nuclear m-cherry fluorescent label so that the cell 
clustering to non-fluorescent ketone-tethered cells (3) could be easily observed. During a 
3-hour period of mixed-culturing (~10
4
 cells/mL) in solution, cells formed spheroid 
structures due to the presence of complementary recognition groups (Figure 2B and 2C). 
Furthermore, when oxyamine-presenting fbs (4) were cultured with control fbs (cells not 
functionlized with ketone groups), spheroid assembly did not occur (Figure 2A). Studies 
were also performed to test whether spheroid size and cell composition could be 
controlled (Supporting Information, Figure S1). Ketone-presenting hMSCs (6) were co-
cultured with oxyamine-functionalized fbs (5) for 1, 2, 3, and 5 h. After 1 h, clusters 
comprised with only a few cells were observed. As the co-culturing duration increased, 
larger spheroid structures were seen. Notably, control experiments were performed 
simultaneously to ensure that spheroid generation was being directed through 
chemoselective oxime conjugation. Shown as insets in figure S1A-D, tissue structure 
formation did not occur without the proper complementary pair displayed from cell 
surfaces, regardless of the mixing duration (1-5 h). Thus, size and composition of 3D cell 
assemblies in solution could be controlled, showing great promise for applications in 
stem cell transplantation and regenerative medicine.  
Spheroid formation was also characterized by scanning electron microscopy (SEM) 
(Figure 2E-G and S2). Cells functionalized with oxyamine (5) and ketone (3) groups were 
able to generate clusters when mixed in solution as displayed in figure 4F and 4G 
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(Supporting Information, Figure S2). However, spheroid assemblies were not observed 
when ketone-presenting fibroblasts were reacted with non-functionalized cells; fbs spread 
out on the surface, migrated, but remained alone (Figure 4E). It is important to note that 
cells were able to form stable, interconnected 3D structures in solution simply upon 
mixing two tailored cell populations. Currently, methods to generate these structures 
require the support of a 3D hydrogel matrix and/or assisted assembly through an external 
stimulus.
5,7-9,13
 
Figure 4.2 Fluorescent, phase contrast, and scanning electron micrographs (SEM) 
describing 3D spheroid formation via liposome fusion and chemoselective cell-surface 
tailoring. Two fibroblast populations were cultured separately with ketone- (1) or 
oxyamine- (2) containing liposomes, resulting in membrane fusion and subsequent 
tethering of ketones and oxyamines from the cell surface. The oxyamine-tethered rat2 fbs 
(4) contained a fluorescent m-cherry nuclear label. The ketone-presenting Swiss albino 
3T3 fbs (3) were not fluorescently labeled. (A) Control experiments (overlay image) 
demonstrate no spheroid formation for cells that did not contain either ketone or 
oxyamine groups. (B and C) However, when two cell populations displaying ketone (3) 
and oxyamine (4) recognition groups are mixed, interconnected spheroid assemblies form 
(overlay images). (D-F) Representative SEM images of control cells and (E and F) 
spheroid assemblies, as described above, are displayed. For all spheroid assemblies 
depicted, cell populations were mixed and cultured together for 3 h before imaging at 
~104 cells/mL. 
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4.3.3 3D Multi-Layered Tissues 
In addition to forming small, 3D cell clusters or spheroid structures in solution, this 
strategy may be employed to direct larger, dense 3D tissue-like networks on a surface 
with geometric control (Figure 3). We used full substrates, as well as surfaces that were 
patterned with cell adhesive and non-adhesive regions to generate multi-layered sheets 
and patterned tissue structures, respectively.
43
 Ketone- (1) and oxyamine- (2) tailored 
liposomes were cultured with separate fb populations, resulting in membrane fusion and 
subsequent presentation of chemoselective sites for oxime conjugation from the surface 
(3 and 5, respectively) (Figure 3A). Culturing these groups on a solid support (~10
5
 
cells/mL), in a layer-by-layer deposition manner, gave rise to multi-layered, tissue-like 
cell sheets, which were characterized by confocal microscopy as shown in figure 3E and 
3F. Fbs naturally only form a single monolayer once they become contact-inhibited. 
However, we have successfully induced fb-fb clustering though oxime-mediated, cell-
surface engineering based on liposome fusion.  
To ensure that oxime chemistry was aiding in the formation of 3D tissue-like 
structures, several control experiments were performed. Cells that did not present ketone 
or oxyamine functionality were seeded onto separate surfaces. A second cell population 
presenting oxyamine (5) or ketone (3) groups from the cell surface was added, resulting 
in the formation of only a 2D monolayer of cells (Figure 3B- and 2C). Similarly, two 
different cell populations that were tethered with oxyamine (5) groups were mixed 
together, and only a 2D monolayer was generated after 4 d of culture. The same results 
were observed after culturing two different ketone-functionalized cell populations for 4 d. 
These results further support the hypothesis that multi-layered cell interconnectivity is 
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driven by complementary, oxime chemistry. We also extended this strategy toward the 
generation of 3D multi-layered co-cultures with hMSCs and fbs (Supporting Information, 
Figure S3). Ketone-functionalized hMSCs (6) were first cultured on a substrate (~105 
cells/mL), and the stem cells were allowed to spread out and grow for 2 d. Oxyamine-
presenting fbs (5) were then added (~105 cells/mL) and co-cultured for an additional 2 d. 
As shown by the confocal images in figure S3B and S3C, 3D multi-layered cell sheets (4  
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Figure 4.3 General schematic and images of oxime-mediated, 3D tissue-like structure 
formation with controlled interconnectivity. (A) Ketone- (1) and oxyamine- (2) 
containing liposomes were added to two separate fb populations, resulting in membrane 
fusion and subsequent presentation of the ketone (3) and oxyamine (5) groups from cell 
surfaces. By culturing these cells on substrates, alternating cell population seeding layer-
by-layer, gave rise to multi-layered, tissue-like cell sheets through stable oxime 
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chemistry. (B) A 3D reconstruction and (C) confocal micrograph showing only a 
monolayer of cells after oxyamine-presenting cells (5) were cultured with adhered non-
functionalized cells. (D) A 3D reconstruction and (E) confocal micrograph of multiple 
cell layers after oxyamine-presenting cells (5) were added to substrates presenting 
ketone-containing cells (3). (H and I) Intact, 3D multi-layered cell sheets can be removed 
from the surface by gentle agitation as displayed by brightfield and fluorescent images. 
The insets in B and E show a z-plane cross-section that indicates the thickness of the cell 
layers. Cells were stained with DAPI (blue, nucleus) and phalloidin (red, actin).  
 
layers) were formed. The proper controls were conducted; without the oxime pair, only a 
2D monolayer of stem cells and fbs was formed (Supporting Information, Figure S3A). 
4.3.4 3D Tissue Release and Cell Viability 
During multi-layer culture, it was possible to control the release of the tissues from the 
surface with gentle agitation (Figure 3D and 5G). The ability to release tissue after 
surface-supported growth in vitro shows great potential for applications in tissue 
engineering and cellular transplantation. Cell viability was also tested for 3D spheroid 
and multi-layered structures of fbs and hMSC/fibroblast co-cultures using the trypan blue 
assay (Supporting Information, Figure S4).
29
 After spheroid (1, 2, 3, and 5 hours of 
mixing in solution) and multi-layer (3, 5, and 7 days on a surface) formation, cells were 
incubated with trypan blue (0.4 %, 2 min). No cells were observed dead in spheroid (1-5 
hours) and multi-layers (3 days). However, after 5 and 7 days of multi-layer generation, 
cells showed an approximate viability of 91 % and 84 %, respectively. The blue intensity 
(fluorescence false colored for enhanced visualization) was compared to a control cell 
population by linescan analysis (Figure S4). The control cells were cultured for 7 days to 
generate a 3D multi-layer and were then fixed. Trypan blue was allowed to react for 2 
min, followed by imaging and quantification. Overall, the viability of cells in conducting 
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membrane fusion to generate 3D tissue-like structures in solution and on a solid support 
is high. Therefore, this method may be very useful for applications in tissue engineering 
and stem cell transplantation. 
4.3.5 3D Tissue Patches with Geometrical Control 
We further demonstrated spatial control by generating a number of 3D multicellular 
micropatterns. Microcontact printing
30
 was used to produce a variety of patterns and 
geometries on a gold substrate. Employing SAM and microfabrication technologies, 
hexadecanethiol (1 mM in EtOH) was printed on a gold surface for 5 s using a 
patterened, polydiemthylsiloxane (PDMS) stamp. The surface was then backfilled with 
tetra(ethylene glycol)-alkanethiol (EG4) (1 mM in EtOH, 16 h) to render the remaining 
regions inert to nonspecific protein absorption. Fibronetin, a cell-adhesive protein was 
then added (10 mg/mL in CBS, 2 h), adhering only to the hydrophobic, patterned areas. 
As shown by the confocal image in figure 4A, only a 2D, circular cell pattern arises after 
ketone-presenting fbs (3) were cultured with fbs, not functionalized with oxyamine 
molecules. However, when liposome fusion occurs to display complementary ketone and 
oxyamine groups from cell surfaces (3 and 5, respectively), multi-layered 3D cell patterns 
were formed (Figure 4B-D). Bar, square, and circular tissue-like structures are depicted 
in figure 4B-D. The ability to generate 3D tissues with controlled geometry would find 
great use in tissue transplantation, in which specifically tailored patches are required.  
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Figure 4.4 Confocal images representing 2D monolayer and 3D multi-layered tissue-like 
structures of fbs with spatial control. (A) A circular, 2D monolayer of fbs (control) result 
after ketone-functionalized fbs (3) and fbs (not functionalized with oxyamines) are 
patterned on a circular, microcontact printed region, presenting fibronectin and allowed 
to grow for 5 days. (B-D) Fbs, functionalized with ketone groups (3) were seeded onto 
microcontact printed regions containing fibronectin and allowed to grow for 2 days. Fbs, 
functionalized with oxyamine groups (5) were then seeded and allowed to grow for 2-3 
more days. Confocal images demonstrating 3D tissue formation in (B) bar, (C) square, 
and (C) circle geometries are depicted. The corresponding z-plane cross-sections that 
indicate the thickness of the cell layers are shown as an inset. Cells were stained with 
DAPI (blue, nucleus) and phalloidin (red, actin).  
 
4.3.6 3D Stem Cell Co-Cultures with Induced Adipocyte Differentiation 
We have explored the general use of this liposome fusion method and have delivered 
ketone and oxyamine groups to a range of cell lines and have demonstrated that 3D 
spheroid and multi-layer can be generated using co-cultures of human mesenchymal stem 
cells (hMSCs) and fibroblasts (Supporting Information, Figures S1 and S3, respectively). 
We next extended our methodology toward stem cell differentiation to determine whether 
3D multi-layered co-cultures could be induced to generate tissues of differentiated 
hMSCs and fbs. As shown in figure 5A, ketone-functionalized hMSCs (6) were first 
cultured on a substrate for 3 d, producing a 2D monolayer of cells (Figure 5B). 
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Oxyamine-tethered fbs (5) were then co-cultured with the hMSCs, and the cells were 
allowed to grow and proliferate for 2 d (Figure 5C). Adipogenic induction media was 
then added, the 3D multi-layered co-culture was stained for nuclei (purple) and lipid 
vacuoles (red), which are characteristic of adipocytes (fat cells). The phase contrast 
images in figure 5D and 5E demonstrate the successful generation of tissue-like 
structures, comprising induced adipocytes and fbs. The ability to co-culture stem cells 
with many other cell types and induce differentiation shows great promise in the field of 
regenerative medicine and stem cell transplantation. 
 
Figure 4.5 General schematic and brightfield images representing oxime-mediated, 3D 
tissue-like structure formation with hMSC/fb co-cultures and subsequent induced 
adipocyte differentiation to generate 3D adipocyte/fb co-culture structures. (A) Ketone-
tethered hMSCs (6) were seeded onto a surface, followed by the addition of oxyamine-
functionalized fbs (5). The co-culture was allowed to grow and divide for 3 d at which 
point, adipogenic differentiation was induced with the addition of the appropriate media. 
This resulted in a 3D multi-layer of adipocytes and fb. (B) A confluent 2D monolayer of 
ketone-presenting hMSCs is represented. (C) A brightfield image displaying a 3D multi-
layer co-culture of hMSCs (6) and oxyamine-functionalized fbs (5) is shown. (D) 
Adipogenic differentiation was induced with media resulting in 3D multi-layered 
adipocyte and fb co-culture structures, represented by low and (E) high-resolution 
brightfield images (after 10 days in culture). Adipocytes were stained with Oil Red O 
(lipid vacuoles) and Harris Hemotoxylin (nucleus). 
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4.4 Conclusions 
In summary, we developed a liposome delivery and fusion method to display ketone 
or oxyamine functional groups from cell surfaces for applications in bio-orthogonal 
ligand conjugation, rewiring cell adhesion, and the generation of stable, 3D spheroid 
assemblies and multi-layered tissue-like structures. This strategy may have diverse 
applications in the field of tissue engineering and regenerative medicine, from growing 
biocompatible tissues and organs in vitro to their cellular transplantation in vivo.
31,32
 For 
example, assembled tissue patches with geometrically defined shape can be grown in 
culture and transplanted or grafted to specific locations.
33
 Furthermore, this strategy may 
allow for time-lapse observation of cell movement in vivo by using a pulse (delivery of 
labeled cells via liposome fusion) followed by a chase (bio-orthogonal reagent to target 
only the labeled cells). When applied in vivo, this method may allow for the monitoring 
of many spatio-temporal developmental events and tumor metastasis. Since the liposome 
fusion method is general, many other types of chemistries in a single liposome can be 
delivered to the membrane surface simultaneously. For example, liposomes containing 
ketones, alkynes, dienes, azides, hydrazides, or dienophiles in varying combinations may 
be delivered to a cell surface for iterative or simultaneous post-functionalization via bio-
orthogonal ligation reactions. 
We have also been able to perform liposome fusion to the same cells several times, 
which may be important to tailor the membrane with multiple groups or to increase the 
concentration of a particular surface functional group (data not shown). By rewiring cell 
adhesion, a number of materials, surfaces, nanoparticles, and biomedical devices for 
various biotechnological applications may be decorated with cells. Since, no 
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biomolecules are used with this strategy, no long-term stability and degradation issues in 
complex cell culture media or in vivo will affect cell targeting or cell assembly. By 
combining this strategy with polymer scaffolds, 3D tissues and organs may be generated 
for paracrine signaling studies, tissue replacement therapies, stem cell plasticity studies, 
or as a model platform for various high-throughput screening studies.34-37 Finally, 
integrating this strategy with traditional liposome delivery, where the interior of the 
liposome contains small molecules or nanoparticle cargoes, a multiplex system where the 
delivery of reagents to the interior of cells and simultaneous labeling of the exterior of the 
cells may be possible for entirely new diagnostic and biomedical applications. 
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CHAPTER 5 
 
Dynamic Control on Cell-Tissue Interactions. 
 
 
5.1 Introduction 
 
Controlling cell-cell interactions and cellular architecture in three-dimensional 
(3D) space and time is critical for the proper development (1) and survival of higher-
order organisms (2). These dynamic interactions are complex but essential for correct cell 
behavior and tissue function based on a myriad of physical, mechanical, and 
hydroynamic forces, as well as autocrine and paracrine signaling (3,4). However, to 
recapitulate these processes in vitro while maintaining these dynamic and discrete cell-
cell contacts is difficult and requires a multidisciplinary coordinated effort, intersecting 
several research fields (5). Thus, the ability to modulate cell-cell interactions in space and 
time would in turn allow for unprecedented control of cell behavior and enable the design 
and utility of new dynamic tissue engineering scaffolds, in vivo imaging capabilities, 
high-throughput tissue-based screening assays, and drug delivery therapies (6,7).  
Several recent approaches to generate co-culture tissue structures in 2D and 3D 
have been developed and employed, including dielectrophoresis (8), microfabrication 
(9,10), hydrogel (11,12), and cell patterning techniques (13,14). Tailoring cell 
membranes by cell-surface engineering methods have also proven to be important for the 
development of co-culture and multicellular micro-tissues (15). In particular, the 
integration of bio-orthogonal chemical strategies (16) with cell surfaces may allow for a 
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range of cell-surface modifications for control of lignd presentation, ligand density, and 
potentially spatio-temporal control of cell-cell interactions. Bio-orthogonal chemical 
reactions have been extensively developed and utilized due to their ability to be 
performed at physiological conditions (Diels-Alder, Oxime, Huisgen cycloaddition, 
Staudinger, etc…), without side reactions, and in complex protein mixtures, cell lysates, 
and in vivo. Furthermore, these chemistries have been applied in many fundamental cell 
studies (17), drug delivery therapies (18), and diagnostic measuring applications (19). 
However, the delivery and incorporation of a range of these chemical groups to a cells 
surface for a variety of cell types remains challenging and not straightforward (20).    
The development of synthetic liposomes and liposome fusion methods have 
proven very useful for numerous studies as cell membrane model systems and as 
microarray platforms to study cell membrane dynamics and for biotechnology 
applications (21,22). Additionally, liposome-to-liposome and liposome-to-cell fusion 
methods have also been developed to deliver therapeutic agents to cells and organelles, 
and to study cellular interactions (23). However, until now, there has been no report 
utilizing liposome-to-cell fusion to deliver dynamic and bio-orthogonal groups directly to 
cell surfaces for subsequent chemoselective conjugation and release of ligands or for the 
temporal programming of controlled cell-cell assembly. A strategy that combines cell-
surface modification, without the use of molecular biology techniques or biomolecules, 
with a stable, dynamic, and switchable bio-orthogonal ligand conjugation and release 
approach to direct tissue formation and subsequent disassembly, would greatly benefit 
fundamental cell behavioral studies and tissue engineering research. 
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Herein, we report a novel liposome fusion based methodology to tailor cell 
surfaces with dynamic and switchable bio-orthogonal chemistries and to direct the 
assembly and disassembly of 3D tissues for applications in stem cell differentiation and 
tissue engineering. We show that this strategy is redox responsive and allows for multiple 
rounds of the controlled conjugation and release of molecules to and from cell surfaces in 
situ. This chemical methodology can simultaneously be used as an analytical probe for 
monitoring cellular interactions, as well as a trigger to alter cell-surface ligands and cell-
cell contacts. 
5.2 Materials and Methods 
5.2.1 Materials 
All chemical reagents were of analytical grade and used without further purification. 
Lipids egg palmitoyl-oleoyl phosphatidylcholine (POPC), egg 1-palmitoyl-2-oleoyl-
phosphatidylglycerol (POPG), 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP), 
egg 1,2-diphytanoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-
4-yl) (ammonium salt) (NBD-PE), and egg 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod-PE) 
were purchased from Avanti Polar Lipids (Alabaster, AL). Antibodies and fluorescent 
dyes were obtained from Invitrogen (Carlsbad, CA). FITC labeled beads were purchased 
from Spherotech, Inc. (Forest Lake, IL), trypan blue viability dye was obtained from 
Hyclone (Fisher Sci, Pittsburgh, PA), and all other chemicals were obtained from Sigma-
Aldrich or Fisher. Swiss 3T3 albino mouse fibroblasts (Fb) were obtained from the 
Tissue Culture Facility at the University of North Carolina (UNC). Rat2 Fb transfected 
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with m-cherry were obtained from the Bear Lab (UNC Chapel Hill, NC). Human 
Mesenchymal stem cells (hMSCs) were purchased from Lonza (Basel, Switzerland). 
 
5.2.2 2-dodecylbenzene-1,4-diol (Hydroquinone Alkane, HQ, A) Synthesis.  
1,4-bis(tetrahydro-2H-pyran-2-yloxy)benzene (B): To a solution of hydroquinone (6.0 g, 
54.5 mmol) in THF (40 mL) was added 2,3-dihydropuran (44.0 mL, 245.3 mmol, 4.5 eq) 
and 3 drops of concentrated HCl. The mixture was stirred at room temperature for 8h, 
diluted with EtOAc (40 mL), washed with NaHCO3 (3 x 50 mL) and brine (1 x 25 mL), 
dried over MgSO4, and concentrated to a white solid. The solid was then dissolved in 
EtOAc and recyrstallized with hexanes to afford a white solid B (10. 02 g, 66 %), 
1
H 
NMR (400 Hz, CDCl3, !): 1.67-1.58 (m, 6H, J = 36; -CH2-), 1.88-1.85 (m, 4H, J = 12; -
CH2-), 2.03-2.00 (m, 2H, J = 12; -CH2-), 3.62-3.60 (m, 2H, J = 8; -CH2-), 3.98-3.96 (m, 
2H, J = 8; -CH2-), 5.34-5.32 (t, 2H, J = 7; -CH-), 7.00 (s, 4H; Ar-H). 
2,2'-(2-dodecyl-1,4-phenylene)bis(oxy)bis(tetrahydro-2H-pyran) (C): To a solution of B 
(2.00 g, 7.0 mmol) in dry THF (40 mL) at 0°C was added tert-butyllithium (4.6 mL of a 
1.7 M solution, 9.1 mmol, 1.3 eq) dropwise over 15 min. The mixture was stirred at 0°C 
for 60 min and then slowly warmed to room temperature over 3h. At this time, 1-
bromododecane (5.08 mL, 21.0 mmol, 3 eq) was added and stirred for 12h. The mixture 
was diluted with DCM (40 mL) and washed with NH4Cl (3 x 50 mL) and brine (1 x 25 
mL), dried over MgSO4, and concentrated to afford a yellow oil. The mixture was 
purified by flash chromatography 95:5 Hex:EtOAc to elute a yellow oil C (2.23 g, 71 %), 
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1
H NMR (400 Hz, CDCl3, !): 0.91-0.89 (t, 3H, J = 8; -CH3), 1.27-1.23 (m, 18H, J = 16; -
CH2-), 1.72-1.68 (m, 10H, J = 16; -CH2-), 2.61-2.58 (t, 2H, J = 12; -CH2-), 3.65-3.63 (m, 
4H, J = 8; -CH2-), 5.80-5.78 (t, 2H, J = 8; -CH-), 6.68 (s, 1H; Ar-H), 6.81 (s, 1H; Ar-H), 
6.84 (s, 1H; Ar-H). 
2-dodecylbenzene-1,4-diol (A): To a solution of C (2.0 g, 4.5 mmol) in 40 mL of a 3:1:1 
mixture of AcOH/THF/H2O was stirred for 16h. The mixture was then concentrated, 
diluted in EtOAc (20 mL) and washed with 1 mM NaOH (2 x 10 mL), dried over 
MgSO4, and concentrated to afford a white solid A (1.12 g, 90 %), 
1
H NMR (400 Hz, 
CDCl3, !): 0.89-0.87 (t, 3H, J = 8; -CH3), 1.30-1.25 (m, 18H, J = 20; -CH2-), 1.57-1.55 
(m, 2H, J = 7; -CH2-), 2.58-2.55 (t, 2H, J = 12; -CH2-), 6.57-6.56 (m, 1H, J = 4; Ar-H), 
6.67-6.65 (m, 2H, J = 7; Ar-H); (ESI) (m/z) [M + Na]
+ 
= 301.15. 
5.2.3 O-dodecyloxyamine (Aminooxy Alkane, AO, D) Synthesis.  
2-(dodecyloxy)isoindoline-1,3-dione (E). To a solution of N-hydroxyphthalimide (1.96 g, 
12.04 mmol, 1.5 eq) and sodium bicarbonate (10.11 g, 12.04 mmol, 1.5) in DMF (20 mL) 
at 80°C was added 1-bromododecane (1.93 mL, 8.02 mmol). The mixture was refluxed 
and stirred for 12 h. The reaction was diluted with DCM and washed with H2O (6 x 50 
mL), 1 M NaHCO3 (3 x 50 mL), and H2O (2 x 50 mL), dried over MgSO4, and 
concentrated to afford a white solid (2.66 g, 87 %). 
1
H NMR (400 MHz, CDCl3, !): 1.02 
(s, 3H; CH3), 1.31-1.29 (m, 14H, J = 8; CH2), 1.47-1.45 (m, 4H, J = 8; CH2), 1.60-1.57 
(m, 2H, J = 12; CH2), 3.72-3.70 (t, 2H, J = 8; CH2), 7.80-7.78, 7.85-7.83 (2 x m, 4H, J = 
8; Ar-H).  
O-dodecyloxyamine (D). To a solution of E (2.65 g, 8.00 mmol) in dry DCM (30 mL) 
under inert atmosphere (Ar) was slowly added hydrazine (1.53 mL, 48.00 mmol, 6 eq). 
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Upon addition, a white precipitate immediately formed. The mixture was stirred for 12 h. 
The reaction was diluted with DCM and washed with H2O (6 x 50 mL), dried over 
MgSO4, and concentrated to afford a pale yellow oil (1.18 g, 74 %). 
1
H NMR (400 MHz, 
CDCl3, !): 1.03 (s, 3H; CH3), 1.33-1.31 (m, 14H, J = 8; CH2), 1.43-1.41 (m, 4H, J = 8; 
CH2), 1.50-1.46 (m, 2H, J = 16; CH2), 3.64-3.62 (t, 2H, J = 7; CH2). (ESI) (m/z) [M + 
H
+
]: 201.22.  
5.2.4 Lipid Vesicle Formation for Fusion Studies 
HQ-tethered alkane (160 µL, 10 mM in CHCl3 at 10 mol %, (A)) and POPC (410 µL, 10 
mg/mL in CHCl3 at 90 mol %) were mixed and then concentrated for 4 hours under high 
vacuum. Likewise, OA-tethered alkane (60 µL, 10 mM in CHCl3 at 5 mol %, (D)), POPG 
(92 µL, 10 mg/mL in CHCl3 at 20 mol %), and POPC (410 µL, 10 mg/mL in CHCl3 at 75 
mol %) were mixed and then concentrated for 4 hours at high vacuum. The dried lipid 
samples were then reconstituted in 3 mL in PBS buffer, pH 7.4. The contents of the vial 
were warmed to 50˚C and then sonicated for 15 min with a tip sonicator until the solution 
became clear, forming small and large and small unilamelar vesicles (LUVs and SUVs, 
respectively). Vesicle-containing solutions were then centrifuged at 30,000 rpm for 30 
min, pelleting out the LUVs and leaving the SUVs in solution. The HQ- or OA-SUVs 
((1) and (3), respectively) were then used in further vesicle (liposome) fusion studies. 
5.2.5 Chemical Oxidative Activation of HQ-SUVs  
HQ-SUVs were prepared as previously described. To a solution of HQ-SUVs (3 mM in 
PBS, 4 mL) was added CuSO4·5H2O (20 "L, 5 "M in PBS) for 5 min, producing 
quinone-tethered vesicles (Q-SUVs, (2)). 
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5.2.6 Transmission Electron Microscopy 
HQ- (1) and Q- (2) SUVs were prepared and activated, respectively, as previously 
mentioned OA- (3) SUVs were also made as described above. Q- (2) and OA-(3) SUVs 
(0.2 mM in PBS) were mixed in a 1:1 ratio at room temperature for 30 min. A 4-!L 
vesicle suspension mixture was then applied to standard lacey carbon EM grid as 
prepared according to published methods. The specimens were blotted from behind and 
then submerged into aurenyl acetate solution for staining. The hydrated specimens were 
then placed into a TF30He Polara G2 (FEI company) electron cryo microscope operating 
at 300 keV. Images were recorded using a Tietz single port model 415 4k " 4k CCD 
camera with a 15 micron pixel size on the chip. Pixel sizes at the specimen level were 
used to calculate accurate dimensions for the specimen. 
5.2.7 Fourier Resonance Energy Transfer (FRET) Characterization 
HQ- (16) and OA- (17) SUVs were prepared as described above with the addition of 
NBD-PE (20 !L, 10 mg/mL in CHCl3 at 2 mol %) and Rhod-PE (28 !L, 10 mg/mL in 
CHCl3 at 2 mol %), respectively. HQ-SUVs were then activated to Q-SUVs as reported. 
NBD fluorescence was measured at 471 nm (excitation) and 531 nm (emission) 
maintaining narrow excitation slits to reduce light scattering interference. Q- and OA-
SUVs containing NBD-PE and Rhod-PE, respectively, were then mixed (1:1) to obtain 
FRET measurements. The NBD dye was excited at 471 nm, and the emission was 
scanned through 600 nm. An emission signal for Rhod-PE was observed at 578 nm. All 
fluorescence measurements were performed in a SPEX Fluorolog-3 Research T-format 
Spectrofluorometer. Fluorescence was followed immediately after mixing OA-SUV (17) 
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with Q-SUV (16) for approximately 2 hours at 2 min intervals. A constant flow of water 
was passed through the cuvette holder for temperature control. The temperature was 
maintained at 25°C. 
5.2.8 Dynamic Light Scattering (DLS) Characterization 
Q- (2) and OA- (3) SUVs were prepared as described and mixed at a 1:1 ratio and were 
monitored over 80 min. DLS experiments were performed using a Nikomp model 200 
laser particle sizer with a 5mW HeNe laser at an excitation wavelength of 632.8 nm. 
Standard deviation determinations were made using Gaussian analysis. A Wyatt DynoPro 
dynamic scattering plate reader was used to collect the data. 
5.2.9 Liposome Fusion to Cells (Cell-Surface Engineering) 
HQ-tethered alkane (160 µL, 10 mM in CHCl3 at 10 mol %, (A)), DOTAP (10 µL, 10 
mg/mL in CHCl3 at 2 mol %), and POPC (398 µL, 10 mg/mL in CHCl3 at 88 mol %) 
were mixed and then concentrated for 4 hours under high vacuum. Similarly, OA-
tethered alkane (60 µL, 10 mM solution in CHCl3 at 5 mol %, (D)), DOTAP (10 µL, 10 
mg/mL in CHCl3 at 2 mol %), and POPC (424 µL, 10 mg/mL in CHCl3 at 93 mol %) 
were mixed and then concentrated for 4 hours under high vacuum. The above-mentioned 
procedure for forming HQ- (4) and Q- (12) SUVs was then performed. A 400-!L aliquot 
of HQ- (4) and OA- (12) SUVs were then added separate populations of Fbs, m-cherry 
labeled Fbs, and hMSCs (3 mM in PBS, 400 µL added to 4 mL cells in culture) and were 
cultured for 16 hours, resulting in vesicle fusion to the cell membrane and subsequent 
presentation of HQ (A) and OA (D) groups from the cell surface ((5), (13), (14), and 
(15)).    
5.2.10 Chemical Oxidative Activation of HQ-Presenting Cells 
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HQ-SUVs (4) were prepared and fused to cells as previously described. CuSO4·5H2O (20 
!L, 5 !M in PBS) was then added to cells in culture (4 mL of CBS-containing media) for 
5 min, producing Q-presenting cells ((6) and (11)). 
5.2.11 Flow Cytometry Characterization and Quantification of HQ (A) and OA (D) 
on the Cell Surface 
Fluorescence activated cell sorting (FACS) analysis was performed in order to quantify 
the approximate number of HQ (A) and OA (D) groups on the cell surface after 
membrane fusion. HQ-SUVs were generated as previously mentioned and cultured with 
Fbs (3 mM in PBS, 400 µL added to 4 mL cells in culture) for 1, 3, 5, and 7 days, 
resulting in the fusion and display of HQ (A) from the cell surface (5). HQ (A) was 
activated to Q, as mentioned, before testing. Q-presenting Fbs (6) were then reacted with 
hydrazide-conjugated biotin (3 mM in CBS, 1 mL added to 4 mL CBS in cell culture, 1 h, 
(9 and 10)). Fluorescein- conjugated streptavidin (1 mM in CBS, 0.5 mL added to 4 mL 
CBS in cell culture, 1 h) was then added. A control cell population (not functionalized 
with HQ groups) was only incubated with biotin-hydrazide and streptavidin-FITC for 1 h, 
respectively, under the same conditions as described above. Cells were then centrifuged 
(5 min, 1000 rpm), re-suspended in RMPI (without phenol red), centrifuged (5 min, 1000 
rpm), and re-suspended in RPMI (10
7
 cells in 2 mL). Fluorescence measurements were 
calibrated using RCP-5-30 beads (10
7
 beads/mL, Spherotech, Inc., Lake Forest, IL) of 
known fluorescein equivalent molecule density (4). Fluorescent intensities based on 
number of cells counted (at least 10
5
/sample) were compared to the standard bead and 
control cells lacking fluorescent molecule conjugation and approximate numbers of 
fluorescent compound bound to the surface was calculated. Flow cytometry was carried 
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out using a Dako CyAn ADP (Beckman-Coulter, Brea, CA), and data was analyzed with 
Summit 4.3 software. 
5.2.12 Electrochemical Oxidative Activation, Conjugation, and Release of HQ-
Presenting Cells (5 and 13) 
HQ-SUVs (4) were prepared and fused to cells (5) as previously described. These cells 
were then treated with trypsin (1 mL, 2 min, 37 °C) and seeded onto a gold surface (10
5
 
cells, 2 x 2 cm
2
) for 2 h in serum-free-containing media, and then 16 h in CBS-containing 
media. Linear sweep voltammetry (LSV) was then performed to oxidize HQ to Q using 
an Ag/AgCl reference, Pt wire auxiliary, and the gold surface containing the HQ-
presenting cells (5) as the working electrode (-100 to 650 mV). PBS was used as the 
electrolyte solution (10 mM, pH 7.4), and the scan rate was 100 mVs
-1
. OA-tethered 
ligands were then reacted with Q-presenting cells (6) to form an interfacial oxime linkage 
on the cell surface. This reaction can be monitored using cyclic voltammetry (CV) with a 
sweeping potential of -100 to 650 mV at 100 mVs
-1
. To release ligands or cells, the 
working electrode was subject to a reducing potential (-100 mV, 10 s, PBS, pH = 7.4), 
resulting in a cleavage of oxime bond. Measurements were performed in a standard 
electrochemical cell. All electrochemical measurements were performed using a 
Bioanalytical Systems potentiostat. 
5.2.13 Fluorescent Characterization of Liposome Fusion to Cells (Cell-Surface 
Engineering).  
A solution of HQ-SUV (4) (1 mg/mL) was added Fbs in culture to give the desired final 
HQ concentration of 100 µg/mL in a total volume of 2 mL and were incubated 4 h. The 
cells (5) were then washed with PBS, followed by activation of HQ to Q as mentioned. 
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Rhod-OA (100 !L added to 4 mL cell culture, 7 mM in H2O) was added to Q-displaying 
cells (6) in culture and was incubated at 37 °C for 30 min, resulting in oxime bond 
formation and Rhod-presenting Fbs (7 and 8). The cells were then washed with PBS 
buffer and removed with a solution of 0.05 % trypsin 0.53 mM EDTA and re-suspended 
in serum-free medium (10
5
 cells/mL). The cells were then seeded to a fibronectin-coated 
surface for 2 h and visualized by fluorescence microscopy under the Texas Red channel 
with an exposure time of 1200 ms. Similarly, a solution containing biotin-hyrdazide (1 
mg/mL in PBS, 0.5 mL added to 2 mL CBS) was added to Q-presenting Fbs (6) for 2 h, 
followed by addition of FITC-streptavidin for 1 h to produce biotin/streptavidin-
presenting Fbs (9 and 10). After 1 h, serum-containing media was added for cell growth 
and imaged after 3 days under the FITC channel with an exposure time of 600 ms.  
5.2.14 Electrochemical Characterization of Ligand Conjugation and Release to Cell 
Surfaces (cell-surface engineering). 
Rhod-OA was conjugated to Q-presenting Fbs (6) as described above. CV was performed 
to determine the presence of the oxime bond (7 and 8), scanning from -100 to 650 mV, 
with a scan rate of 100 mVs
-1
, in PBS (pH = 7.4). To release Rhod-OA, a constant 
reducing potential (-100 mV, 10 s) was applied, and CV was then used to determine the 
regeneration of HQ and Q redox peaks (-100 to 650 mV). The cells were then activated to 
Q by conducting LSV, and biotin-hydrazide was conjugated as reported above (9 and 10). 
CV was again performed after conjugation to determine the presence of the hydrazide 
bond (-100 to 650 mV, 100 mVs
-1
).  
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5.2.15 Fibroblast (Fb) Culture 
Swiss 3T3 albino mouse Fbs and m-cherry labeled, Rat2 Fbs were cultured in Dulbecco’s 
Modified Eagle Medium (Gibco) containing 10 % calf bovine serum (CBS) and 1 % 
penicillin/streptomycin at 37°C in 5 % CO2. When ready for experimentation, cells are 
removed from the tissue culture plastic using a solution of 0.05 % trypsin 0.53 mM 
EDTA and re-suspended in serum-free medium (10
5
 cells/mL).   
5.2.16 Cell Patterning Characterization of Liposome Fusion to Cell Surfaces 
Mixed self-assembled monolayers (SAMs) presenting OA and EG4 alkanethiolates were 
patterned using microfluidic lithography (5). The percentage of OA groups was minimal 
(1/9 OA:EG4, 1 mM n EtOH total) to ensure resistance to nonspecific protein and cell 
adhesion. Fbs were first cultured with HQ-SUVs (4) and then activated to Q (6) as 
previously described. Cells were then treated with trypsin (1 mL) and seeded on the OA-
patterned surface (10
5
 cells/mL) in serum-free medium for 2 h and then CBS-containing 
medium for 3 days. During this time, cells adhered, spread, and proliferated, filling out 
the patterned regions of the surface due to the interfacial oxime reaction and were then 
stained and imaged. As a control, Fbs were cultured with SUVs, not displaying HQ, and 
were then seeded to OA-patterned substrates (1:9 OA/EG4); the cells did not attach. Fbs 
were then released from the surface by application of a reductive potential (-100 mV, 10 
s, PBS, pH = 7.4), which cleaves the interfacial oxime linkage. Substrates were then 
stained and imaged by fluorescence microscopy. 
5.2.17 Mass Spectrometry (MS) Characterization 
Preparation of gold-coated MALDI sample plates. Gold-coated MALDI sample plates 
(123 x 81 mm) (Applied Biosystems, Foster City, CA) were prepared by electron-beam 
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deposition (Thermionics Laboratory Inc, Hayward, CA) of titanium (5 nm) and then gold 
(12 nm). In order to form self-assembled monolayers (SAM) of alkanethiolates on the 
plates, the slides were immersed in a 1-mM solution of aminooxyundecanethiol in EtOH 
for approximately 1 min, rinsed with EtOH and dried, and then backfilled with a 1-mM 
solution of mercaptoundecanol in EtOH for 1 h. Once removed from solution, the 
surfaces were rinsed with EtOH and dried before use. Liposome preparation. HQ-
containing liposomes (4) were generated as previously described, activated to Q (5) (10 
!L, 5 !M CuSO4·5H2O in PBS added to 2 mL), and were then delivered to and allowed 
to react with the AO-terminated MALDI sample plate (90 min). The plates were then 
washed with water (3 x 3 mL) and EtOH (2 x 3 mL) and dried before use. Cell 
preparation. Swiss 3T3 albino mouse Fbs were incubated with HQ-LUVs (3 mM in tris 
buffer, 1 mL added to 4 mL culture media, 37 °C in 5 % CO2, 16 h, 4). HQ-presenting 
Fbs (5) were then treated with trypsin (1 mL) and seeded (10
7
 cells/mL) to the MALDI 
sample plates in serum-free medium (droplet on the surface). HQ was then oxidized (2 
!L, 5 !M CuSO4·5H2O in PBS) to Q (5) and cells were allowed to react with the surface 
for 3 h. Plates were then rinsed thoroughly with 0.1 % SDS in PBS (2 x 3 mL) and EtOH 
(2 x 3 mL) and dried before testing to remove the cells and proteins. MALDI Analysis. 
MS analysis was carried out using an AB SCIEX TOF/TOF
TM
 5800 System (Applied 
Biosystems, Foster City, CA). 
5.2.18 human Mesenchymal Stem Cell (hMSC) Culture 
hMSCs and basic, growth, and differentiation media were obtained from Lonza (Basel, 
Switzerland). hMSCs were cultured in Dulbecco’s Modified Eagle Medium (Gibco) 
containing 10 % fetal bovine serum (FBS) and 1 % penicillin/streptomycin at 37°C in 5 
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% CO2. Adipogenic differentiation was induced by culturing with induction medium as 
described in the Lonza protocol.  
5.2.19 3D Spheroid Co-Culture Generation 
HQ-SUVs (4) and OA-SUV (12) were added to two separate Fb or hMSC populations in 
culture for 16 h, resulting in fusion and display of HQ and OA groups from the cell 
surface (5, 13, 14, and 15). The HQ-displaying cells (5 and 13) were activated by 
chemical oxidation as previously described before co-culturing. Fluorescence imaging. 
OA-presenting Rat2 Fbs (14) contained an m-cherry label (nucleus) for enhanced 
visualization, while the Q-presenting Swiss 3T3 albino mouse Fbs (6) contained no 
fluorescent label. These two cell populations were treated with trypsin and mixed 
together (100 µL, 1:1) in serum-containing (10 % CBS) media in a 10 mL-flask and 
incubated at 37 °C and 5 % CO2 for 1, 2, 3, and 5 h. After mixing, the cells were seeded 
on a glass surface and visualized under a Nikon TE2000-E inverted microscope in the 
Texas Red channel with an exposure time of 1200 ms. Image acquisition and processing 
was performed using Metamorph software. 
5.2.20 Co-Culture Spheroids for Phase Contrast and SEM Imaging 
Similarly, activated Q-presenting hMSCs (11) were co-cultured with OA-displaying Fbs 
(15) in solution. These two cell populations were treated with trypsin and mixed together 
(100 µL, 1:1) in serum-containing (10 % FBS) media in a 10 mL-flask and incubated at 
37 °C and 5 % CO2 for 1, 2, 3, and 5 h. After mixing, the cells were seeded on a glass 
surface and visualized under a Nikon TE2000-E inverted microscope (Brightfield 
channel, 75 ms) or by scanning electron microscopy (described below). Control 
experiments were also performed in which Q-hMSCs (11) were mixed and co-cultured 
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with Fbs (not functionalized with OA groups) under the same conditions as described 
above, and images were taken. Image acquisition and processing was performed using 
Metamorph software.    
5.2.21 Scanning Electron Microscopy (SEM) of 3D Spheroids 
After spheroids co-cultures of Fbs (15) and hMSCs (11) were generated in solution as 
described above, cells were delivered to a glass slide (0.8 x 0.8 cm
2
) and then fixed with 
10 % formalin in PBS for 15 min. The substrate was then washed with water (15 min), 
and cells were then dehydrated stepwise in 30, 50, 70, 90, and 100 % ethanolic solutions 
for 15 min each. After critical point drying and sputtering 2 nm of gold, the sample was 
ready for imaging using a Hitachi S-4700 field emission scanning electron microscope 
(Hitachi High Technologies America, Inc., Schaumburg, Illinois). 
5.2.22 3D Multi-Layered Co-Culture Cell Tissue Generation 
HQ-SUVs (4) were cultured with hMSCs (3 mM in PBS, 400 µL added to 4 mL cells in 
culture, 16 h), resulting in membrane fusion and display of HQ from the cell surface (13). 
HQ-hMSCs (13) were then treated with trypsin (1 mL), seeded on a gold surface as 
mentioned above (10
5
 cells/mL), and were allowed to grow and proliferate for 3 days. 
The HQ groups were then activated to Q by performing LSV (-100 to 650 mV) and were 
incubated for 4 hours before adding OA-functionalized Fbs (10
5
 cells/mL) (15) that had 
been treated with trypsin (1 mL). The Fbs (15) were seeded to Q-presenting hMSCs (11) 
for 2 h in serum-free medium, followed by the addition of serum-containing media (4 
mL) to promote cell growth. The cells were cultured for 3, 5, and 7 days before staining 
and confocal imaging. Controls showed no multi-layer formation when OA or Q groups 
were not presented on the cell surfaces or when two Q- or OA-displaying cells interacted 
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with one another. Only when the correct oxime pair is combined do multi-layered co-
cultures. After generation, substrates were fixed, stained, and imaged by confocal 
microscopy as described below. 
5.2.23 3D Spheroid and Multi-Layered Co-Culture Generation and Release. 
Spheroids. HQ- (4) and OA- (12) SUVs were generated as previously reported, added to 
hMSCs and Fbs (3 mM in PBS, 400 µL added to 4 mL cells in culture), respectively, and 
cultured for 16 h. After activation, these two cell populations (11 and 15) were then 
treated with trypsin (1 mL) and mixed together (100 µL, 1:1) in serum containing (10 % 
FCS) media in a 10 mL flask and incubated at 37 °C and 5 % CO2 for 1, 2, 3, and 5 h. 
After mixing for the allotted time, cells were seeded onto a gold surface and visualized 
under a Nikon TE2000-E inverted microscope under the brightfield setting (75 ms). 
Image acquisition and processing was performed using Metamorph software. Multi-
layers: HQ- (4) and OA- (12) SUVs were added to hMSC and Fb (3 mM in PBS, 400 µL 
added to 4 mL cells in culture), respectively, and were cultured for 16 h. hMSCs 
displaying HQ (13) groups were treated with trypsin (1 mL) and cultured on gold slides 
(10
5 
cells/mL) and allowed to grow for 2 days and then activated by conducting LSV (-
100 to 650 mV). OA-presenting Fbs (15) were then treated with trypsin (1 mL) and added 
(10
5 
cells/mL) to Q-hMSCs (11). These cells were co-cultured for 3, 5, and 7 d, resulting 
in the formation of 3D multi-layered co-cultured structures of hMSC and Fb. To 
selectively release cells in either spheroid or multi-layered tissue structures, a reduction 
potential of -100 mV was applied for 1 min in serum-free medium and cells were imaged 
by phase contrast or confocal microscopy as described. 
 
 122!
5.2.24 Cell Staining for Imaging.  
Cells were fixed with formaldehyde (4 % in PBS, 10 min), permeated (PBS containing 
0.1 % Triton X–100, 10 min), and rinsed in PBS (2 x 5 min). Fluorescence imaging-  A 
fluorescent dye mixture containing phalloidin-TRITC (red, actin) and anti-vinculin 
(green, focal adhesions) was made in PBS with 5 % normal goat serum and 0.1 % Triton 
X –100. Cells were incubated with the dye solution for 1 h and were then rinsed in PBS 
for 5 min. A second fluorescent dye mixture consisting of phalloidin-TRITC (red, actin), 
DAPI (blue, nucleus), and Cy-2 (green, focal adhesions) was then made in PBS with 5 % 
normal goat serum and 0.1 % Triton X –100. Cells were incubated with the dye solution 
for 1 h and were then rinsed in PBS for 5 min. The substrates were secured in 
fluorescence mounting medium (Dako, Carpinteria, CA, USA), which enhances the 
visualization of cells when viewed under a fluorescent microscope on a glass cover slip. 
Exposure times for imaging DAPI, actin, and focal adhesions were 400, 1200, and 600 
ms, respectively. Confocal imaging- A fluorescent dye mixture containing phalloidin-
TRITC (red, actin) and DAPI (blue, nucleus) was then made in PBS containing 5% 
normal goat serum and 0.1% Triton X –100. Cells were incubated with the dye solution 
for 2 h. The substrates were then secured in fluorescence mounting medium (Dako, 
Carpinteria, CA, USA), which enhances the visualization of cells when viewed under a 
fluorescent microscope on a glass cover slip. An average of 84 scans were taken to 
generate 3D reconstruction images. 
5.2.25 hMSC Differ5entiation and Immunhistochemistry 
 Adipogenic differentiation of Q-hMSCs (11) was induced after the growth of 3D tissue-
like structures and co-culture with AO-Fb (15) by culturing substrates with induction 
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medium as described in the Lonza protocol. Surfaces were then fixed with formaldehyde 
(4 % in PBS, 30 min), immersed in a solution containing water and 60 % isopropyl 
alcohol (3-5 min) and stained with Oil Red O (red, lipid vacuoles, 5 min) and Harris 
Hemotoxylin (purple, nucleus, 1 min). Substrates were visualized by phase contrast 
microscopy using a Nikon TE2000-E inverted microscope. Image acquisition and 
processing was performed using Metamorph software. 
5.2.26 Confocal Microscopy 
 Cell clusters and tissue formation were generated, stained, and secured on a glass slide as 
previously described above and were visualized with a Nikon Eclipse TE2000-E inverted 
microscope (Nikon USA, Inc., Melville, NY). Data was analyzed by Metamorph software 
and a spectral confocal microscope (LeicaMicrosystems, Bannockburn, IL). 3D 
reconstructions of fluorescent images were generated using Volocity software with an 
average of 84 scans/image. 
5.2.27 Cell viability assay of 3D spheroid and multi-layered co-culture structures 
Cell viability of 3D spheroid and multi-layered tissue-like structures was assessed by 
performing a trypan blue viability assay (Hyclone, Fisher Sci, Pittsburgh, PA). Fb (15) 
and hMSC (11) spheroid and multi-layer co-culture structures were prepared as 
previously described. A solution of 0.4 % trypan blue in PBS was made and diluted in 
CBS (1:1) containing the spheroids (1, 2, 3, and 5 h after mixing) in solution and multi-
layer cell sheets (3, 5, and 7 d after a second cell population was added) on a glass slide. 
Trypan blue was allowed to react with the cells for 2 min, at which time spheroids and 
surfaces were imaged for blue fluorescence using a Nikon TE2000-E inverted 
microscope. A control experiment was performed in which 3D multilayered hMSC and 
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Fb co-cultures were generated for 7 days and then fixed with paraformaldehye and 
stained with trypan blue as described above. Images were compared to the control to 
approximate the % viability of cells in multilayers.   
5.2.28 Cell Viability Assay of Cells After Potential Application 
 HMSCs and Fbs were cultured with HQ-functionalized liposomes for 1, 3, 5, and 7 d as 
mentioned (5 and 13) and tested for viability after being subject to varying potentials. All 
cell populations maintained viability > 95 %. Measurements were performed in PBS, pH 
= 7.4. Each potential was held for 10 s, ranging from -100 to 650 mV, in ~185 mV 
increments. Cell viability was approximated by conducting a trypan blue assay after 
being subject to different potentials.    
5.3 Results and Discussion 
5.3.1 Overview of the Method 
In order to deliver and tailor cell surfaces with dynamic and bio-orthogonal 
chemical groups for cell membrane manipulation and control of cell-cell interactions, we 
first developed a liposome fusion-based model system. Hydroquinone (1, HQ) and 
aminooxy alkanes (3, AO) were synthesized and incorporated into liposomes (fig. S1-
S5). We have previously shown in solution and on conducting substrates how HQ is in 
the ‘off state’ and can be activated to the ‘on state’ quinone (Q) by mild chemical or 
electrochemical oxidation. Q can then chemoselectively react with AO-tethered ligands 
to form stable oxime linkages at physiological conditions (fig. S1) (24-26). The oxime 
linkage can then be selectively cleaved under reductive conditions to regenerate HQ with 
simultaneous release of the AO-tethered groups. This redox-active, oxime-based 
conjugation and release chemistry is bio-orthogonal and can be carried out in complex 
 125!
protein mixtures, cell lysates, and in cell culture (26). Thus, our rationale was to combine 
this dynamic, switchable, and bio-orthogonal conjugation and release strategy with 
liposome fusion to tailor cell surfaces in vitro for studies in cell-surface manipulation and 
tissue engineering.   
 
Figure 5.1 Schematic and transmission electron micrographs (TEM) demonstrating 
dynamic liposome-liposome fusion and liposome-cell fusion for tailoring cell surfaces. 
(A) Hydroquinone (HQ)-containing liposomes (1) (3 mM in tris buffer, pH 7.4) are in the 
‘off state’ and are thus, activated to the ‘on state’ quinone (Q) (2) by mild chemical 
oxidation (20 µL, 5 µM CuSO4!5H2O in PBS at 10 mol %, 5 min) and mixed with 
aminooxy (AO)-containing liposomes (3). Mixing these two populations (0.2 mM total in 
PBS, 1:1) over 2 hours results in the formation of (B) multi-adherent, partially fused, and 
completely fused liposomal structures driven by oxime bond formation. Over time, the 
liposomes grow in size due to fusion. (C) General schematic representing the dynamic 
control of cell surfaces based on liposome-cell fusion for the delivery and tailoring of 
bio-orthogonal groups. POPC (398 µL, 10 mg/mL in CHCl3 at 88 mol %), DOTAP (10 
µL, 10 mg/mL in CHCl3 at 2 mol %), and HQ-functionalized alkane (160 µL, 10 mM in 
CHCl3 at 10 mol %) are mixed to form liposomes (3 mM in tris buffer, pH 7.4). The HQ-
tethered liposomes (4) are then added to cells in culture (400 µL to 4 mL, 16 h), resulting 
in fusion and subsequent presentation of HQ groups from the cell surface (5). HQ is then 
activated to Q (6), which reacts chemoselectively with a range of AO (or RONH2)-
tethered ligands or cells via a covalent and stable oxime linkage (7). Upon a mild change 
in redox environment, the oxime bond is cleaved (-100 mV, 10 s, pH 7.4) to release the 
ligand or cell, followed by regeneration of the HQ-presenting cell (5) for subsequent 
rounds of dynamic and controlled conjugation and release. 
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5.3.2 Biophysical Characterization 
To evaluate if liposome-to-liposome fusion can occur via oxime chemistry,  we 
activated HQ- (1) to Q-containing liposomes (2) and then mixed them with AO-
containing liposomes (3) (fig. S5). We observed rapid liposome aggregation and fusion 
(Fig. 1A) as shown by transimission electron microscopy (TEM) image analysis (Fig. 
1B). It was demonstrated that over time, an oxime-driven process directed liposomes to 
first aggregate and then fuse, forming larger assemblies (Fig. 1B). Fluorescence 
resonance energy transfer (FRET) characterization of liposome fusion displays a clear 
FRET signal, only when the complimentary oxime pair is present in the liposomes (fig. 
S6).  Furthermore, dynamic light scattering (DLS) analysis shows the spontaneous 
liposomal growth due to this oxime-driven liposomal fusion (fig. S7). Aggregated or 
fused liposomal structures were not observed  in control experiments where HQ-
containing liposomes were not activated or when either oxime pair was missing.  
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Figure 5.2 Biophysical characterization of liposome adhesion and fusion based on 
chemoselective oxime formation between Q- and AO-containing liposomes. Top- FRET 
studies: Q- (160 µL, 10 mM in CHCl3 at 10 mol %) and NBD-PE- (20 µL, 10 mg/mL in 
CHCl3 at 2 mol %) containing liposomes (16) were excited at 471 nm, producing light 
emission at 531 nm (green trace). When these liposomes (200 µL, 1:1) were mixed with 
AO- (60 µL, 10 mM in CHCl3 at 5 mol %) and rhodamine-PE/POPG- (28 µL, 10 mM in 
CHCl3 at 2 mol %) functionalized liposomes (17), a FRET emission peak is observed at 
578 nm indicating oxime-mediated liposomal adhesion and fusion. No FRET signal is 
observed with non-activated HQ liposomes or when liposomes without AO groups are 
mixed. Fluorescence was monitored for 2 h at 2 min intervals, and the temperature was 
maintained at 25 °C. Bottom left: DLS characterization of liposome adhesion and fusion 
based on chemoselective oxime formation between Q- and AO-containing liposomes. Q- 
and AO-containing liposomes (2 and 3, respectively) were mixed (0.2 mM in PBS, 100 
µL, 1:1) and monitored by DLS to observe the changes in liposome size over reaction 
time. Over a period of 80 min of mixing, liposomes grew in size due to adhesion, partial, 
or complete fusion (red trace). As a control, liposome size remained constant when Q-
containing liposomes (2) were added to liposomes not functionalized with AO groups or 
un-activated, HQ liposomes (1) with AO liposomes (3) (black trace). Bottom right: Mass 
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spectrometry characterization of oxime bond formation at the cell surface. (A) Self-
assembled monolayers (SAMs) of AO-terminated alkanethiol (1 mM in EtOH, 1 min, 
backfilled with 1 mM mercaptoundecanol in EtOH, 1 h) were formed on gold-coated (12 
nm) MALDI sample plates (123 x 81 mm). MALDI analysis was performed directly on 
the surface to display mass [M + H]
+
 of 437 corresponding to the AO-terminated 
alkanethiol connected by disulfide linkage. (B) Q-displaying Fbs (6) were seeded (10
7
 
cells/mL, 3 h in serum-free conditions) on gold-coated MALDI sample plates presenting 
AO-terminated alkanethiol. The cells were then washed several times (0.1% SDS in PBS, 
2 x 3 mL and EtOH, 2 x 3 mL) and dried before testing to result in (C) oxime conjugation 
on the surface. MALDI was again performed, and a mass [M + H]
+ 
of 478 corresponding 
to the product of Q and AO conjugation was observed. 
 
5.3.3 Dynamic Cell-Surface 
After the successful characterization of liposome-to-liposome fusion, we aimed to 
employ a similar strategy to generate electroactive, dynamic, and switchable cell 
surfaces. Therefore, we applied our liposome fusion method to deliver the bio-orthogonal 
HQ (4) and AO (12) groups for subsequent fusion and presentation from cell membranes. 
For these studies, HQ alkane was mixed with POPC, and DOTAP (a cationic lipid) in a 
10:88:2 ratio, and AO alkane with POPC, and DOTAP (5:93:2) (fig. S5). After addition 
to cells (swiss 3T3 fibroblasts (Fbs)) in culture, the liposomes first fuse, delivering the 
chemical groups to cell surfaces  (Fig. 1C). HQ can then be activated to generate Q, 
which will conjugate chemoselectively with AO-tethered ligands or cells to form a stable, 
interfacial oxime linkage. The oxime bond at the cell membrane can then be selectively 
cleaved with the simultaneous release of the ligand or cell and regenerate the HQ-
presenting cell. This dynamic cycle is non-cytotoxic (fig. S8), redox triggered and 
switchable (fig. S1), performed in situ and under physiological conditions, and provides 
unprecedented control of cell-cell and cell membrane interactions through the 
conjugation and release of ligands and cells. 
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Figure 5.3 (Top) Fluorescent and electrochemical characterization of cyclical cell-
surface tailoring and the release of ligands based on redox responsive chemoselective 
chemistry. (A) Fibroblasts (Fb), not fused with liposomes presenting HQ groups show no 
redox signal or fluorescence. (B) HQ-containing liposomes (4) are added to Fbs (3 mM in 
tris buffer, 400 µL to 4 mL, 16 h), resulting in membrane fusion and presentation of HQ 
from the surface (5). The stable HQ (5) to Q (6) interconversion can be monitored by 
cyclic voltammetry (CV) (-100 to 650 mV, pH 0, 100 mVs
-1
) due to its diagnostic redox 
peaks (black trace, HQ = 130 mV, Q = 258 mV). (C) Activated Q-presenting Fbs (6) can 
be chemoselectively reacted with rhodamine-AO (7 mM in H2O, 100 µL to 4 mL, 30 
min) for cell-surface tailoring (7 and 8). This results in stable, fluorescently labeled cells 
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(red) and a diagnostic shift in redox signal (red trace, 252 mv, 284 mV). (D) In a 
reductive environment (-100 mV, 10 s, pH 7.4), the oxime bond is cleaved with the 
release of rhodamine and the regeneration of HQ-presenting Fbs (5) as indicated by a loss 
in fluorescence and the redox peaks of the HQ to Q cycle (black trace). (E) Cell surfaces 
can once again be conjugated for a second time with hydrazide-tethered biotin (9 and 10) 
and fluorescein-presenting streptavidin (1 mg/mL in PBS, 0.5 mL to 2 mL, 1 h each), 
resulting in fluorescently labeled cells (green) and a shift in redox peaks (green trace). 
(Bottom) A general schematic and corresponding fluorescent images demonstrating 
dynamic control of cell adhesion and release from patterned substrates (F). Fbs were 
cultured with HQ-containing liposomes (4), resulting in membrane fusion and subsequent 
display of HQ from cell surfaces (5). Mild chemical oxidation (20 µL, 5 µM 
CuSO4!5H2O in PBS at 10 mol %, 5 min) converts the HQ to Q groups on the cell surface 
(6). Q-presenting Fbs (6) (10
4
 cells/mL, 2 h) were then added to a substrate patterned 
with AO-terminated ligands (1 mM in EtOH, 1:9 AO/EG4). Cells adhered to the substrate 
due to a biospecific interfacial oxime ligation and then proliferated (4 d) within the 
patterned region as shown in lower (G) and higher (H) magnified fluorescent 
micrographs. Upon electrochemical reduction, the interfacial oxime is cleaved and the 
cells are released from the substrate (I). Cells were stained for actin (red, phalloidin), 
nucleus (blue, DAPI), and anti-vinculin (green, Cy-2). 
 
 
Figure 3 demonstrates the dynamic and switchable conjugation and release of ligands to 
and from the cell membrane. After HQ-containing liposomes (4) were fused with Fbs (5) 
on a conductive substrate, cyclic voltammetry (CV) was performed, and distinct HQ to Q 
redox peaks were observed (Fig. 2A) (27). Upon activation to Q (6) (400 mV, 10 s) and 
conjugation of AO-tethered rhodamine (7 and 8) to cells, a shift in CV peaks, 
characterisitic of oxime formation (27), was observed. The rhodamine-labeled Fbs were 
also imaged, and red fluorescence was observed (Fig. 2B). After application of a non-
cytotoxic, reductive potential (-100 mV, 10 s, fig. S10), rhodamine was released from the 
cells, and HQ was regenerated on the cell surface as indicated by CV and fluorescence 
microscopy (Fig. 2C). We then re-activated the HQ-presenting Fbs to Q and conjugated 
biotin-hydrazide, followed by FITC-streptavidin. It was found that the cells could once 
again conjugate and release molecules from the cell surface shown by CV and 
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fluorescence microscopy (Fig. 2D). The oxime linkage is stable, and only upon 
application of a mild reductive potential does the oxime cleave and release ligands (27). 
In general, this dynamic strategy can be used for controlling the chemical structure of cell 
surfaces in 3D space and time with micro- or nanoelectrode arrays, where the cell surface 
ligands can be replaced with any biomolecule of interest, creating a new tool for the 
modulation of cell interactions.  
5.3.4 Cell Viability and Flow Cytometry  
Several assays were performed to evaluate cell viability as a function of applied 
redox potential (fig. 4). As a result, no change in cell viability was observed after 
applying different electrochemical potentials (-100 to 650 mV, 10 s) on cells cultured 
with HQ for up to 7 days. Other control experiments concluded that removing either HQ 
or AO from the fusion liposomes resulted in no ligand conjugation at the cell surface. 
When AO-alkane or HQ-alkane  was added directly to cells in culture but not in liposome 
form no incorporation of AO or HQ groups in cell surfaces were observed.  Additionally, 
when chemical or electrochemical activation does not occur, conjugation and release of 
ligands was not observed. Furthermore, we determined the amount of HQ molecules at 
the cell membrane upon initial liposome fusion by FACS analysis. FACS analysis also 
demonstrated that HQ remains incorporated in the membrane after several rounds of cell 
growth and division and that HQ can still be actived for conjugation and release of 
ligands (fig. 4). These results may lead to new ways to tailor and monitor in vitro and in  
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Figure 5.4 Fluorescence activated cell-sorting (FACS) analysis to determine the number 
of HQ molecules per cell. HQ-containing liposomes (4) were added to Fbs in culture (3 
mM in tris buffer, 400 µL to 4 mL, 1, 3, 5, and 7 d). The amount of HQ on cell surfaces 
as delivered by membrane fusion was determined after 1, 3, 5, and 7 days. Before 
conducting FACs, cells were chemically (20 µL, 5 µM CuSO4!5H2O in PBS at 10 mol %, 
5 min) activated to Q (6), followed by conjugation of biotin-hydrazide (9) (3 mM in CBS, 
1 mL added to 4 mL CBS in cell culture, 37ºC in 5% CO2, 1 h) and fluorescein-
streptavidin (1 mM in CBS, 0.5 mL added to 4 mL CBS in cell culture, 37ºC in 5% CO2, 
1 h). A control population in which Fbs (not functionalized with HQ groups) were 
reacted with biotin-hydrazide and FITC-streptavidin under the same conditions was also 
tested. All sample populations were centrifuged (5 min, 1000 rpm), resuspended in RPMI 
(10
7
 cells/mL), centrifuged, and resuspended in RPMI. 1-mL samples were tested against 
a standard bead (10
7
 beads/mL) with known fluorescein molecule density. (A) The 
relationship between the number of cells scanned (~10
5
) and fluorescence intensity of 
control population and cells incubated with HQ-functionalized liposomes for 1, 3, 5, and 
7 days as determined by flow cytometry analysis is reported. The fluorescence intensities 
decrease over time, indicating that cells are able to carry the HQ moiety through division 
and growth. The control cells show little to no fluorescence. (B) The number of 
fluorescein molecules was calculated by comparing the relative mean intensity to a 
standard bead with known FITC equivalent molecule density. The numbers of HQ 
molecules per cell are listed, showing a decrease in density on the cell surface over time. 
(C) The relationship between the mean fluorescence intensity (3 trials per day, error bars) 
and liposome incubation day is shown as a linear decrease from 1 to 7 days. Cell viability 
assay of hMSCs and Fbs when subjected to mild redox potentials. HMSCs and Fbs were 
cultured with HQ-functionalized liposomes (4) (3 mM in tris buffer, 400 µL to 4 mL) for 
1 (blue triangle), 3 (red circle), 5 (green square), and 7 (black star) days and tested for 
viability after being subject to varying redox potentials (-100 to 650 mV, 10 s, ~185 mV 
increments, PBS, pH 7.4). All cell populations (13 and 15) maintained viability >95% 
(trypan blue viability assay, 0.4 % in PBS, 2 min) and were indistinguishable from 
control populations not exposed to redox potentials. 
 
 
vivo events that occur at cell membranes and allow for new types of pulse and chase type 
experiments for cell imaging and for tracking cell movement (28,29). 
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5.3.5 Dynamic Cell Adhesion 
The incorporation and utility of HQ on the cell surface was further investigated by 
attaching and releasing cells from an OA-patterned substrate (Fig. 2C). HQ-presenting 
Fbs (5) were activated to Q (6) and then seeded onto an inert substrate, presenting AO 
groups (30). The Q groups on the cell surface (6) reacted biospecifically with the 
patterned OA ligands to form an interfacial oxime linkage. The cells attached and then 
proliferated, filling out the patterned regions. An electrochemcial trigger was then applied 
to cleave the oxime linkage, and cells released from the substrate. Furthermore, a novel 
MALDI mass spectrometry analysis of cell membrane incorporation shows oxime 
conjugation between Q presenting cells and OA terminated surfaces (Fig. S11) (31). This 
strategy allows for spatial and temporal control of cell interactions in 2D and may be 
extended to other materials and nanoparticles for designing new cell-based assays and 
renewable microarray platforms (32,33).  
5.3.6 Dynamic 3D Cell Assembly 
We extended this methodology to demonstrate the dynamic control over cell-cell 
interactions by co-culturing HQ-presenting human mesenchymal stem cells (hMSC) (13) 
with AO-displaying Fbs (15) to form 3D tissue structures. Upon chemical activation (see 
Supp. Info.) and mixing in solution, 3D spheroid assemblies were able to be rapidly 
generated (Fig. 3A). By increasing the mixing duration, control of the spheroid size could 
be achieved (fig. S12). The interconnected cells that make up the spheroids could then be 
disassembled, back to individual cells by mild electrochemical reduction (-100 mV, 10 s) 
(Fig. 3C). Additionally, spheroids were formed when Swiss 3T3 albino mouse Fbs 
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presenting HQ groups were activated (6) and co-cultured with nuclear m-cherry-labeled 
Rat2 Fbs displaying AO groups (14) (Fig. 3B). Figure 3D exhibits a cryo scanning  
 
Figure 5.5 Schematic and corresponding images of 3D dynamic spheroid and multi-
layered tissue assembly and disassembly via liposome fusion and chemoselective cell-
surface tailoring. (A) Human mesenchymal stem cells (hMSCs) are functionalized with 
HQ groups (13) (3 mM in tris buffer, 400 µL to 4 mL, 16 h) after liposome fusion and are 
then activated to Q (11). Fbs presenting AO groups (14) are then co-cultured (1 mL, 1:1, 
3 h) with Q-displaying hMSCs (11), producing (B and C) 3D spheroid assemblies, 
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interconnected through chemoselective oxime chemistry. Mild electrochemical reduction 
(-100 mV, 10 s, pH 7.4) causes oxime cleavage and the dynamic disassembly of cells as 
shown in (D). (E) Activated, Q-tethered hMSCs (11) are cultured on a substrate (10
5
 
cells/mL, 3 d), resulting in a 2D cell monolayer (F). AO-presenting Fbs (15) are added 
(10
5
 cells/mL, 2 d) to the hMSCs (11), and a 3D interconnected multi-layered structures 
(G). A reductive potential applied to the substrate cleaves the oxime bond and induces 
the dynamic release of Fbs from the multi-layer, regenerating the 2D monolayer of 
hMSCs (H). The nuclei of OA-tethered Fbs (14) shown in C are stained with m-cherry 
for enhanced visualization. HMSCs (11) and Fbs (15) displayed in F-H are stained for 
actin (red, phalloidin) and nucleus (blue, DAPI).     
 
electron micrograph (SEM) of an oxime ligated, spheroid assembly of  hMSC (15) and 
Fbs (13) attached to a substrate. Viability for the cells in the spheroids was analyzed over 
time (1 to 5 hours, trypan blue assay, blue false colored) and found to be > 99%. Control 
experiments when no activation occurs or when one of the oxime compliments is not 
present in a cell type showed no spheroid formation. These results indicate that 3D co-
culture assemblies in solution can be generated in a straightforward manner with the 
ability to control both the size, compostion, and the duration of cell-cell interactions. This 
strategy is general and may be used for numerous studies, including autocrine and 
paracrine signaling events and when combined with microfabricated scaffolds as a tissue 
engineering platform.   
5.3.7 Dynamic 3D Tissue on Solid Surface 
In addition to forming spheroid assemblies, we demonstrate that 3D multi-layered co-
culture tissue structures are able to be generated on a solid support. We cultured 
activated, Q-presenting hMSCs (11) on a substrate to form a 2D monolayer (Fig. 5E-F) 
and  then added AO-displaying Fbs (15). Chemoselective ligation occurs between the two 
cell populations followed by 3D multi-layer tissue growth after 3 days (Fig. 5G). When 
the proper oxime pair is not present, only a single monolayer of hMSC is observed with 
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no Fbs adhering. We found that cells were viable for many days (> 7 days) and that the 
HQ and AO could be carried forward on the cell surface (FACS analysis over time, fig. 
S4) even through cell growth and proliferation. The multi-layers were able to be 
disassembled by applying a mild reductive potential to the substrate (-100 mV, 10 s, pH = 
7.4), which cleaved the oxime linkage and released the interactions between cells. 
Overall, this dynamic method to generate 3D multi-layer tissue structures may be used to 
control cell-cell interactions for many co-culture-based cell behavioral and cell tissue 
applications (34). 
5.3.8 Dynamic Platform for Stem Cell Differentiation 
We further employed this dynamic strategy to study stem cell differentiation by 
applying our liposome fusion-based delivery of activatable bio-orthogonal groups to cell 
surfaces to generate 3D multi-layered cell tissues and induce adipocyte differentiation 
(Fig. 6). HQ-presenting hMSCs were activated and co-cultured with Fbs as described 
previously. This tissue was grown in media that induced adipocyte differentiation after 10 
days, resulting in 3D multi-layered co-culture tissues of adipocytes and Fbs (Fig. 6D). 
Application of a mild reductive potential disassembled the 3D tissue, leaving a relatively 
pure, 2D adipocyte monolayer (Fig. 6E-F). The dynamic and controlled 3D multi-layer 
cell disassembly indicates that cell-cell interactions, even for complex stem cell 
differentiation processes over long time periods, can be precisely manipulated. By 
assembling and disassembling the co-cultures on demand, a time course of cell behavior, 
due to length of cell-cell interactions, is able to be determined for a range of cell lines and 
co-culture-based applications (35,36). 
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Figure 5.6 Schematic and corresponding phase contrast images displaying the formation, 
differentiation, and release of 3D dynamic tissues using a Fb/hMSC co-culture. (A) 
Activated, Q-tethered hMSCs (11) are cultured on a substrate (10
5
 cells/mL, 3 d) and 
form a 2D monolayer as shown by the image in (B). AO-presenting Fbs (15) are then 
added (10
5
 cells/mL, 2 d), producing a 3D multi-layered, interconnected co-culture (C). 
When the appropriate induction media is delivered to the co-culture, hMSCs differentiate 
into adipocytes, resulting in a 3D multi-layered co-culture of Fbs and adipocytes (D). A 
reductive potential (-100 mV, 10 s, pH 7.4) applied to the substrate results in oxime 
cleavage and the dynamic release of Fbs, leaving only the adhered adipocytes on the 
surface as a 2D monolayer shown by lower (E) and higher (F) magnified images. 
Adipocytes were stained for lipid vacuoles (red, Oil Red O) and nucleus (purple, Harris 
Hemotoxylin). 
 
 
5.4 Conclusions 
In summary, we have developed a new general and straightforward liposome 
fusion based methodology to deliver dynamic and switchable bio-orthogonal chemistries 
to tailor cell membranes and direct the formation of 3D co-culture tissue structures. We 
demonstrated and extensively characterized the conjugation and release of molecules to 
and from cell surfaces in situ, as well as the triggered assembly and disassembly of 3D 
spheroid and multi-layered tissues. Additionally, dynamic co-cultures of hMSCs and Fbs 
were able to be generated and differentiated with this redox oxime strategy.    
 The dynamic and bio-orthogonal oxime chemistry reported has several key 
advantages to serve as a cell-surface engineering and cell-tissue generating system. First, 
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the oxime complimentary pair is synthetically straightforward, and ketone-, hydrazide, 
and AO-tethered ligands are commericially available. Second, oxime reactivity can be 
switched ‘on’ and ‘off’ with a change in the redox environment and therefore, can be 
used to monitor cell-surface incorporation of moleucles and cell-surface interactions. 
Third, the oxime bond forms rapidly and is stable under physiological conditions until 
subject to a chemical or electrochemical reducing potential. Fourth, the redox 
manipulation is non-cytotoxic. Fifth, this liposome fusion-based method is general and 
can be used to deliver the oxime pair to a range of cell lines for a variety of applications. 
Lastly, this methodology can be used to deliver a variety of other bio-orthogonal ‘click’ 
chemistries to cell surfaces. 
Future applications of this strategy may be extended to study and manipulate stem cell 
fate of 3D multi-layered co-culture tissues and for controlling stem cell plasticity. 
Integration of this approach with 3D polymer scaffolds may lead to the design of new 
tissue enginering and regenerative medical therapies, devices, and applications. 
Theranostic applications, where simultaneous delivery of therapies and diagnostic 
monitoring, may also be possible for a variety of in vitro and in vivo imaging and cell 
tracking studies. With the introduction of an electroactive cell surface, it may be possible 
to track dynamic biophysical events, such as lipid diffusion and endo- and exocytosis. By 
generating a photo-inducible linker within the bio-orthogonal pair lipids a light sensitive 
cleavable system may also be generated for spatial and temporal control of cell-cell 
interactions (11,37). By altering the lipid composition and mix of bio-orthogonal groups 
in cell membranes via liposome fusion and delivery, potential cell to cell fusion 
experiments and the generation of tailored giant unilamellar vesicles may be possible. 
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Finally, by tailoring and controlling cell surfaces and cell-cell interactions, new types of 
autocrine and paracrine signaling studies for fundamental cell behavior and tissue 
regeneration applications may be explored (38,39). 
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CHAPTER 6 
A Dual Receptor and Reporter for Multi-Modal Cell-Surface 
Engineering 
 
6.1 Introduction 
Proper understanding of biological system is the key for any therapeutic and medical 
based research and technology. Visualizing and quantifying the signaling molecules and 
events with spatial and temporal control in cellular processes goes a long way in serving 
the purpose. Advances on genetic engineering producing new variants in green 
fluorescent proteins coupled with development in fluorescence microscopy has provided 
the basic tools to investigate the complex processes in cell biology.1 The fluorescent 
protein based indicators can be designed to target sub-cellular compartments, whole 
organisms and tissues and can respond to a variety of biological signals and events. 
Although GFP and its variants2-6 are extremely useful for tracking the localization and 
expression of proteins and investigate important cellular processes, small-molecule 
probes like organic dyes7, quantum dots8 and different class of nanoparticles9 with less 
steric bulk, faster rates of labeling and the ability to provide readouts in addition to, or 
other than fluorescence is desired.  
Cell-surface modification can facilitate the characterization of a number of cellular 
processes and signal transduction pathways in terms of identifying key proteins and 
signaling molecules.10 One major application of engineering cell surfaces can be in 
modifying the cell membrane with molecular and detection probes for subsequent 
 144!
tracking and chasing in cell based therapy.11 Cell based therapy has been widely used as a 
therapeutic approach towards regenerative medicine. In particular, stem cells can be used 
to restore tissue functions either as integrated participants in the target tissue or as 
vehicles that deliver complex signals to a target tissue without actually participating into 
the tissue itself.12 So any fluorescence based reporter system that can provide us with a 
spatial and temporal control in tracking the delivered cell from its injection through 
transport inside the body will be highly beneficial to the field of tissue engineering and 
drug delivery. 
Calcein dye is a polyanionic derivative of fluorescein that exhibits fluorescence that is 
essentially independent of pH between 6.5 and 12. It is well retained in cells. These 
features have made it a popular and versatile dye for various applications, including cell 
volume changes in neurons and other cells, endocytosis, gap junctional communication, 
membrane integrity and permeability, angiography, etc. 13-17 Dabcyl has been routinely 
used as a general-purpose dark quencher for many commonly used fluorophores 
including calcein. It quenches the fluorphores by FRET (Fluorescence Resonance Energy 
Transfer) which is a dynamic quenching mechanism that does not affect the probe’s 
absorption spectrum.18 FRET is a highly distance dependent interaction between a 
reporter dye in an excited state and a quencher in its ground state. Energy is transferred 
from one molecule (fluorophore) to the other (the quencher) without the emission of a 
photon. In order for efficient FRET quenching to take place the fluorophore and the 
quencher molecules must be closer to each other (10 – 100 A°). In this study we have 
developed a liposome fusion based dual receptor-reporter system where cell surfaces 
were tailored and made fluorescent with a lipid tail conjugated calcein dye. Spatial and 
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temporal control on the cell-surface fluorescence was achieved by coupling the dye with 
its FRET quenching partner dabcyl using oxyamine exchange chemistry. We also applied 
the methodology to make three dimensional fluorescent tissue spheroids. Delivering the 
fluorescent tissue patches can not only have potential uses in surgery and regenerative 
medicine, particularly in wound healing applications but might also enable us to answer 
many fundamental questions in cell and molecular biology. 
6.2 Materials and Methods 
6.2.1 Materials 
All chemical reagents were of analytical grade and used without further purification. 
Lipids egg palmitoyl-oleoyl phosphatidylcholine (POPC) and 1,2-dioleoyl-3-
trimethylammonium-propane (DOTAP) were purchased from Avanti Polar Lipids 
(Alabaster, AL). Antibodies and fluorescent dyes were obtained from Invitrogen 
(Carlsbad, CA). FITC labeled beads were purchased from Spherotech, Inc. (Forest Lake, 
IL) and all other chemicals were obtained from Sigma-Aldrich or Fisher. Swiss 3T3 
albino mouse fibroblasts (fbs) were obtained from the Tissue Culture Facility at the 
University of North Carolina (UNC). 
6.2.2 Formation of Lipid Vesicles 
 To generate ketocalcein-containing liposomes for cell fusion studies, ketocalcein (46 
!L, 10 mM solution in CHCl3 at 10 mol %) was dissolved with egg-POPC (424 !L, 10 
mg/mL in CHCl3 at 93 mol %) and 1,2-dioleoyl-3-trimethylammonium-propane 
(DOTAP, 10 !L, 10 mg/mL in CHCl3 at 2 mol %) in chloroform followed by 
concentration under high vacuum for 4 h. The dried lipid samples were then reconstituted 
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and brought to a final volume of 3 mL in PBS buffer, pH 7.4. The contents of the vial 
were warmed to 50 ˚C and sonicated for 20 min, in a tip sonicator, until the solution 
became clear, and LUVs containing ketocalcein groups were formed. 
6.2.3 Fluorimetry 
 Liposomes were made starting with 2.7 mM of DOTAP and POPC and 0.3 mM of 1 
dissolved in chloroform. Following literature procedure, the liposomes were synthesized 
and size selected for a distribution of 60-100 nm, which was verified by TEM. After the 
liposomes were made, they were diluted 1:10 into 2 mL of pH 7 phosphate buffer, and a 
fluorescent scan from 500 – 600 nm with excitation at 495 nm was made. To monitor the 
quenching reaction, dabcyl hydrazide was saturated into the solution and the fluorescence 
was monitored at 520 nm with 495 nm excitation over 12h. To measure recovery, 
liposomes were synthesized using 2.7 mM of DOTAP and POPC and 0.3 mM of 5. To 
measure recovery, liposomes were synthesized using 2.7 mM of DOTAP and POPC and 
0.3 mM of 5. These quenched liposomes were then diluted 1:10 into 2 mL of pH 7 
phosphate buffer and 50 mg of methyloxyamine was added. To monitor the exchange 
reaction, the fluorescence was measured at 525 nm with 495 nm excitation over 12h. 
6.2.4 Flow Cytometry 
 Fluorescence activated cell sorting (FACS) analysis was performed in order to 
quantify the approximate number of ketone and oxyamine groups at the cell surface after 
membrane fusion. Liposomes (5) were prepared as described above and were delivered to 
Swiss 3T3 albino mouse fbs in culture (3 mM in tris buffer, 400 µL added to 4 mL, 16 h). 
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A time course assay was also conducted using FACS to determine whether the chemistry 
was being carried on after cell growth and division. Fbs were cultured with ketocalcein-
containing liposome for 2, 4, and 6 d followed by fluorescein-conjugated streptavidin (1 
mM in CBS, 0.5 mL added to 4 mL CBS in cell culture, 1 h). A control cell population 
(not displaying ketone groups) was only incubated with biotin-hydrazide and 
streptavidin-fluorescein for 1 h each, under the same conditions. Cells were then 
centrifuged (5 min, 1000 rpm), resuspended in RPMI (without phenol red), centrifuged (5 
min, 1000 rpm), and resuspended in RPMI (~107 cells/2 mL). Fluorescence 
measurements were calibrated using RCP-5-30 beads (~107 beads/mL, Spherotech, Inc., 
Lake Forest, IL) of known fluorescein equivalent molecule density. Fluorescent 
intensities based on number of cells counted were compared to the standard bead and 
control cells lacking fluorescent molecule conjugation and approximate numbers of 
fluorescent compound bound to the surface was calculated. Flow cytometry was carried 
out using a Dako CyAn ADP (Beckman-Coulter, Brea, CA), and data was analyzed with 
Summit 4.3 software.   
6.2.5 Fibroblast (Fb) Culture 
 Swiss 3T3 albino mouse fbs and Rat2 fbs were cultured in Dulbecco’s Modified 
Eagle Medium (Gibco) containing 10 % calf bovine serum (CBS) and 1 % 
penicillin/streptomycin at 37 °C in 5 % CO2. Delivery of functionalized liposomes to 
cells. Cells were seeded onto a tissue culture plate and allowed to grow for 48 h at 37 °C 
in 5 % CO2 in CBS media. Solutions of ketocalcein-LUV (5) were added to cells for 4 h. 
The cells were then washed with PBS (4 x 4 mL) and imaged under a fluorescence 
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microscope with an exposure time of 1/1200 s. Cell-surface reaction to ketoncalcein-
presenting cells. Solutions of ketocalcein-LUV were reacted with dabcyl hydrazide (1 
mg/mL) for 3 h and then added to the culture to give the desired final ketocalcein 
concentration of 100 µg/mL in a total volume of 2 mL. The cells were incubated with the 
keto-LUVs for 4 h and washed with PBS (4 x 25 mL. The cells were then removed with a 
solution of 0.05 % trypsin 0.53 mM EDTA and re-suspended in serum-free medium 
(~104 cells/mL). The cells were then seeded to a fibronectin-coated surface for 2 h. After 
2 h, serum-containing media was added for cell growth and imaged after 3 days.  
Fluorescence recovery of quenched cells. Cells treated with quenched ketocalcein-
LUVs were treated with biotin hydrazide (3mg/mL, 1:20 v/v) for 16 h. The conjugated 
dabcyl hydrazide was exchanged by biotin over time and the green fluorescence was 
recovered. The presence of biotin on cell-surface was confirmed by adding rhodamine 
conjugated streptavidin (1 mg/mL) which has high affinity towards biotin and turns the 
cells fluorescent red. 
6.2.6 3D Co-Culture Spheroid Generation 
 Ketocalcein-LUVs were generated as previously reported and added to Swiss 3T3 
albino mouse fb (3 mM in tris buffer, 400 µL added to 4 mL, 16 h) and were cultured, 
resulting in fusion and display of ketones from the cell surface and also making the cells 
fluorescent green. 200 µL of 10 mM RGD-oxyamine was added to 4 mL of the 
fluorescent cell. After 3 h the cells were trypsinized and added to a Swiss 3T3 albino 
mouse fb solution. These two cell populations were then trypsinized and mixed together 
in serum containing (10 %  FCS, pH of 7.4) media in a 10 mL flask and incubated at 37 
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°C and 5 % CO2 for 1, 2, 3, and 5 h. After mixing for the allotted time, cells were seeded 
onto a glass surface and visualized under a Nikon TE2000-E inverted microscope under 
the brightfield setting (75 ms exposure time). Controls were also performed where fbs 
displaying ketone groups were reacted with RGD with no oxyamines and scrambled 
RGD with oxyamines and co-cultured with fbs (not displaying ketones groups) for each 
of the corresponding time points, 1, 2, 3, and 4 h, seeded onto glass, and imaged under 
the brightfield setting (75 ms). Image acquisition and processing was performed using 
Metamorph software.  
6.3 Results & Discussion 
6.3.1 Motivation of Work 
In order to create our cell surface receptor/reporter system, we pooled many different 
features from divergent fields. For our studies, we sought the simplest molecule that was 
both fluorescent, had a handle for cell surface immobilization, and could be act as a lipid. 
To combine these functionalities into one molecule, we used a calcein derivative 1. 
Calcein is a cell impermeable fluorescent dye used for live/dead cell assays and is highly 
charged, and when coupled with a 12 carbon chain, it acts like a lipid where the calcein 
serves as the charged head and the dodecyl chain serves as the greasy tail. This feature 
makes 1 prefer the surface of the lipid instead of its hydrophobic core and stay on 
membrane surfaces. At pH 7, calcein forms a tautomer that contains a ketone, which 
provides a handle for functionalization. Despite previous studies that have synthesized 
both the ketone and oxyamine derivatives of fluorescein, we reasoned we could directly 
couple hydrazines and oxyamines to this ketone. Additionally, this molecule is simple to 
synthesize requiring only one step to generate 1 from inexpensive starting materials. In 
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order to functionalize the cell surface with a cell surface receptor, we wanted to combine 
a cell labeling methodology with oxyamine/ketone chemistry to gain access to a 
chemoselective bio-orthogonal reaction strategy, thereby creating a fluorescent cell 
surface receptor. To functionalize the cell surface and introduce the fluorescent cell 
surface receptor, liposome fusion was used. Positively charge liposomes have been 
shown to fuse non-specifically to cells surfaces. In previous studies, these liposomes were 
doped to contain synthetic fluorescent lipids to label cell surfaces and mark certain 
populations in cell culture.19 For our studies, POPC 2 served as the background lipid, 
DOTAP 3 served as the cationic lipid used to initiate cell surface fusion, and we mixed in 
a fluorescent lipid containing a ketone. For the immobilization strategy, oxime and 
hydrazone formation from a ketone was chosen. These chemistries offer several 
significant advantages as an immobilization strategy. They are bio-orthoganol, take place 
in the presence of cells, they do not require catalyst, they can be exchanged in the 
precence of other oxyamines and hydrazines, and synthesizing oxyamines and hydrazides 
is relatively simple.20 To create the cell surface reporter/receptor, we leveraged 
oxyamine/hydrazine exchange reaction. Many groups have harnessed the ability for an 
oxyamine to exchange for another for enzymatic labeling and small molecule library 
synthesis. For our studies, the initial ligand was dabcyl hydrazide, 4, a broad-spectrum 
fluorescent quencher. Here, we coupled the hydrazide derivative to the calcein dye to 
synthesize calcein derivative 5. With the dabcyl coupled to the calcein, the fluorescence 
was effectively quenched. However, when another oxyamine or hydrazide ligand was 
exchanged for the dabcyl hydrazide on the cell surface, the fluorescence was recovered, 
thereby providing signal that the ligand of interest had bound the receptor on the cell 
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surface. Before undertaking liposome studies, we synthesized both 1 and 5 in solution 
and were able to exchange the dabcyl hydrazide from 5. We verified this with NMR and 
mass spectrometry.  
6.3.2 Fluorimetry Studies  
After the solution studies, flouremetry was used to monitor both the quenching and 
exchange reactions on the liposomes. Liposomes were made starting with 2.7 mM of 
DOTAP and POPC and 0.3 mM of 1 dissolved in chloroform. Following literature 
procedure, the liposomes were synthesized and size selected for a distribution of 60-100 
nm, which was verified by TEM. After the liposomes were made, they were diluted 1:10 
into 2 mL of pH 7 phosphate buffer, and a fluorescent scan from 500 – 600 nm with 
excitation at 495 nm was made. The scan showed the presence of the calcein derivative in 
the liposome. To monitor the quenching reaction, dabcyl hydrazide was saturated into the 
solution and the fluorescence was monitored at 520 nm with 495 nm excitation over 12h. 
Before the addition of dabcyl hydrazide, the liposomes were highly fluorescent with a 
peak at 525 nm. However, as 4 reacted with the calcein on the liposome surface, the 
fluorescence decreased and was fully quenched after 10h. After the quenching reaction, a 
scan was made from 500-600 nm with an excitation at 495 nm, and it was observed the 
fluorescence was reduced by a factor of 5. To measure recovery, liposomes were 
synthesized using 2.7 mM of DOTAP and POPC and 0.3 mM of 5. A scan of these 
liposomes showed they were similar in fluorescence to the liposomes quenched by 
reaction. These quenched liposomes were then diluted 1:10 into 2 mL of pH 7 phosphate 
buffer and 50 mg of methyloxyamine was added. To monitor the exchange reaction, the 
fluorescence was measured at 525 nm with 495 nm excitation over 12h. As the exchange 
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took place and the dabcyl hydrazide was removed from the molecule, fluorescence was 
recovered leading to an increase in signal. The exchange reaction took 12h to fully 
recover and after the exchange reaction had gone to completion, another scan with the 
same parameters as before showed the fluorescence had fully recovered and was 
comparable to the fluorescence before the quenched reaction.    
 
Figure 6.1 Design and Characterization of Cell Surface Fluorescent Receptor/Reportor 
system. A) List of molecules used in this study. B) Fluorescent liposomes were 
synthesized by sonication containing 1. C) These fluorescent liposomes were quenched 
via a chemoselective and bio-orthogonal reaction with dabcyl hydrazide. D) The 
fluorescence was recovered by oxyamine exchange in the cell dye. E) Graph of 
fluorescent intensity vs. wavelength. Both the recovered and initial fluorescent liposomes 
were highly fluorescent. However, once reacted with the dabcyl hydrazide, a efficient 
quencher, the fluorescence from the liposomes was significantly reduced. F) Graph of 
fluorescent intensity vs. time for the liposome quenching reaction measured at 525 nm 
with 495 nm excitation. G) Graph of fluorescent intensity vs. time for the fluorescent 
recovery reaction measured at 525 nm with 495 nm excitation. 
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6.3.3 Flow Cytometry and Cell Viability 
Once the solution and liposome studies were successful, we moved onto 
integrating this methodology with cells. Liposomes containing 1,2,3 were synthesized 
and fused with fibroblasts for 4h. The cells were allowed to culture for 1, 4, and 6d and 
their fluorescence was measured by FACS analysis. FACS analysis allowed for the cell 
fluorescence to be measured. As a control, liposomes were not fused to a certain cell 
population. Compared to the control, there was a large increase in fluorescence after 
fluorescent liposome fusion. As the cells were allowed to grow in the cell culture, the 
fluorescence decreased over time, most likely due to the dilution and degradation of the 
lipids. These results verified the introduction of fluorescence to the cells. Next, the 
quench and recover was verified on the cell surface. Liposomes were synthesized using 
5,3,2 and then fused to cell surfaces as before. Once the liposomes were fused to the 
surface, FACS analysis demonstrated similar fluorescence to the control. To verify the 
fluorescence recovery on the cell surface, the cell media was exchanged for media that 
had 1 mg/mL of methyloxyamine. The cells were allowed to culture for 12h and then the 
media was exchanged again. These cells were allowed to grow for 1, 4, and 6d and then 
analyzed by FACS. The fluorescence intensity matches that of the cells containing 1 
demonstrating recovery of the fluorescence after the oxyamine exchange reaction on the 
cell surface. Next, the viability of fibroblasts was verified with the trypan blue assay. 
Cells were fused with both fluorescent and quenched liposomes and their viability was 
measured after 1, 3 and 5 d. The cells were found to be >90% viable and were 
comparable to control cell populations not fused with the liposomes.  
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6.3.4 Fluorescence Recovery by Cell Surface Exchange Reaction 
After the cell fluorescence and viability were verified, the fluorescent recovery on 
the cell surface was verified with fluorescence microscopy. Fibroblasts were fused with 
quenched lipids. Fluorescent microscopy revealed the cells had no appreciable 
fluorescence. After this, 1 mg/mL of methyl oxyamine was added to the media. The cells 
were imaged after 6h and cells were becoming fluorescent. After 12h, the cells were fully 
fluorescent and were comparable with cells fused with non-quenched lipids. This data 
demonstrates the ability of the exchange reaction to take place on the cell surface even in 
the presence of other cells without harming cell viability. No recovery was observed 
without an oxyamine-terminated ligand or in the presence of an amine one. 
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Figure 6.2. Cell viability and fluorescent recovery. A) Lipsomes containing 1 were fused 
to fibroblast surfaces resulting in fluorescent labeling of the cell surface. B) Bar graph of 
the fluorescence intensity of the cells vs. time determine by FACS. No liposomes were 
fused to the control. C) FACS analysis of the cells showed an increase in fluorescence vs. 
the control, which decreased over time as the lipids were diluted by cell division. No 
liposomes were fused to the control D) Quenched Liposomes were fused to fibroblast 
surfaces to study fluorescent recovery by oxyamine exchange. After the quenched 
liposomes were fused to the cell surface, an oxyamine was added to the cell media and as 
the oxyamine exchanged the dabcyl , the fuorescence was recovered. E) Cell viability 
studies of cell fused with liposomes, both fluorescent and quenched. Cells were found to 
be >90% viable using the trypan blue assay. F) FACS analysis after the cells had 
recovered their fluorescence after 1,4, and 6d. As control, cells were fused with 
liposomes and cells were fed quenched liposomes, but no oxyamine exchange reaction 
took place. G) A series of fluorescent images taken after methyloxymine was added to 
the cell media. After 12h of oxyamine exchange, the cells were fluorescent.  
 
 
 Figure 6.3 Cell surface ligand immobilization and  protein surface functionalization. A) 
Cells were fused with quenched liposomes and biotin hydrazide was added to the media 
to exchange the dabcyl and functionalize the cell surface with biotin. Then, TRITC 
labeled streptavidin was immobilized to the biotin on the cell surface. B) Fluorescent 
Micrograph of the cells fused with the quenched liposomes. C) Fluorescence recovery 
12h after media containing 1 mg/mL of biotin hydrazide was added to the cells to label 
cell surfaces with biotin. D) Biotin presenting cells after 4h of exposure to media 
containing 1 mg/mL of TRITC labeled streptavidin. The streptavidin had bound the cell 
surface and made them fluoresce red. 
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6.3.5 Cell-Surface Receptor 
      Once the cell compatibility and cell surface exchange reaction were verified, we 
wanted to demonstrate the ability to modify the cell surface with proteins using the 
ligands introduced to the cell surface. For these experiments, we chose the biotin 
streptavidin complex. Biotin-streptavidin has one of the highest affinities in nature and 
has been used to modify a variety of materials. After quenched liposomes containing 5 
were fused to cells, the cell media was exchanged to contain 1 mg/mL of biotin 
hydrazide. After 12h, the cells were imaged and observed to be fluorescent, signifying the 
exchange reaction has taken place on the surface. Next, the media was changed to 1 
mg/mL of TRITC streptavidin and allowed to react with the surface for 4h. The TRITC 
streptavidin recognized and bound the biotin on the cell surface and the cells became 
fluorescently red, demonstrating streptavidin binding to the cell surface. As controls, the 
cells did not become fluorescent when biotin was added to the media instead of biotin 
hydrazide and TRITC streptavidin did not bind the cells when methyloxyamine was 
present instead of biotin hydrazide.  
6.3.6 3D Cellular Assembly  
      For the final experiment, the cell surface receptors were used to create cell 
assemblies. Quenched liposomes containing 5 were fused to the cell surface using the 
same procedure as above. Then, the tripeptide RGD was reacted to the cell surface. RGD 
is a tripeptide that has been shown to act as an epitope for fibronectin. It activates the 
integrin receptors on the cell surface that mediate cell adhesion to the extracellular 
matrix. A second cell population was added to the first and recognized the RGD ligand 
on the cell surface and bound to it, leading to the formation of cell assemblies. As a 
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control, the cell surfaces were reacted with the scrambled peptide DRG instead of RGD 
and the cell became fluorescent, but did not form cell assemblies. Once fed RGD, the 
cells became fluorescent and formed tissue-like structures demonstrating the ability of 
these cell receptors to occur in the presence of cells. A timecourse showed an increase in 
the diameter of the assemblies. Additionally, it was observed not all the cell are 
fluorescent demonstrating the ability of the methodology to not only modify the cell 
surface, but mark which cells have been modified with a cell ligand. The largest structure 
formed was several hundred microns wide and contained multiple layers of cells 
demonstrating the ability of this methodology to generate large 3D structure from simple 
materials. 
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Figure 6.4 Formation of cell assemblies by cell surface engineering. A) Cells were fed 
quenched liposomes. These cells were reacted with RGD oxyamine to both recover the 
fluorescence and generate RGD presenting cells. These cells were mixed with another 
population of cells bound and recognized these RGD presenting cells forming cell 
assemblies. B) Brightfield image of fibroblasts fed quenched liposomes then reacted with 
a scrambled oxyamine peptide. C) Fluorescent micrograph of the same cells 
demonstrating the fluorescence had been recovered, but no assemblies formed due to the 
lack of a bio specific interaction. D) Overlay of both brightfield and fluorescent images 
of cells fed quenched liposomes then reacted with RGD and mixed with another 
population of non-labeled cells. Cells were allowed 1h to form in solution. The same 
experiment repeated for E) 2h, F) 4h, and G) 8h. The cell clusters grew in size and the 
RGD cells are marked by their fluorescence. 
 
6.4 Conclusions  
In conclusion, we have developed a general methodology based on simple chemistry to 
modify cell surfaces with a fluorescent molecule capable of not only marking cells, but 
fluoresces when a molecule binds the surface. The cell surfaces were modified with 
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liposomes driven by positively charged lipids. Both the quenching and exchange 
reactions were studied on the liposomes using fluoremetry and took place in about 12h. 
The liposomes were then characterized on the cells. Cell viability and FACS 
demonstrated the cells remained viable after fusion and were fluorescent. Additionally, 
the dabcyl could be exchanged on the cell surface to recover the fluorescence. Next, the 
availability of the ligand was verified using biotin hydrazide-TRITC-streptavidin. 
Finally, cell assemblies were synthesized using RGD ligand. However, the method is 
general. These quenched fluorescent pairs are simple to synthesize in solution and there 
are more than 20 dyes with similar structures that could be applied to. In future, we hope 
to study other quenched and two color FRET pairs.  
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CHAPETER 7 
 
General Conclusions and Future Directions 
 
7.1 General Conclusions 
 
       This dissertation focused on the use of chemoselective liposome fusion as a tool for 
engineering cell-surface and it’s further application in tissue engineering. Chapter II 
discussed the development of a general method to pattern electroactive and 
chemoselective fluid lipid bilayers on gold surfaces for a range of biospecific ligand-
receptor interaction studies on model membranes. In this study, a variety of oxyamine-
tethered ligands (fluorescent dye, sugar) were successfully immobilized in arrays using 
microfluidic lithography. This platform is rapid and flexible and can be extended to many 
areas in biochemistry, cell biology and material science to study fundamental membrane 
activity and enzymology. 
   Chapter III described the development of a chemoselective synthetic cell receptor 
system based on liposome delivery and fusion strategy. Ketone and oxyamine groups 
were introduced to a liposomal system and chemoselective vesicle fusion was achieved 
using molecular recognition and interfacial oxime bond formation. Subsequent delivery 
of the decorated liposomes to cells lead to fusion and modification of a cell surface by 
bio-orthogonal reactive groups that serve as synthetic chemoselective cell receptors. 
Ketone and oxyamine modified cells were patterned on solid surfaces, displaying 
oxyamine and ketone groups respectively. 
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   Chapter IV focused on the application of the liposome delivery and fusion strategy to 
generate 3D spheroid cellular assembly with controlled interconnectivity and patterned  
multi-layered tissue like structures. Furthermore, 3D multi-layered stem cell and 
fibroblast (fb) co-cultures were generated, and differentiation was induced to form tissue-
like structures of adipocytes and fbs.  
    Chapter V described the development of a new general and straightforward 
liposome fusion based methodology to deliver dynamic and switchable bio-orthogonal 
chemistries to tailor cell membranes and direct the formation of 3D co-culture tissue 
structures. We demonstrated and extensively characterized the conjugation and release of 
molecules to and from cell surfaces in situ, as well as the triggered assembly and 
disassembly of 3D spheroid and multi-layered tissues. Additionally, dynamic co-cultures 
of hMSCs and Fbs were able to be generated and differentiated with this redox oxime 
strategy.    
Chapetr VI described the development of a general methodology based on simple 
chemistry to modify cell surfaces with a fluorescent molecule capable of not only 
marking cells, but fluoresces when a molecule binds the surface. The cell surfaces were 
modified with liposomes driven by positively charged lipids. Both the quenching and 
exchange reactions were studied on the liposomes using fluoremetry and took place in 
about 12h. The liposomes were then characterized on the cells. Cell viability and FACS 
demonstrated the cells remained viable after fusion and were fluorescent. Additionally, 
the dabcyl could be exchanged on the cell surface to recover the fluorescence. Next, the 
availability of the ligand was verified using biotin hydrazide-TRITC-streptavidin. 
Finally, cell assemblies were synthesized using RGD ligand. 
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7.2 Future Directions 
     As discussed in the dissertation cell-surface engineering has a prominent role to play 
in the field of tissue engineering and other biomedical applications. In future I plan to 
extend the liposome fusion strategy to deliver bioorthogonal chemoslective functional 
groups to other biologically and medically important cell lines. Specifically I want to 
couple microfabrication and other surface chemistry tool with the liposome delivery 
method with study the spatial aspects of T cell costimulation in a three dimensional 
environment1. It is increasingly clear that the spatial organization of CD28 and TCR 
signaling influences the activation of CD4 T cell activation2. Efforts have been there to 
develop patterning techniques to identify the molecular mechanisms that allow T cells to 
read these patterns. My future goals will be to make these surfaces dynamic and 
chemically active which will lead to the better understanding of the kinetics of T cell 
signaling. 
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